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Summary 
Ligament and tendon injuries often occur in human joints during sports and trauma. 
Disadvantages such as donor site morbidity (autograft), disease transmission (allograft) 
associated with present therapies have stimulated research on tissue engineering 
strategy. In this strategy, cell seeding technique, scaffold and mechanical stimulus are 
essential factors for the success of ligament and tendon tissue engineering. 
This dissertation describes a method to fabricate fibroblast cell sheet and assemble it 
on a knitted scaffold for engineering ligament/tendon analogs. Firstly, the cell sheet 
formation process was characterized and showed that fibroblast cell sheet comprised 
multilayer of fibroblasts with major type I and small amount of type III collagen in 
ECM as evident by immunohistochemical and histology evaluation. With an increase 
in ascorbic acid or FBS concentration, fibroblasts were more active as shown in higher 
cell viability, total collagen content as well as transcript levels of type I and type III 
collagen expression. 
Once a sheet of fibroblast was obtained, it was assembled onto knitted scaffolds by 
wrapping technique. The composite of cell sheet/scaffold constructs had transformed 
into tissue-like analogs. Immunohistochemical analysis showed that the components of 
the analogs were similar to that of ligament/tendon tissue, consisting primarily of type 
I collagen and small amount of type III collagen and tenascin-C. In comparison with 
knitted PLLA and knitted silk scaffold, the cellular metabolism was more active on 
silk sponge modified knitted silk scaffolds as shown in cell viability, collagen content 
and RT-PCR analysis for ligament/tendon related gene markers (e.g., type I and type 
III collagen and tenascin-C). As the silk sponge cover the macropores and holds the 
silk fibers together, silk sponge enhanced the structural strength of cell sheet/scaffold 
hybrid when compared with cell sheet on knitted PLLA and knitted silk scaffold. 
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When tissue analog was cultured in bioreactor, the cyclic strain promoted cell 
proliferation and matrix protein expression as indicated by cell viability, collagen 
content, immunohistochemical and RT-PCR analysis. Moreover, fibroblasts showed 
higher degree of alignment after 20 days of bioreactor culture. Cyclic loading 
increased mechanical strength and reduced tensile stiffness of the tissue analogs. 
Moreover, the microporous structure of silk sponge enhance cell  when exposed to 
cyclic loading as there were more cell anchor points sending mechanotransduction 
signals to fibroblast through cell surface receptors. 
In conclusion, compared to FBS, ascorbic acid is more essential in cell sheet formation 
process and 15% FBS with 100µg/ml ascorbic acid is optimized culture condition to 
culture fibroblast cell sheet. Furthermore, the approach of assembling fibroblast cell 
sheet onto silk sponge modified knitted silk scaffold is promising to enhance fibroblast 
cell sheet and produce tissue-like and functional ligament/tendon analogs. Tissue 
analogs culture under cyclic loading condition efficiently enhances cell function for the 
purpose of ligament/tendon reconstruction. 
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Chapter 1. Introduction 
Ligaments and tendons are soft tissues which connect bones to bones and muscles to 
bones, and stabilize human joints. Ligament and tendon injuries often occur in human 
joints during sports and trauma. There are several forms of ligament and tendon 
injuries: complete tear, partial tear, stretch injury. Rupture and other injuries to 
ligaments and tendons can cause great pain, decrease the functionality of the joint 
complex and eventually lead to degenerative joint diseases (Braden et al. 2005). Over 
200,000 people seek medical attention each year in United States for injuries to 
ligaments and tendons. However, natural healing of ligament and tendon injuries is 
insufficient due to limited healing capacity of these tissues (Doroski et al. 2007). 
Although certain ligament and tendon injuries can be repaired by suturing the injured 
tissue together, some heal poorly in response to this therapeutic approach. Therefore, 
surgical grafts are needed for ligament and tendon reconstruction surgery. Current 
therapeutic options include autografts, allografts and prosthetic devices. Autografts 
have produced the most satisfactory long-term results and are referred to as the “gold 
standard” (Polu et al. 1999). However, donor site morbidity remains the limiting factor 
for autografts. Allografts result in immunological foreign body reaction and risk in 
disease transmission (Noyes et al. 1984; Jackson et al. 1993). The synthetic grafts 
failed due to wear debris, mechanical limitations as well as poor tissue ingrowths 
(Vunjak-Novakovic et al. 2004). 
Disadvantages in current therapeutic grafts have encouraged the research on tissue 
engineering approach. In tissue engineering approach, the basic principle is to 
construct cell-scaffold composites (Langer et al. 1993). This approach generally 
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involves the presence of reparative cells, a structural template, facilitated transports of 
nutrients and metabolites, and a provision of molecular and mechanical regulatory 
factors. Cells, scaffolds templates and biochemical/biomechanical signals can be 
utilized in various ways to engineer tissue in vitro and/or in vivo in order to mimic 
some aspects of the in vivo environment during normal tissue development (Sipe 2002). 
For clinically relevant tissue engineering analogs usually involves the use of 
autologous cells (less immunological response), biodegradable scaffolds (temporary 
structure for tissue development), and bioreactors (designed to control cell culture 
environment) (Vunjak-Novakovic et al. 2004). 
Scaffold structure, mechanical properties, and degradation rate largely determine mass 
transport and mechanotransduction at cellular level. For tissue engineering of load-
bearing tissues, mechanical properties of the scaffold are important factors in scaffold 
design. Mechanical properties of the scaffold should be similar to natural tissue and 
degrade gradually during the new tissue formation process until the new tissue is 
eventually mechanically competent. 
Tissue engineering bioreactors are generally designed to control cell culture 
environment by direct enhanced effect and by enhancing mass transfer. Regulation of 
biochemical and biomechanical signals which are normally present in natural tissues is 
essential for proper development of functional tissue properties. 
As ligament and tendons serve a predominant mechanical function, it is important to 
optimize biocompatible scaffolds for provision mechanical competent structure, and 
bioreactor system to utilize biomechanical signals to direct cellular activity and 
phenotype in vitro in order to obtain functionally tissue-engineered ligament and 
tendon analogs which can be implanted into human body and replace the damaged 
tissues. Approaches to select cell seeding method, design of three-dimension scaffold 
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and regulation of biomechanical factors using bioreactor system will be discussed in 
greater depth in the rest sections of this chapter. This chapter will end with the 
objectives and significances of this thesis. 
1.1 Introduction to Ligament and Tendon 
Tendons and ligaments are typically described as soft connective tissues composed of 
closely packed, parallel collagen fiber bundles that attach muscle to bones, and bones 
to bones, respectively. Due to their high tensile strength, the function of ligaments is to 
maintain the stability of the joints in the musculoskeletal system and tendons serve to 
transmit tensile loads between muscles and bones (Figure 1.1). In this section, 
ligament and tendon anatomy and mechanical properties of ligament and tendon will 
be introduced. 
 
Figure 1.1 (a) Tendons of the foot; (b) Ligaments of the knee joints 
1.1.1 Anatomy of Ligaments and Tendons 
Ligaments and tendons are comprised of a cellular component and an extracellular 
matrix (ECM) component. Tendons and ligaments contain a variety of cell types, 
(a) (b) 
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including fibroblasts, fibrocartilage cells and, occasional, fat cells. Fibroblasts are the 
most common and can be found in all regions of tendons and ligaments. They are 
typically arranged in elongate rows within the parallel bundles of collagen fibers with 
rod or spindle-shaped fibroblasts (Lin et al. 2004). However, while the fibroblasts do 
not occupy a large volume of ligament/tendon tissues; the cells are responsible for 
secreting and maintaining the ECM component within the tissue. Relatively low cell 
population along with their low mitotic activity, may be the reason why tendons and 
ligaments seem to possess a poor healing capacity (Louie et al. 1998). 
 
Figure 1.2 Schematic diagram of the structural hierarchy of tendon (Kastelic et al. 
1978) 
 
Tendons are complex composite materials, composed primarily of water (55% of wet 
weight), proteoglycans (<1% of wet weight), cells and type I collagen (38% of wet 
weight), along with much smaller amounts of other collagens, such as collagens type 
III, V, XII and XVI. The predominant proteoglycan in tendon is decorin. The primary 
structure in the structural hierarchy of tendons is collagen polypeptides which are 
characterized by the presence of glycine at every third amino acid. Three collagen 
polypeptides can wind into a triple helical collagen molecule. Collagen polypeptides 
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could form larger collagen molecules such as collagen monomers by cleavage of N- 
and C-terminal. Collagen monomers are further assembled into fibrils, which are 
grouped in fibers. The bundles of collagen fibers along with fibroblasts are grouped 
into fascicles (Figure 1.2). Adult human tendons have a bimodal distribution of 
collagen fibril diameters. The mean diameters are between 60 and 175nm (Dyer et al. 
1976; Goh et al. 2003). 
Ligaments are morphologically and microscopically similar to tendons (Figure 1.3). 
However, there are biochemical differences between the two. When compared with 
tendons, ligaments are more metabolically active in other word. They have more cells, 
a higher DNA content and greater amount of reducible crosslink between collagen 
fibers.  Water contributes 60% or more of the wet weight of ligaments. A significant 
part of this water is associated with the ground substance which refers to the portion of 
the matrix consisting of proteoglycans. This part of water plays crucial role in 
providing lubrication and spacing to the gliding function at the intercept point where 
fibers cross in the tissue matrices. Four classes of matrix macromolecules (collagens, 
proteoglycans, elastin, and glycoproteins) contribute approximately 40% of the wet 
weight of ligaments. Ligaments contain predominantly type I and III collagens. Type I 
collagen comprises approximately 90% of the collagen in ligaments whereas type III 
collagen accounts for approximately 10%. Similarly, there is a bimodal distribution of 
collagen fibril diameters in ligaments, the majority of which are 40 to 75 nm in 
diameter, with a small number of fibrils are between 100 and 150 nm in diameter 
(Amiel et al. 1984; Amiel et al. 1990; Goh et al. 2003). Elastin only comprises less 
than 5% of the wet weight of ligaments. When exposed to mechanical loading, elastin 
will change from a random coiled structure to a more ordered configuration. This 
organization change contributes a small part of the tensile resistance in ligament and 
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helps restore the crimp pattern of the collagen fibrils after deformation (Buckwalter et 
al. 1987). Ligaments contain two classes of proteoglycans: articular cartilage type 
proteoglycans and smaller proteoglycans that contain dermatan sulfate. The articular 
cartilage type proteoglycans maintain water in the tissue and alter fluid flow during 
loading. Small dermatan sulfate proteoglycans (mainly decorin and biglycan) usually 
lie on the surface of collagen fibrils and affect the formation, organization of the 
collagen fibrils (Buckwalter et al. 1987). 
 
Figure 1.3 Schematic diagram of the structural hierarchy of ligament (Viidik 1973) 
Although many aspects of the biology of tendons and ligaments have been known for a 
long time, some basic aspects of tendons and ligaments, such as the process by which 
the tissue develops, has not been fully understood. It is known that development of the 
skeleton involves a stepwise set of processes, which includes the migration of cells to 
the site of future skeletogenesis, tissue interaction, cell condensation, and 
differentiation. Tendons and ligaments develop in a similar way, which is, from the 
same initial population of mesodermal cells as the skeleton, ECM molecules, such as 
tenascin, fibronectin and syndecan, initiate condensation formation and set the 
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condensation boundary. They develop under the influence of a complex network of 
signals and cell interactions. Hox genes modulate cell proliferation and adhesion 
within condensations (Brian K. Hall 2000). Bone morphogenetic proteins (BMPs) and 
fibroblast growth factor (FGF) regulate cell growth. The condensation phase ceases 
when Noggin initiates the differentiation phase. With specific reference to tendons and 
ligaments, growth factors such as growth and differentiation factors (GDFs 5, 6, and 7) 
are involved in positional signaling and can also induce ectopic tendon and ligament 
formation (Macias et al. 1997; Wolfman et al. 1997). As for fibrillogenesis, it has been 
shown that the typical rowlike orientation of ligament cells precedes fibrillogenesis 
and that it is the arrangement of these cells that determines the organization of collagen 
bundles. Collagen fibrils first appear as incomplete fibril segments that are much 
shorter than in adult tendon (Birk 1995; Birk et al. 1997). They subsequently fuse 
together in the ECM during a short time interval in development (Birk 1995; Goh et al. 
2003). Some researcher suggested that the fusion of fibril segments occurs by lateral 
association and in controlled by molecular interactions in the ECM that are modulated 
by the tendon fibroblasts (Birk et al. 1997). 
1.1.2 Mechanical Properties of Ligaments and Tendons 
Ligaments and tendons are three-dimensional anisotropic structures (Figure 1.4) 
(Quapp et al. 1998). Ligaments and tendons are suited to transfer load from bone to 
bone, or muscle to bone along longitudinal direction. Thus their properties are 
commonly studied via a uniaxial tensile test of a bone-ligament-bone complex or 
muscle-tendon-bone grafts (Woo et al. 2000). Tendon and ligaments transmit load with 
minimal energy loss and deformation. But they are not entirely nonextendable and 
directly transfer the length change or force of a contracting muscle to the bone. Typical 
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tensile stress-strain curves for ligaments and tendons are shown in Figure 1.5(a) and 
Figure 1.5(b) respectively. Tendon and ligaments are generally classified as 
viscoelastic materials. The nonlinear, linear tensile response of a human ligament and 
tendon has been characterized as consisting of four specific regions. With reference to 
the stress-strain curve, the initial concave portion of the curve has been termed the 
“toe” region (i.e. Figure 1.5(b) region I). This toe portion of the curve is the result of 
the waviness of ligaments and tendons fiber bundle straightening out. Following the 
toe region, ligaments and tendons show a relatively linear response to stress (i.e. 
Figure 1.5(b) region II). The fibers of ligaments and tendons become more parallel and 
have lost their crimped appearance. The slope of the curve in this region is often 
referred to as the elastic modulus, or Young’s modulus of elasticity. Microfailure of 
fibers occurs at the end of this linear region. Beyond the linear region (i.e. Figure 
1.5(b), region III), more fiber failures occur in an unpredictable fashion. In this region, 
collagen fibers in ligaments and tendons slide past one another as collagen crosslinks 
fail (O'Brien 1992). In the fourth portion of the curve (i.e. Figure 1.5(b), region IV), 
macroscopic failure occurs because of the tensile failure of the fibers and shear failure 
between fibers. Once maximum load is reached, complete ligament and tendon rapture 
occurs rapidly. Furthermore, the fibers recoil and entangle at the rupture end (Jozsa et 
al. 1997). Besides the stress-strain response, tendon and ligament also undergoes 
stress-relaxation, creep, and a hysteretic loop. The estimated range for the normal 
physiological loading of ligaments and tendons encompasses both the nonlinear “toe” 
and a portion of the linear region (Noyes et al. 1984). 
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Figure 1.4 Stress-strain curves of human MCLs along and transverse to the collagen 
fiber direction (Quapp et al. 1998) 
 
 
Figure 1.5 (a) Schematic stress-strain curve of ligament (Woo et al. 1999) (b) Tensile 
stress-strain curve for tendon (Goh et al. 2003) 
1.1.3 Ligaments and Tendon Injury and Healing 
Ligament and tendon injuries are generally considered to be acute or chronic. There 
are three main mechanisms of ligament and tendon injury: laceration, contusion and 
tensile overload. Tensile overload may result in midsubstance tears, tears at the 
musculotendinous junction, avulsion from bone, or avulsion fracture of the bone at the 
insertion site (Bluman et al. 2005). Furthermore, overuse injuries of ligament and 
(a)  (b)
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tendons is the main form of occupational injuries as well as in all sports injuries. 
Overuse injuries imply that ligaments and tendons have been strained repeatedly the 
extent that microfailure occurs (Figure 1.6). In this situation, ligament and tendon 
tissue are unable to heal as their basal healing ability is overwhelmed by repetitive 
microtrauma (Jozsa et al. 1997). Other tensile overload induced ligament and tendon 
injuries include high and rapid impact sustained by soft-tissue structure (Yeow et al. 
2008). This type of injury occurs when to a ligament or tendon is moved into a 
position for which it is not designed or the load on the ligament and tendon exceed the 
maximum capacity of the ligament and tendon. 
 
Figure 1.6 Schematic presentation of tendon and ligament overuse injury (Jozsa et al. 
1997) 
When a ligament or tendon is injured, the body initiates a process of healing and scar 
formation that can be divided into three overlapping phases. The phases of ligament 
and tendon healing include: inflammation phase, proliferation/fibroplasia phase and 
remodeling/maturation phase (Lin et al. 2004). The duration of the phases could vary 
greatly due to age, location of injury or even disease. Inflammation phase starts 
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immediately after ligament/tendon injury. It is marked by hematoma formation and 
this phase could last for a few weeks. During this phase, the inflammatory and 
macrophage cells phagocytize cell debris as well as destroyed tissue. Furthermore, 
fibroblasts start to migrate to the injury site. These are an increase in 
glycosaminoglycan, water and type III collagen content, which collectively stabilizes 
the newly formed ECM (Jozsa et al. 1997; Woo et al. 1999; Lin et al. 2004). In the 
proliferation phase fibroblasts proliferate and produce matrix proteins, especially type 
III collagen which bridges the torn ends. During this phase, the number of leukocytes 
and macrophages decrease slowly and fibroblast activity increases (Gelberman et al. 
1991; Jozsa et al. 1997). Early in this phase, the collagen synthesized by fibroblast is 
mainly type III collagen. However, type III collagen is replaced by type I collagen 
after 2 weeks of healing. Moreover, the fibroblasts become regularly arranged along 
the long axis of the ligament/tendon and the collagen synthesized by fibroblast form 
thin fibrils with time. But the newly-formed collagen fibrils form only loose irregular 
network which is not organized (Jozsa et al. 1997). This process could last for 6 weeks 
resulted in increasingly organized matrix, predominantly type I collagen (Woo et al. 
2006). Finally, in the remodeling phase, the number of fibroblast starts to decrease and 
the collagen fibers are aligned with increased collagen matrix maturation which could 
continue for years (Frank et al. 1983). Despite the similarity of healing process, 
ligaments and tendons show a different capacity to heal which is mainly due to 
intrinsic properties of the ligament and tendon as well as external factors such as 
location nutrition and environment (Woo et al. 1999). 
The healing process of ligament and tendon is slow and movement and exercise is of 
most importance in maximizing the healing. Stretching during the inflammatory phase 
should be minimized. Improper stress in this phase may disrupt the healing process 
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(Jozsa et al. 1997). After inflammatory phase, controlled stretching can result in 
acceleration of collagen synthesis, fibril formation as well as fibril alignment. 
Although the mechanical properties of the healing ligament and tendon improve over 
time and proper exercise could optimize the healing, ligaments and tendons do not 
reach the levels of normal tissue. In terms of viscoelastic properties, the viscous 
behavior of ligament and tendon increases after healing process (Woo et al. 2006), 
because in the healed ligament and tendon, there is a higher amount of proteoglycans, 
higher ratio of type V to type I collagen. As the results, there is an increase in the 
number of collagen fibrils with smaller diameters in the healed ligament or tendon 
(Frank et al. 1997). 
1.2 Current therapy for ligament and tendon injury 
The ideal graft for the ligament and tendon repair should have: (a) proper mechanical 
strength to withstand the forces during joint function, (b) minimal morbidity with no 
significant functional loss associated with harvesting the grafts and (c) no source of 
disease transmission and should be nonimmunogenic and nonmutagenic (Simon et al. 
1987). 
Mainly two options have been utilized for the replacement of damaged ligament and 
tendons using biological substitutes:  autografts and allografts. In addition, a variety of 
synthetic materials have been used for ligament and tendon replacements such as 
Dacron, Gore-Tex, polyesters and so on. In the following sections, advantages and 
disadvantages of each clinical option for ligament and tendon replacement will be 
discussed in details. 
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1.2.1 Biological Grafts 
As having the most satisfactory long-term results, autografts have been referred as the 
“good standard” for ligament and tendon replacement. Currently, autografts of patellar 
tendon, hamstring tendon and quadriceps tendons are commonly used tissues for 
anterior cruciate ligament repair (Table 1.1). Success of ligament grafts has been 
relying on the revascularization and remodeling of the transplanted grafts. Regardless 
of graft type, most methods drill tunnels in the femur and tibia for graft passage and 
fixation. 
Patella tendon autograft with bone plugs at each end is presently the most commonly 
used graft for ligament reconstruction surgery. The central 1/3 or lateral 1/3 of the 
patella tendon has been harvested with a piece of bone from the patella along with a 
piece of bone from the patella tendon insertion area into the tibia. This “bone-patellar 
tendon-bone” autograft is then channeled up through the tibia bone tunnel across the 
knee joint and into the femur tunnel. Then the bone plugs are fixed in the bone tunnel 
by screws. Popularity of “bone-patellar tendon-bone” among surgeons is related to its 
time-zero maximum load to failure strength (Noyes et al. 1984) and its bone-to-bone 
fixation capabilities. Usually bone attachment of the grafts heals in 6-8 weeks and the 
tensile strength of the graft is approximately 2950N to failure (Noyes et al. 1984). 
Another common used autograft for ACL reconstruction is hamstring tendon. 
Hamstring tendon graft can be used as single strand, or doubled or even quadrupled 
folded (Maeda et al. 1996; Michael P. Wallace 1997). Compared with patellar graft, 
hamstring tendon grafts could be folded and provide a multi-bundle replacement that 
better approximates the anatomy and the function of normal ACL (Fu et al. 2000). The 
disadvantage associated with this method is mainly the healing response between soft 
tissue and bone and bone tunnel enlargement due to micro-motion of the graft. 
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For all autografts, the key limitation is donor site morbidity. When using patellar grafts, 
complications such as patellar fracture, ligament rupture, osteoarthrosis and 
biomechanical alternations have all been reported (Bonamo et al. 1984; Langan et al. 
1987; Burks et al. 1990; Jackson et al. 1990; Robers et al. 1990). Furhtermore, 
hamstring tendon regeneration is another concern when using hamstring tendon grafts 
(Nikolaou et al. 2007). Other considerations include the limited amount of tendon 
available for harvesting. 
During the past decades, the interest of using allografts for ligament and tendon 
reconstruction has increased significantly as there is no donor site morbidity (Table 
1.1). Furthermore, it allows the harvesting of larger and more varied grafts material. As 
in ACL reconstruction, allograft tissue have include: (a) patellar graft, (b) iliotibial 
band, (c) Achilles tendon, (d) semitendinosus and gracilis tendons, and (e) ACL (Shino 
et al. 1986). Moreover, the surgical time is faster due to no harvest procedure needed. 
However, the major concern of using allografts is the risk of disease transmission 
bacterial infection and immunogenic response. Biological and biomechanical change 
during sterilization process should also be taken in account (Shelton et al. 1998). 
As both types of biological grafts are limited, researchers have been looking for 





Table 1.1 Biological grafts for ligament reconstruction surgery 
 Advantages Disadvantages 
Autografts:   






(Bonamo et al. 1984; Langan et al. 1987; Burks et al. 1990) 
Hamstring Tendon Provide a multi-bundle replacement (Fu et al. 2000) 
Limited availability; 
Healing between soft tissue and bone; 
Hamstring tendon regeneration; 
Bone tunnel enlargement. 
(Nikolaou et al. 2007) 




Sterilization caused biological and biomechanical change; 
Limited availability. 
(Shelton et al. 1998) 
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1.2.2 Artificial Grafts 
Artificial ligament is appealing because it could avoid all the drawbacks in auto- and 
allografts. Artificial ligaments are readily available; their design could ensure great 
strength and proper fixation without slipping under cyclic loading. Moreover, these 
devices would not cause defect pathology. However, the overriding considerations of 
these devices are their biocompatibility and durability (Table 1.2). 
In 1914, silk sutures was used as ligament and tendon reconstruction materials (Henze 
et al. 1914). Polyethylene rod implant was used as ACL reconstruction devices. The 
polyethylene grade used for artificial joints is ultra-high molecular weight 
polyethylene. Although polyethylene is inert and resistant to in vivo hydrolytic 
degradation, this polyethylene implant failed mainly due to fatigue from repetitive 
bending and torsion of the rod at the entrance to the femoral tunnel and was also 
weaker than natural ACL tissue (Chen et al. 1980). Another inert material such as 
polypropylene and nylon were used for ligament reconstruction (Meyers et al. 1979). 
However, although these materials can support tissue integration, they lose tensile 
strength (Leininger et al. 1964) or creep excessively (Mendenhall et al. 1987) in vivo. 
Thus these implants have consequently faded from use. Carbon fibers tows were also 
used as ligament substitute due to their bio-inert properties. However, carbon fibers 
tows often disintegrated after implantation and left large amount of debris which led to 
strong foreign body reaction (Amis et al. 1988). Moreover, extreme brittleness of 
carbon fibers was a handicap in fabrication and operation, which limited usage of 
carbon fibers in ligament and tendon substitutes. 
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Expanded polytetrafluoroethylene (ePTFE), also known as Gore-Tex®, was also used 
to make ligament and tendon substitutes. Gore-Tex artificial ligament had a plaited 
structure and had eyelet at both end for screw fixation in knee joints (Bolton et al. 
1985). Although short-term (2 years) follow-ups were good, 5-year results showed an 
increasing number of failures and other joint discomfort (Paulos et al. 1992). That was 
mainly due to bending fatigue of ePTFE fiber as large diameter fibers was used to 
ensure the overall strength of the prosthesis and the inra-articular abrasion when the 
knee flexed and the tibia rotated. 
One of the polyesters, polyethylene terephthalate, also known as Dacron has also been 
used for tendon and ligament prosthesis. Dacron tendon reconstruction was based on a 
Dacron cord as central load-carrying core with a silicone rubber outer layer to provide 
smooth gliding within surrounding tissue and fixed by suturing or screws. Moreover, 
Dacron implants were modified with porous structured ends to trigger tissue ingrowth 
for better anchorage (King et al. 1975). Furthermore, the Stryker-Meadox implant with 
Dacron velour tube that contains dense Dacron tapes was developed to trap tissue 
ingrowth. Leeds-Keio which consists of a porous woven tube of PTFE and polyester 
also depended on tissue ingrowth to become a collagen-polyester composite structure. 
However, the tissue ingrowth of those implants could not consider as neo-ligament or 
neo-tendon but just tissue response of debris from the implants which led to weaker 
implants with time (Keen et al. 1999). 
Another major concern for all the artificial graft mentioned above is stress shielding 
which is mainly due to lack of tissue remodeling process of host tissue. Therefore, the 
ideal graft devices should be a bioresorbable implant which could degrade gradually 




Table 1.2 Synthetic grafts for ligament and tendon replacement 
 Advantages Disadvantages 
PE and PP 
Bio-inert; 
Resistant to hydrolytic; 
Bone to bone fixation capabilities. 
Material fatigue and creep; 
Weaker than normal ACL. 
(Chen et al. 1980; Mendenhall et al. 1987) 
Carbon fiber Bio-inert 
Debris; 
Brittle. 
(Vunjak-Novakovic et al. 2004) 
Gore-Tex High strength; Limited debris. 
Bending fatigue; 
Intra-articular abrasion. 
(Paulos et al. 1992) 
Dacron High strength; Supported collagenous ingrowth 
Stress-shielding; 
Rupture of femoral or tibial insertion; 
Elongation. 
(Vunjak-Novakovic et al. 2004) 
Stryker-Meadox 
Leeds-Keio Modiified Dacron replacement to trap tissue ingrowth 
Not neo-tissue only tissue response to debris. 
(Keen et al. 1999) 
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1.3 Review of Tissue Engineering Approach 
The limitations of current therapeutic approach to reconstruct ligament and tendons 
have prompted ongoing research aimed at developing a tissue-engineered ligament or 
tendon graft to address the deficiencies of existing therapies. The success of tissue 
engineered ligament and tendon would depend ⑴ reparative cells with the capacity for 
proliferation and matrix synthesis, ⑵ a structural scaffold that facilitates cell adaption 
and ⑶ an environment the provides sufficient nutrient transport and appropriate 
regulatory stimuli (Petrigliano et al. 2006). Approaches to select cell seeding method, 
material and structure of three-dimension scaffolds as well as regulation of 
biomechanical factors using bioreactor system will be discussed in greater depth in the 
following sections. 
1.3.1 Cell Sheet Technique in Tissue Engineering 
Tissue engineering has currently been based on the concept that three-dimensional 
biodegradable scaffold functions as alternatives for excellular matrix (ECM) and 
seeded cells reform their native structure according to scaffold degradation (Langer et 
al. 1993). In order to seed cells onto a 3D scaffold, cells must be first removed from 
tissue culture polystyrene (TCP). When cells are confluent on TCP surface, cells 
connect to each other via cell-to-cell junction proteins and other ECM proteins. The 
most common method of cell removal is enzymatic digestion in which e.g. trypsin is 
used to digest ECM and yield disaggregated cells. After detaching from TCP, the cells 
are suspended and injected onto defected tissue or 3D scaffolds for further culture. 
However, the above seeding technique has some disadvantages of low seeding 
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efficiency, poor cell distribution and loss in cell viability. In order to overcome these 
problems, a novel cell seeding method is developed. Moreover, enzymatic removal of 
cell from TCP could result in cell damage and loss of differentiated phenotypes 
(Fujioka et al. 2003; Canavan et al. 2005). Instead of harvest dissociated cells from 
TCP, the cells are harvested from TCP together with cell-to-cell junction protein and 
ECM produced by the cells as a viable cell sheet. Furthermore, ECM preserved in cell 
sheet will help the cells attach to defected tissue, biodegradable scaffold as well as 
another cell sheet and plays a desirable role in maintaining cell viability (Yang et al. 
2005; Haraguchi et al. 2006). 
Cell sheet can be used as single cell sheet, homotypic layers of cell sheets or 
heterotypic layers of cell sheets in order to reconstruct damaged tissues (Yang et al. 
2006; Yang et al. 2007). Researchers (Shimizu et al. 2003; Itabashi et al. 2005) 
harvested cardiomyocyte cell sheet and showed synchronization when different 
cardiomyocyte cell sheet overlay each other. Furthermore, in vivo study showed 
cardiomyoctye cell sheets could survive and growth for a long time post surgery 
(Shimizu et al. 2006). Polysurgery of cardiomyocyte cell sheet could be used to 
produce thick vascularized tissues (Shimizu et al. 2006). Likewise, Kushida et al. 
(Kushida et al. 2000) successfully cultured Madin-Darby canine kidney cells sheet 
with similar cell morphology as natural tissue. However, in all the above research, the 
cell sheets are only applicable to non-bearing tissue. As the ECM produced by cells 
under normal TCP is randomly distributed, the mechanical properties of the cell sheet 
are not competent with natural load-bearing tissue which has aligned ECM providing 
mechanical strength to withstand the extreme load. Therefore, scaffold reinforcement 
is needed when cell sheet technique is applied to load-bearing tissue engineering. 
Kumar et al. (Kumar et al. 2005) harvested osteoblast cell sheet and seeded onto 
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hydroxyapatite scaffold for bone tissue engineering. Researchers seeded cell sheet onto 
scaffolds or sutures for ligament and tendon tissue engineering applications (Ouyang et 
al. 2006; Hairfield-Stein et al. 2007). 
There are many ways to stimulate cell sheet formation and harvest cell sheet for tissue 
engineering applications (Hyeong Kwon et al. 2003; Ito et al. 2005; Ito et al. 2005; 
Kikuchi et al. 2005). It has been reported that ascorbic acid and ascorbates can be used 
to stimulate cell proliferation and collagen synthesis in vitro to form cell sheet. 
Ascorbates are essential requirement in normal connective tissue metabolism and 
effective for collagen biosynthesis at different level from gene transcription to 
expression (Chan et al. 1990). Ascobates have been shown to be a cofactor in the 
hydroxylation of praline to hydroxyproline and of lysine to hydroxylysine, which are 
required to stabilize collagen triple helix chain (Murad et al. 1981). However, 
Anderson et al. (Anderson et al. 1991) showed that although culture supplement with 
ascorbic acid results in large increase in collagen production, there was no significant 
collagen molecule crosslinking and collagen fibrils assembly in short-term culture. 
Furthermore, (Grinnell et al. 1989) found that only after long-term culture (4 to 5 
weeks) with ascorbic acid, collagen molecules crosslink and form collagen fibrils. 
(L'Heureux et al. 1998) reported that by using ascorbic acid, after 5 weeks, smooth 
muscle cells (SMCs) formed cell sheet that can be removed from TCP and formed 
tubular structure for blood vessel tissue engineering. Moreover, fibroblast, SMC and 
endothelial cell sheet were stratified to construct tissue-engineered blood vessels 
(L'Heureux et al. 2006). Similarly, researchers (Michel et al. 1999; Ng et al. 2006) 
performed in vitro reconstruction of skin tissue with fibroblast cell sheet after 5 weeks 
culture in presence of ascorbic acid. (Yamauchi et al. 2003) cultured endometrial 
epithelial cells and endometrial stromal cells with ascorbate in suspension culture and 
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was able to achieve multicelluar spheroid. (Park et al. 2006) cultured chondrocytes in 
presence of ascorbic acid and form chondrocyte pellet for cartilage reconstruction. In 
these studies, researchers used only certain concentration of ascorbic acid/ascorbate 
and culture time to trigger cell sheet formation. This may be due to limited 
understanding about effect of ascorbic acid/ascorbate concentration and culture time 
on cell sheet formation process. Hence, further assessing the dosage response of 
ascorbic acid and culture time on cell sheet formation is an important endeavor with 
further instruction to optimize cell sheet culture condition. 
In summary, by using cell sheet technique, ECM produced by cells during culture is 
preserved. These proteins help cell adhere onto tissues as well as biodegradable 
scaffold. By assembly cell sheet onto scaffold system, we can achieve even cell 
distribute on scaffold along with competent mechanical strength for further application 
in load-bearing tissue engineering. It is essential to understand cell sheet formation 
process and to characterize cell sheet behavior on scaffold system in order to fulfill the 
requirements in functional tissue engineering. 
1.3.2 Selection of Biodegradable Scaffold 
At presents, tissue engineering techniques generally require the use of a scaffold. 
Biomaterial scaffolds provide a structural template for cell attachment and tissue 
development (Vunjak-Novakovic et al. 2004). They are used as alternatives for 
extracellular matrix and that the seeded cells reform their native structure according to 
scaffold degradation (Shimizu et al. 2003). Ideally, a scaffold should have the 
following characteristics: (i) three-dimensional and highly porous with an 
interconnected pore network for cell growth and transport of nutrients and metabolic 
waste; (ii) biodegradable or bioresorbable with a controllable degradation and/or 
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resorption rate to match tissue forming in vitro or in vivo; (iii) suitable surface 
chemistry for cell attachment, proliferation, and/or differentiation; (iv) mechanical 
properties to match those of the tissues at the site of implantation (Hutmacher 2001). 
1.3.2.1 Selection of Scaffold Material 
In tendon and ligament tissue engineering, a lot of biomaterials (e.g. collagen, 
polyesters, silk) have been used. 
Poly (glycolic acid) (PGA), Poly (latic acid) (PLA), and their copolymer: PGA & 
PLA are widely investigated biodegradable polyesters. Once degraded, the degraded 
components (glycolic acid and/or lactic acid) can be removed by natural pathway. 
With additional methyl group, PLA is more hydrophobic than PGA. As the result, PLA 
has a much longer degradation time. Although PGA and PLA can form copolymer 
with any ratio between PGA and PLA, the properties of the resulting copolymer are 
not a linear combination of the properties of the pure PGA and PLA. Due to the chiral 
structure of, PLA has two forms: D-PLA and L-PLA. However, there are more L-PLA 
existed in nature. The mixture of D, L-PLA has amorphous structure, whereas the pure 
polymer of either of the stereoisomers tends to be more crystalline. These unique 
properties give researchers wide selections for scaffolds. Experimental results showed 
that ACL fibroblasts and MSCs attached and proliferated on PLGA and D-PLA films 
(Ouyang et al. 2002) as well as knitted PLGA scaffold (Ouyang et al. 2003). MSCs 
seeded knitted PLGA scaffold also showed promising results after implanted into 
rabbit as Achilles tendon replacement (Ouyang et al. 2002; Ouyang et al. 2003; 
Ouyang et al. 2004). However, PLGA degraded fast during in vitro tissue culture. The 
mechanical properties of PLGA decreased dramatically after 2 weeks which is shorter 
than the healing time of natural ligament and tendon. Thus, PLA which has a slower 
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degradation rate than PLGA might be more suitable material for long term tissue 
culture both in vitro and in vivo. As PLLA is hydrophobic material, surface 
modification was needed to improve cell attachment and proliferation (Yamaguchi et 
al. 2004). 
The major concern of using polyesters as scaffold materials was the acidic degradation 
residues. Local accumulation of degradation residues resulted in decrease in local PH 
degree which is toxic to local tissue (Taylor et al. 1994). Another concern was the 
release of small degradation particles which could trigger further inflammatory 
response (Gibbons 1992). Therefore, natural polymers which give rise to less 
inflammatory response would be more suitable for tissue engineering application. 
Collagen Scaffold: Since collagen is the most abundant protein in human body and 
accounts more than 80% of the dry weight a natural ligament or tendon, it is 
reasonable to reconstruct ligament/tendon with it. Furthermore, collagen can be easily 
processed to form gel and bundles of parallel fibers (Lee et al. 2001). The triple helical 
part of the collagen does not elicit antigenic response. But the associated cellular 
debris, ground substance and/or the nonhelical region of the collagen molecule cause 
antigenic response (Hutmacher 2001). Many methods have been reported to purify and 
remove foreign antigen (Friess 1998). It has been reported that collagen can support 
the growth of ligament fibroblasts under static tension (Vunjak-Novakovic et al. 2004). 
However, the use of collagen was limited by its inferior mechanical properties. 
Subsequently, cross-links are involved to enhance mechanical properties and resistance 
to chemical and/or enzymatic breakdown. In normal connective tissue, the most 
common crosslink types are hybroxulysinonorleucine (HLNL), 
dihybroxulysinonorleucine (DHLNL) and histodinohydroxymerodesmosine (HHMD). 
As it is difficult to mimic native crosslinking process, chemical crosslinking agent 
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such as glutaraldehyde, formaldehyde, polyepoxy compounds, acrylazide, 
carbodiimides and hexmethylene diisocyanate are used to crosslink collagen fibers 
(Khor 1997). Leaching of chemical cross-linking agent remained a great challenge in 
scaffold fabrication. Physical methods like ultraviolet, gamma radiation are also used 
to fabricate crosslinked collagen fibers. Although no toxic chemical leaching, UV and 
gamma radiation treatment would degrade collagen molecule as well (Caruso et al. 
2005). Furthermore, experimental data (Dunn et al. 1992; Dunn et al. 1995) showed 
that although cross-link collagen fibers supported cell attachment, spreading, and fiber 
coverage with ECM deposition for short-term effect, the capacity of the engineered 
tendon/ligament analogs to withstand mechanical loading decreased with increasing in 
culture time. As the result, the scaffold fiber could not impart repeatable stresses to the 
attached cells. Moreover, the poor mechanical integrity of the scaffold gave raise to the 
concerns regarding anchoring of the analogs both in vitro (bioreactor) and in vivo. 
Although novel crosslinking agents like dicatechol nordihyroguaiaretic acid (NDGA) 
were used to crosslinked collagen fibers (Koob et al. 2002), no biocompatible and 
further in vivo testing of such materials has been reported. Moreover, high cost, 
variability, complex handling and potential disease transmission all limited the usage 
of collagen in ligament and tendon tissue engineering (Lee et al. 2001). Hence, other 
biological materials with higher ultimate strength and mechanical integrity should be 
used as scaffold material for ligament and tendon tissue engineering. 
Silk: Silk, which has been used clinically as hemostats and surgical sutures for decades, 
is generally defined as protein that is spun into fibers by silkworm, as well as spiders, 
flies. Silk from different sources have different amino acid composition and 
mechanical properties. Silk from Bombyx mori silkworm is the largest and most stable 
source. B. mori silk consist of two proteins: a heavy chain (~390KDa) and light chain 
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(~26KDa). The amino acid composition of B.mori silk fibroin consisted primarily 
glycine, alanine and serine in a sequence of Gly-Ala-Gly-Ala-X (X: Ser or Tyr) to 
form repetitive β-sheet structure (He et al. 1999). As a result, silk has extraordinary 
tensile strength and environmental stability. In addition, silk can be processed into 
many textile structures as well as non-woven silk matrices. 
As a group of proteins, silk undergoes proteolytic degradation when exposed to α-
chymotrypsin (Horan et al. 2005). The degradation rate depends on the structure, 
morphology and local environmental conditions of implantation of silk scaffold. In 
vivo degradation tests showed that degradation half-lives of silk in subcutaneous 
condition were six weeks and silk fibers loss their tensile strength within one year 
(Greenwald et al. 1994). These advantages raise the interest using silk as scaffold for 
tendon and ligament tissue engineering. However, native silkworm silk fibers are 
allergenic due to sericin, a protein coating on the silk fiber (Altman et al. 2003). By 
heating raw silk fibers in alkali solution, sericin can be removed. The regenerated silk 
fibroin show good biocompatibility when compared with PLA (Meinel et al. 2005). 
However, removal of sericin changes hydrophilic silk surface into hydropobic silk 
fibroin thus reduces cell attachment. In order to increase cell adhesion, researchers 
(Sofia et al. 2001; Chen et al. 2003) modified silk fibers with RGD peptide and other 
bioactive component to promote cell-matrix binding. Liu et al. (Liu et al. 2007) used 
NDGA as a cross-linking agent to replace sericin with gelatin to biomimic the natural 
structure of native silk. However, in these studies, only short-term in vitro culture 
results were shown. Long-term results may be affected by the degradation of silk 
scaffold. Although silk undergoes photolytic degradation, there is limited 
understanding about silk degradation in culture medium. Therefore, further assessing 
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silk degradation of ascorbic acid in culture medium is an important endeavor with 
further instruction to design silk scaffold for implantation. 
In summary, compared with collagen and polyesters, silk shows versatility in 
processing, biocompatibility, the ease of sterilization, thermal stability, controllable 
degradation rate and extraordinary mechanical properties (Vepari et al. 2007). These 
all make silk promising material for ligament and tendon tissue engineering. 
1.3.2.2 Selection of Scaffold Architecture 
In order to fabricate three-dimensional scaffold, some techniques have been applied to 
process biomaterials. Due to the fibrous nature of tendons and ligaments, textile 
techniques have the potential to be used to fabricate scaffolds for tendon and ligament 
tissue engineering. However single fiber filament does not match the mechanical 
properties of natural ligament/tendon tissue. To improve mechanical properties, fiber 
bonding techniques were developed to prepare strong scaffold with interconnecting 
fiber network (Hutmacher 2001). 
Three-dimensional braiding is one of common method to create a scaffold with 
controlled pore size, integrated pores, resistance to wear and rupture, and high 
mechanical properties. Researchers (Cooper et al. 2005; Laurencin et al. 2005) used 
3D braiding technique to fabricated a three-region (femoral tunnel attachment; 
ligament region; tibial tunnel attachment) PLGA graft for ACL tissue engineering 
(Figure 1.7). Three regions had different pore size and fiber orientation to trigger 
different tissue formation thus formed to biomimetic bone-ligament-bone graft. 
Furthermore, in vivo study showed healing and regeneration of ACL after replacement 
of the three-region graft (Cooper et al. 2007). Different material and surface 
modification technique could be involved to improve cell attachment and fabricate 
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grafts with desirable mechanical properties and degradation rate (Lu et al. 2005). 
Furthermore, in order to mimic the mechanical properties of natural ligament/tendon  
tissue, Altman and his colleagues (Altman et al. 2002; Horan et al. 2006) organized the 
silk fibroin into a wire-rope geometry (Figure 1.8) to reduce the high stiffness of silk 
and achieved similar mechanical properties of tissue. Freeman et al. (Freeman et al. 
2007) combined braiding and twisting to achieve braid-twist PLLA scaffold with 
higher ultimate tensile strength and ultimate strain compared with braided PLLA 
scaffold. 
 
Figure 1.7 Schematic of three-region braided scaffold (Cooper et al. 2005) 
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Figure 1.8 Schematic of an ACL 6-cord matrix hierarchy (Altman et al. 2002) 
 
Figure 1.9 Cross-sectional diagram of fibers with eight deep channels 
However, some researchers pointed out that because of the limited internal space of 
braided fiber scaffold, new tissue ingrowths among the braided fibers were poor 
(Zange et al. 1997). Thus many research groups then changed their focus to other 
scaffold fabrication techniques. Researchers (Lu et al. 2005) used PLA fiber to 
fabricate capillary channel fibers with eight open grooves. With the unique ability to 
move fluids instantaneously by capillary action, it was able to transport oxygen and 
nutrients deep within the scaffolds. Some other researchers focus their interest in using 
knitted scaffold for ligament/tendon tissue engineering. Knitted scaffold was shown to 
possess sufficient porosity and mechanical strength (Zdrahala 1996; Ozawa et al. 
2002). But knitted structure has macro size pores which need special techniques to 
seed cells. In order to seed cells onto knitted scaffolds, special cell seeding techniques 
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were needed. Ouyang et al. has successfully seeded MSCs onto knitted PLGA 
scaffolds using cell-gel suspension (Ouyang et al. 2003). Further in vivo study 
indicated that cell seeded knitted PLGA scaffolds were able to withstand the 
mechanical force in vivo shortly after implantation, allow cell infiltration, conduct 
tissue formation, and be absorbed gradually after the host neotissue formation (Ouyang 
et al. 2002). However, cell-gel composite could dissociate from scaffold during motion 
(Ge et al. 2005). Furthermore, gel system faced nutrient transmission problems 
(Jockenhoevel et al. 2001). In contrast, Sahoo et al. (Sahoo et al. 2006) covered the 
macro pores of knitted PLGA scaffold with electro-spun PLGA nanofibers and seeded 
procine BMSCs onto the scaffold. Cells on nanofiber modified scaffold showed higher 
proliferation and ECM synthesis. Liu et al. (Liu et al. 2008) used silk sponge to modify 
knitted silk scaffold and seeded hMSCs onto the scaffolds. In vitro study showed 
higher cell proliferation and matrix protein synthesis on sponge modified scaffold 
compared with scaffold using cell-gel seeding technique. However, by inject seeding, 
cell distribution remained a challange. Ouyang et al. (Ouyang et al. 2005) used cell 
sheet technique to seed cells onto knitted PLLA scaffold and achieve ligament analog 
with even cell distribution. As knitted scaffold provides less anchor points for cell 
sheet to attach, cell sheet on knitted scaffold would tear into strands or peal off under 
mechanical loading. As the result, further modification of knitted scaffold is needed to 
improve cell sheet attachment. 
In summary, knitted scaffold possess good mechanical strength with less material used 
and internal communicating space. Thus knitted scaffold could withstand the 
mechanical load in human joints with less inflammatory response. Additionally, usage 
of silk as knitted scaffold material could provide sufficient mechanical strength with 
desirable cell viability. Further modification of knitted silk scaffold could provide 
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more anchor points for cell sheet attachment. It is essential to understand degradation 
properties of silk knitted scaffold system and to compare cell sheet behavior on 
different silk scaffolds in order to design knitted scaffold for in vitro and in vivo tissue 
formation. 
1.3.3 Bioreactor System 
In vivo, tissue formation is directed by multiple factors including: (1) structural 
template for cell attachment and tissue development; (2) physiological milieu and 
biochemical regulatory factors; and (3) physical regulatory signals (Vunjak-Novakovic 
et al. 2005). The fibroblasts within ligament and tendon expose to dynamic stress 
during joint motion, and the structural properties of the ligament/tendon are influenced 
by these forces. Researchers pointed out that dynamic loading on benefit ligament 
strength of knee joint and prolonged immobilization on ultimate failure strength (Woo 
et al. 1999). Therefore, mechanical stimulation may lead to positive changes in 
functional tissue engineering. Cao et al. (Cao et al. 2006) indicated that although 
tenocyte cultured under constant strain possessed higher ultimate load, tendon analog 
was thinner with more compacted collagen fiber which is different from natural tissue. 
These findings indicated that constant strain was not suitable for ligament and tendon 
tissue engineering. In contrast, Berry et al. (Berry et al. 2003) showed enhanced cell 
proliferation under cyclic loading. It was also reported that cyclic strains caused an 
increase in collagen and proteoglycan synthesis by ligament and tendon cells (Toyoda 
et al. 1998; Hsieh et al. 2000; Park et al. 2006). Webb et al. (Webb et al. 2006) also 
reported increased in fibroblast proliferation and collagen synthesis under cyclic 
loading. Noth et al. (Noth et al. 2005) found that cyclic loading unregulated collagen 
type I, type III fibronectin and elastin gene expression of MSC. Moreover, Butler et al. 
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(Butler et al. 2008) showed that mechanically stimulating MSC-collagen gel hybrid in 
bioreactors further enhanced mechanical properties of the hybrid compared to 
nonstimulated samples. 
As the result, bioreactors providing cyclic loading effect were designed to accelerate in 
vitro ligament/tendon analog formation. Cacou et al. (Cacou et al. 2000) fabricated a 
mechanical loading apparatus and found that cell seeded collagen gels under cyclic 
loading exhibited an increase in stiffness compared with unloaded samples. Yost et al. 
(Yost et al. 2000) designed a uniaxial cell stretcher to provide mechanical stimulation. 
Altman (Altman et al. 2002) et al. designed a bioreactor that could provide both 
tensile-compressive loading and torsional loading. The experimental data showed that 
under mechanical loading fibroblasts exhibited significant cell alignment and oriented 
collagen fibers with up-regulated collagen type I and III and Tenascin-C expression. 
Garvin et al. (Garvin et al. 2003) used Tissue Train culture plate to provide tensile 
stress on fibroblast seeded collagen gel and found that fibroblast aligned with strain 
direction. In our research group, Moe (Moe 2005) designed a bioreactor providing 
cyclic loading through rotating spool. Fibroblasts showed higher cell viability and up-
regulated collagen type I, III and Tenascin-C expression under mechanical stimulation 
than under static culture. In these studies, the mechanical force transmitted from the 
scaffold materials via transmembrane cellular adhesion molecules. As in cell sheet, all 
the ECM is preserved and the mechanotransduction signals are transmitted through 
ECM-cell as cell-cell signaling molecules. ECM will also deform under mechanical 
loading which may affect cellular response of cell sheet. Hence, assessment of cyclic 
loading affect on cell sheet seeded scaffolds would give better understanding to the 
effect of mechanotransduction on in vitro tissue culture. 
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1.4 Problem Definition and Hypothesis: 
Cell sheet technique is applied in order to enhance cell attachment onto the scaffolds 
and promote cell proliferation and matrix synthesis. Knitted scaffold is a suitable 
substrate that can be used to reinforce cell sheet and direct cell growth and regenerate 
tendons and ligaments analogs in vitro. It is hypothesized that by assembly fibroblast 
cell sheet onto knitted scaffold system and culture the hybrid structure in advanced 
bioreactor system, it could achieve the full advantage of both the cell sheet technique 
and macroporous knitted scaffold and form ligament and tendon analog with proper 
biochemical and biomechanical properties for further implantation. 
However, when applying cell sheet technique for ligament and tendon tissue 
engineering. The following subjects were not fully investigated in previous studies: 
a. Cell behavior during cell sheet formation process need to be studied to 
optimize fibroblast cell sheet culture condition. 
b. Due to poor mechanical properties of fibroblast cell sheet, scaffold 
reinforcement is needed when cell sheet is used for ligament and tendon tissue 
engineering application. 
c. Effect of scaffold material and scaffold geometry on fibroblast cell sheet for in 
vitro tissue culture. 
d. Effect of cyclic loading on fibroblast cell sheet for in vitro tissue analogs 
formation. 
1.5 Project Objectives and Significance 
The purpose of this study was to culture fibroblast cell sheet, assembly fibroblast cell 
sheet onto knitted scaffold system and culture in bioreactor system in order to 
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reconstruct ligament and tendon for implantation. The specific objectives of this thesis 
are: 
 To characterize the dosage response of ascorbic acid and fetal bovine serum (FBS) 
on fibroblast behavior during fibroblast cell sheet formation process 
 To investigate the effect of knitted scaffold geometries in relationship to cell 
viability, ECM protein production as well as cell morphology 
 To characterize the degradation of PLLA and silk materials in culture condition 
 To compare cellular response to different biodegradable materials 
 To determine the effect of silk sponge modified knitted silk scaffold on fibroblast 
cell sheet behavior compared with normal knitted silk scaffold 
 To investigate the effect of mechanical stimulation on fibroblast cell sheet behavior 
The study of dosage response of ascorbic acid and FBS on fibroblast cell sheet 
formation process should provide optimized culture condition for fibroblast cell sheet 
fabrication. Fibroblast cell sheet characterization may also contribute to a better 
understanding of effect of ascorbic acid and FBS on collagen production from 
transcriptional level to post-transcriptional level. Furthermore, by assembly cell sheet 
onto knitted scaffold system, cell sheet will integrate into scaffold system and form 
ligament and tendon tissue analogs. The study of cell sheet on knitted scaffold system 
may lead to a better understanding of cell-ECM-scaffold interaction. The study of the 
effect of bioreactor system on in vitro tissue growth could provide understanding of 
mechanotransduction on tissue formation and repair. 
In this study, only skin fibroblasts rather than tenocytes or ligament fibroblasts were 
used to culture fibroblast cell sheet for further seeding. This is mainly because skin 
fibroblast shows higher in vitro cell viability and ECM production than ligament and 
tendon fibroblast (Van Eijk et al. 2004).  Furthermore, compared with isolation of skin 
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fibroblast, isolation of fibroblast from ligament and tendon is practically difficult and 
the isolation process can cause tissue defect in ligament/tendon (Liu et al. 2006). 
Moreover, as ligament/tendon fibroblast and dermal fibroblast are all derived from 
mesoderm and have similar characteristics in cell morphology and ECM component, 
skin fibroblast is proven to have the potential cell source for ligament and tendon 
engineering as dermal fibroblast seeded scaffolds could develop into ligament and 
tendon like tissue (Liu et al. 2006; Tischer et al. 2007). Furthermore, as no specific 
ligament or tendon is selected as in vivo model, all the knitted scaffolds are not tailored 
to match the mechanical properties of the natural tissue. Furthermore, cell viability, 
matrix protein production, cell morphology and the mechanical properties of tissue 
analogs are studied between different sample groups rather than compared to natural 
tissue. 
In order to achieve the objectives, cell viability, protein expression and mechanical 




Chapter 2. Materials and Methods 
In order to achieve the goals of this study, experiments are designed to characterize 
and optimize fibroblast cell sheet formation process, to characterize in vitro 
degradation of knitted scaffold of different material, to study cell sheet behavior on 
knitted scaffold of different material and the effect of mechanical stimulation on neo-
tissue formation. The scheme and methodology of all sets of experiments are discussed 
in the following sections. The details of experiment protocol and mechanism are 
described in Appendix. 
2.1 Cell Sheet Characterization and Culture Condition Optimization  
2.1.1 Human Dermal Fibroblast Expansion and Cell Sheet Culture 
Human dermal fibroblasts (HDF) were derived by enzymatic digestion of a skin 
sample obtained from abdominoplasty of a 26 year-old female adult with informed 
consent and under a protocol approved by an Institutional Review Board, National 
University of Singapore. The cells were resuspended in culture medium containing 
Dulbecco’s modified Eagle’s medium (DMEM; GIBCO, Grand Island, NY), fetal 
bovince serum (10% v/v; HyClone, Logan, UT), penicillin (100 units/ml) and 
streptocycin (100μg/ml) (GIBCO, Grand Island, NY), and transferred into cell culture 
dishes. The cells were incubated at 37°C with 5% humidified CO2. Confluent 
fibroblasts of fifth passage (P5) (Van Eijk et al. 2004) were used for cell sheet 
formation. The confluent fibroblasts were cultured with medium with different amount 
of FBS as well as L-ascorbic acid (Sigma, St. Louis, US) to characterize cell sheet 
formation process and optimize culture condition for fibroblast cell sheet formation. 
FBS and ascorbic acid concentration was listed in table 2.1. 
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Table 2.1 Culture conditions for fibroblast cell sheet 
                               Ascorbic Acid (µg/ml) 
         FBS (v/v%) 
0 50 100 
10 √ √ √ 
15 √ √ √ 
20 √ √ √ 
25  √  
2.1.2 Cell Viability 
Cellular reducing conditions are known indicators of cell viability and cell death, thus 
Alamar BlueTM functions as a cell viability indicator by using the reducing power of 
living cells to measure the cell viability (USBiological, USA). The sample medium 
was replaced by medium containing 10% (v/v) alamar blue. After 3h of incubation, the 
medium was transferred into 96-well plate and absorbance at 570nm and 600nm was 
was measured spectrophotometrically (Ansar Ahmed et al. 1994) (Sunrise, Sunrise 
Intruments). Percent reduction of Alamar BlueTM was used to indicate the reducing 
power of fibroblast cell sheet. The working mechanism, experimental procedure as 
well as formula to calculate percent reduction of Alamar BlueTM was stated in details 
in Appendix A.1. 
Fibroblast cell sheet viability assay was carried out at 1, 3, 7, 14, 21, 28 and 35 days 
incubation. At each time point, parallel samples of n=6 were used. 
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2.1.3 Collagen Quantification 
As a parameter for matrix synthesis, total amount of collagen was determined by Sircol 
Collagen Assay Kit (Biocolor, UK). Cell sheets were rinsed twice with PBS and then 
transferred into a 1.5ml centrifuge tube. 900µl of water was added into the tube and 
cell sheets were further homogenized with tissue homogenizer (TH-220, Omni 
International, Inc, US). After homogenization, the volume of each tube was brought to 
900µl with PBS. 
Pepsin from porcine mucosa (4000U/mg, Sigma, US) was dissolve in 0.5M acetic acid to 
make the final concentration of 1µg/µl. 100µl of pepsin solution was added to digest 
non-collagenous proteins. After 2hr, 100µl of 1N NaOH was added to stop pepsin 
digestion. The 200μl of that solution was transferred into a 1.5ml centrifuge tube and 
1ml dye was added in. The mixture was shaken for 30min and centrifuged at 13krpm 
for 10min. After remove all the unused dye, the deposit was dissolved in 1ml alkali 
reagent. Solution was properly mixed and transferred into 96-well plate and the 
absorbance at 540nm was recorded down. The collagen content was calculated by 
calibrating the standard curve. Although pepsin added would also contribute to the OD 
at 540nm, the amount of pepsin added was the same for all samples. Therefore, the OD 
generated by the pepsin was constant for all different samples. As the results, no 
negative control with pepsin alone was measured in this thesis.  
The details of working mechanism of SircolTM Collagen assay and how to obtain the 
standard curve were stated in Appendix A.2. 
For cell sheet characterization, SircolTM collagen assay was carried out to measure the 
matrix protein production at 7, 14, 21, 28 and 35 days of incubation. At each time 
point, parallel samples of n=6 were used. 
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2.1.4 Normalize Collagen Content over Cell Viability 
In order to calculate collagen production of fibroblast cell sheet efficiency. Collagen 
content of fibroblast cell sheet under different culture condition was normalized with 
cell viability by the following formula: 
 
With higher normalized collagen content value, fibroblast was more efficient to 
synthesis and form crosslinked collagen fibril within cell sheets. 
2.1.5 Cell Sheet Thickness by Confocal Method 
5-chloromethylfluorescein diacetate (CMFDA) (Figure 2.1A) was used to stain the 
living cells. CMFDA is fluorescent chloromethyl derivative that can freely diffuse 
through the membranes of live cells. Once inside the cell, the cytosolic esterases cleave 
the acetate groups of CMFDA, releasing the fluorescent product, 5-
chloromethylfluorescein (Figure 2.1B). 
After 5 weeks of culture, medium of cell sheet was aspirated and replaced by medium 
containing only DMEM and 10mmol/L CMFDA (ITS, Singapore). The samples were 
then incubated at 37°C with 5% humidified CO2 for 30 minutes. After that, the staining 
medium was aspirated and replace with fresh DMEM and the samples were incubated 
at 37°C with 5% humidified CO2 for 1 hour. After incubation, the samples were 
washed twice with PBS and fixed by 4% formaldehyde. The stained samples were 
mounted in PBS and measured by a confocal laser scanning microscope following the 
manufacturer instructions (Olympus Fluoview FV500, Olympus, Japan). Parallel 
samples of n=6 were used. Optical section images form planes 1μm apart in the z 
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direction were collected starting from the adhesion plane of the cell sheet up to the 
apical plane of each plane. The distance between these two planes was kept as a 













Figure 2.1 (A) Chemical structure of CMFDA, (B) Chemical Structure of 5-
chloromethylfluorescein 
2.1.6 Histological and Immunohistochemistry Examination 
After 5 weeks of culture, cell sheets were rinsed twice with PBS and further transferred 
onto PLLA thin film. After that, cell sheets were fixed in 4% buffered formaldehyde 
solution. They were then dehydrated through alcohol gradients and embedded in 
paraffin blocks. Transverse sections (10μm) were prepared from these specimens using 
a microtone (Leica Instrument, Bensheim, Germany) and subsequently stained with 
hematoxylin-eosin (H&E) in order to determined cell sheet thickness. 
In addition, streptavidin-biotin method (CHEMICON IHC Select TM, US) was used to 
evaluate different types of collagen in cell sheet (at day 10 and day 35). Histological 
sections were incubated with primary monoclonal antibodies (mouse anti-human 
collagen type I and collagen type III) (Sigma, USA) before horseradish peroxidease 
(HRP) labeled secondary antibody (Goat Anti-Mouse). Sections were counterstained 
with hematoxylin. 
The details of experiment protocol were stated in Appendix A.4.  
(A)  (B) 
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2.1.7 RNA Isolation and Quantitative RT-PCR 
At 7, 21 and 35 days of culture, RNA of fibroblast cell sheet was isolated and used to 
characterize the gene copy number with RT-PCR. Briefly, cell sheets were washed 
twice by PBS and transferred from TCP to 1.5ml centrifuge tube using cell scrapper. 
The total RNA of fibroblast cell sheet was isolated by using RNeasy Mini Kit (Qiagen, 
USA) following the supplier’s instructions. The final extracted RNA was stored at -
80°C. 
The RNA samples were reverse transcribed into cDNA according to the 
manufacturer’s protocol (iScript cDNA synthesis Kit, BioRad). The “housekeeping” 
gene, glyceraldehydes-3-phosphate dehydrogenase (GAPDH) which presents in all 
cells was used to normalize the data and utilized as a marker that has an unchanged or 
constant level of expression in all samples. Quantitative PCR was conducted to 
determine the gene expression level of type I and III type collagen, which were 
identified as phenotypic markers. Primers specific for type I collagen, type III collagen 
and GAPDH (Research Biolabs, Singapore) were obtained from published literature 
(Cooper et al. 2006; Liu et al. 2008). The details of the primers are given in Table 2.2. 
Quantitative PCR was performed on an iCycler instrument (BioRad, USA). The 
thermal parameters were as follow: activation step: 15min at 95°C; three step cycling; 
denaturation for 30s at 95°C, annealing for 1min at 58°C, extension for 1min at 72°C 
for 50 cycles. A melt curve was subsequently performed to analyze the products 
generated, which began at 50°C and increased to 95°C in 0.5°C increments. At least 
three replicates were performed on each sample and each experimental gene was tested 
by three PCR runs. Data were analyzed by iQ5 supplied by the vendor (BioRad, USA). 
The Ct value for each sample was defined as the cycle number at which the 
fluorescence intensity reached a certain threshold where amplification of each target 
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gene was within the linear region of the reaction amplification curves. Relative 
expression level for each gene of interest was normalized by the Ct value of GAPDH 
using an identical procedure (2ΔCt formula, Perkin Elmer User Bulletin #2).  Each 
sample was analyzed in triplicate. 












2.2 Preparation of Scaffold Systems 
2.2.1 Preparation of Knitted PLLA Scaffold 
Poly (L-lactic acid) (PLLA) (30 filaments/yarn) was purchased from Alany 
International Research Company. Silver-reed SK270 knitting machine (Figure 2.2A) 
was brought from Suzhou Harisa Machiery. 
Endless 3 yarns of PLLA were guided into the 12 needles of the knitting machine to 
get 20mm scaffold width. The plain weft knitted fabrics manufactured with six stitches 
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per centimeter and 1-mm loop size. The length of the knitted PLLA scaffold fabricated 
was standardized to 40mm (Figure 2. 2B). 
2.2.2 Preparation of Knitted Silk Scaffold 
Raw Bombyx mori Silk fibers (local name: “Nang Lai” silk fibers) were provided by 
collaborator from Thailand. Endless 1 yarn (80 filaments/yarn) of silk fibers was 
guided into 12 needles of the knitted machine to get 20mm scaffold width. The plain 
weft knitted fabrics manufactured with six stitches per centimeter and 1mm loop size. 
After knitting, raw silk scaffolds were immersed in an aqueous solution of 0.2% (w/v) 
Na2CO3 solution with additional 0.2% (w/v) SDS with temperature of between 90 and 
95oC. After 30min, sericin was completely removed. After Na2CO3 treatment, 
degunned knitted silk scaffolds were washed with distill water to remove Na2CO3, 
SDS and sericin residue. Knitted silk scaffold before and after degumming is shown in 
Figure 2.2C and Figure 2.2D. 
2.2.3 Preparation of Silk Sponge Modified Knitted Silk Scaffold 
Silk sponge modified knitted silk scaffold was prepared by forming microporous silk 
sponge in the opening of a knitted silk scaffold. Briefly, silk fibers were first 
degummed using the method above. After degumming, silk fibroin were dissolved in 
CaCl2-CH3CH2OH-H2O (molar ratio=1:2:8) at 75oC with continuous stirring. Silk 
fibroin solution was subsequently dialyzed against distilled water using a SnakeSkin 
Pleated Dialysis Tubing (PIERCE, MWCO 3500). A knitted sericin-removed silk 
scaffold was immersed in the silk solution and frozen at -80oC for 4 hours. After that, 
it was freeze-dried for 12 hour to allow the formation of microporous silk sponge, 
which filled up the opening of the knitted silk scaffold. The scaffolds obtained were 
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immersed in methanol for 30min to induce conformation change from random coil to 
β-sheet in microporous sponge to prevent resolubilization in the cell culture medium. 
Finally, the scaffolds were dried overnight in a fume hood. Silk sponge modified 
knitted silk scaffold is shown in Figure 2.2E. 
 
Figure 2.2 Knitting machine and various type of scaffold (B: knitted PLLA scaffold; C: 
knitted silk scaffold before degum; D: knitted silk scaffold after degum; E: silk sponge 
modified knitted silk scaffold) 
2.3 Scaffold Degradation Test 
Knitted silk and silk sponge modified knitted silk scaffolds were immerged in standard 
culture medium to study material degradation under in vitro culture condition. After 1, 
7, 14, 28 and 42 days of immerged, scaffolds were washed twice with PBS and fully 
dried using vacuum oven (OV-11, JEIO TECH, Korea). 
Knitted PLLA scaffold were also immerged in standard culture medium to study 
material degradation. After 1, 7, 14 and 28 days of immerged, scaffolds were washed 
twice with PBS and fully dried using vacuum oven. 
2.3.1 FTIR spectroscopy 
FTIR spectra of all types of scaffolds were obtained with FTIR spectrometer (Nicolet 
Avatar 360, Thermo Scientific, USA) in the spectral region of 2000-1000 cm-1 to 
determine the molecular conformation. All samples were measured by transmittance 
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method. The crystalline index, referring to relative β-sheet structure content, was 
determined using the ratio of the absorbance at 1665 and 1628 cm-1, known as amide I 
peaks (Barth 2007). Furthermore, amide II at 1540cm-1 as well as amide III at 1265 
cm-1 (Ayutsede et al. 2005) was used to determine crystalline structure of silk material. 
2.3.2 Gel Permeation Chromatograph 
Knitted silk scaffold and silk sponge modified knitted silk scaffold at each degradation 
time point were dissolved in CaCl2-CH3CH2OH-H2O (molar ratio=1:2:8) at 75oC with 
continuous stirring. Solution was subsequently dialyzed against distilled water using a 
SnakeSkin Pleated Dialysis Tubing (PIERCE, MWCO 3500). After that, solution was 
further diluted to 0.1% (wt/v) using distilled water and filtered through 0.22µm syringe 
filter for GPC measurement. 
GPC measurements were performed with gel permeation chromatography column 
(Ultrahydrogel Linear, Waters, USA) with refractive index detector (Waters 2414, 
Water, USA). HPLC grade water was used as mobile phase with a flow rate of 
1ml/min. Calibration was carried out using PEG standards according to the 
manufacturer’s instructions. At each assessment time point, knitted PLLA scaffold was 
dissolved in HPLC grade THF and filter through 0.22µm syringe filter. GPC 
measurements were performed with gel permeation chromatography column (Phenogel 
5µ 100A, Phenomenex, USA) with refractive index detector (RID-10A, Shimadzu, 
Japan). HPLC grade THF was used as mobile phase with a flow rate of 0.3ml/min. 
Calibration was carried out using PEG standards. 
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2.3.3 Differential Scanning Calorimetry 
The thermographs of silk fibroin and silk sponge modified silk fibroin were acquired 
using a differential scanning calorimeter (DSC822e, Mettler Toledo) from 20oC to 
300oC at the rate of 10oC /min under a nitrogen atmosphere. As for knitted PLLA 
scaffold, differential scanning calorimetry was performed form 0oC to 230oC at the rate 
of 10oC /min under a nitrogen atmosphere. 
2.3.4 Mechanical Properties 
At each assessment time point, 6 specimens from each group were used to determine 
the mechanical properties of the scaffolds. Scaffolds were taken out from Petri dishes 
and washed with PBS. Then the specimens were mounted on the a universal testing 
machine, UTM (Instron 3345 Tester, Series IX and Merlin Software, Instron Corp., 
MA, USA) fitted with a 1000N load cell. Mechanical properties were measured by 
loading the sample to failure at room temperature. After the mounting, phosphate 
buffer solution was dropped onto the specimens to keep them wet. At a test speed of 
10mm/min, a tensile load was applied. Ultimate load was obtained from load-
elongation curve of each specimen. While tensile stiffness was calculated from the 
linear region of the load-elongation curve (see Appendix A.6). 
2.4 Effect of Scaffold Geometries on in vitro Tissue Culture 
2.4.1 Cell Sheet Seeding and Three Dimensional Culture 
After five weeks culture in presence of ascorbic acid, fibroblasts formed cell sheets, 
comprising cells and ECM, which could be manually peeled off from the cell culture 
dishes. 20×40mm knitted PLLA scaffolds were sterilized by 1 hour 70% ethanol 
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treatment. Then the scaffolds were washed twice with PBS and dried up. After 
sterilization, the scaffolds were placed on top of the cell sheets and incubated for 24 
hours. After incubation, the cell sheet was detached and wrapped around scaffolds 
using cell scrappers. Further, the cell sheet seeded scaffolds could be further folded or 
rolled to form different formats (flat, fold and roll) (Figure 2.3). The cell sheet-scaffold 
hybrids were then placed in static culture chamber (Figure 2.4(a)). The cell sheet 
seeded scaffolds were culture with DMEM supplemented with 15% FBS and 50µg/ml 
ascorbic acid at 37°C with 5% humidified CO2. The culture medium was changed 











             Rolled                                Folded                                          Flat 
Figure 2.3 Procedure of fabricating and assembling fibroblast sheet with scaffold and 
different geometries (rolled, folded and flat) of cell sheet-scaffold hybrid 
2.4.2 Cell Viability 
Fibroblast viability on different scaffold geometries was examined by Alamar BlueTM 
assay (USBiological, USA). The sample medium was replaced by medium containing 
10% (v/v) alamar blue. After 3h of incubation, the medium was transferred into 96-
well plate and percentage reduction of alamar blue was then measured 
spectrophotometrically (Ansar Ahmed et al. 1994) (Sunrise, Sunrise Intruments). 
Cell viability assay was carried out at 1, 3, 7, 14, 21 and 28 days of incubation. At each 
time point, parallel samples of n=6 were used. 
2.4.3 Collagen quantification 
Collagen content of cell sheet-scaffold hybrid was tested at 7, 14, 21, and 28 days of 
incubation respectively. At each time point, parallel samples of n=6 were used. 
At each assessment time point, cell sheet seeded scaffolds were rinsed three times with 
PBS and were further cut into four parts. Collagen content of each part was measure by 
Sircol Collagen Assay Kit as described in Section 2.1.3. The total collagen amount of 
cell sheet-scaffold hybrids was calculated by summing up collagen content of all four 
parts. 
  49
2.4.4 Live Cell Labeling 
After 28 days of culture, cell sheet-scaffold hybrids were stained with live cell tracking 
stain CMFDA as described in Section 2.1.5 to investigate the morphology and viability 
of fibroblast cell sheet with different geometry. 
2.4.5 Mechanical Testing 
  
Figure 2.4 Samples for Mechanical Test with Masking tape; (a) sample mounted on 
Instron machine, (b) ruptured samples 
 
After 28 days of in vitro tissue culture, 6 specimens from each geometry group were 
used for biomechanical testing. The specimens were taken out from tissue culture 
chambers and rinsed twice with PBS. Then the specimens were mounted on the a 
universal testing machine, UTM (Instron 3345 Tester, Series IX and Merlin Software, 
Instron Corp., MA, USA) fitted with a 1000N load cell. Masking tape was used to 
prevent any slippage of the scaffold from the machine grips during testing (Figure 
2.4(a)). Mechanical properties were measured by loading the sample to failure at room 
(a)  (b) 
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temperature without any pretension and preconditioning. After the mounting, 
phosphate buffer solution was dropped onto the specimens to keep them wet. At a test 
speed of 10mm/min, a tensile load was applied. Only the samples with failure occurred 
at the centre portion (Figure 2.4(b)) were used to analyze the mechanical properties. 
Ultimate load was obtained from load-elongation curve of each specimen. While 
tensile stiffness was calculated from the linear region of the load-elongation curve. 
2.5 Scaffold Material and Cyclic Loading Effect on in vitro Tissue 
Culture 
2.5.1 Cell Sheet Seeding and Three Dimensional Culture 
After five weeks culture in presence of 15% FBS and 100µg/ml ascorbic acid, 
sterilized 20×70mm scaffolds (knitted PLLA, knitted silk and silk sponge modified 
knitted silk scaffold) were placed on top of the cell sheets and incubated for 24 hours. 
After incubation, the cell sheet was detached and wrapped around central 20×40mm of 
scaffolds using cell scrappers. Further, the cell sheet seeded scaffolds were rolled 
(Figure 2.3). Then the cell sheet seeded scaffolds were placed in non-treated Petri 
dishes (Figure 2.5(a)) or fixed to lab designed bioreactor (Moe 2005) (Figure 2.5(b)). 
The schematic diagram of the bioreactor was shown in Figure 2.6. One end of the 
scaffolds was attached to the spool and the other end was attached to clamp systems of 
the culture chamber. The spool was further fixed to a stepper motor. Thus, the cyclic 
mechanical strain is applied on scaffolds by the rotation of the spool, which is driven 
by the stepper motor.  
Uniaxial cyclic strain of 1.8% at 0.1Hz was used 24 hours per day to stimulate cell 
sheet growth on knitted scaffold system. The cell sheet seeded scaffolds were cultured 
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with DMEM supplemented with 15% FBS and 50µg/ml ascorbic acid at 37°C with 5% 
humidified CO2. The culture medium was changed every 3 days. 
  
Figure 2.5 Cell sheet seeded scaffold in static (a) and bioreactor culture (b). 
 
Figure 2.6 Schematic diagram of the bioreactor 
 
2.5.2 Cell Viability 
Fibroblast viability on scaffold of different material was examined by Alamar BlueTM 
assay (USBiological, USA). For static cultured samples, sample medium was replaced 
by medium containing 10% (v/v) alamar blue. As for bioreactor cultured samples, the 
specimens were taken out from the bioreactor and place in non-treat Petri dishes. Same 
amount of medium containing 10% (v/v) alamar blue added into the Petri dishes. After 







reduction was then measured spectrophotometrically (Sunrise, Sunrise Intruments). 
Cell viability assay was carried out at 1, 3, 6, 10 and 21 days incubation. At each 
assessment time point, parallel samples of n=6 were used. 
2.5.3 Collagen quantification 
The specimens were taken out from bioreactor or culture dishes and place in non-treat 
Petri dishes. Specimens were further rinsed twice with PBS. Total collagen content of 
specimens was tested using Sirol Collagen Assay Kit (Biocolor, UK) as described in 
Section 2.4.3. 
Collagen content of cell sheet on scaffold of different materials was tested at 6, 10 and 
20 days of incubation respectively. While, collagen content of cell sheet-scaffold 
hybrid under was tested at 6, 10 and 20 days of incubation respectively. At each time 
point, parallel samples of n=6 were used. 
2.5.4 Live Cell Labeling 
After 20 days of culture, were taken out from bioreactor or culture dishes and place in 
non-treat Petri dishes and stained with live cell tracking stain CMFDA as described in 
Section 2.1.5 to investigate the morphology and viability of fibroblast cell sheet on 
different scaffold and cell sheet under different culture condition (static and bioreactor). 
2.5.5 Histological and Immunohistochemistry Examination 
After 20 days of culture, cell sheet-scaffold hybrids were taken out from bioreactor or 
culture dishes and place in non-treat Petri dishes and rinsed twice with PBS and fixed 
in 4% buffered formaldehyde solution. They were then dehydrated through alcohol 
gradients and embedded in paraffin blocks. Transverse and longitudinal sections 
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(10μm) were prepared from these specimens using a microtone (Leica Instrument, 
Bensheim, Germany) and subsequently stained with hematoxylin-eosin (H&E). 
In addition, streptavidin-biotin method was used to evaluate different types of collagen 
and tenascin-C in newly regenerated tissue. Histological sections were labeled with 
primary monoclonal anticollagen type I and III, antitenascin-C antibodies at 1:200 
dilutions from 1mg/ml stock solution (Sigma, USA). Subsequent experimental steps 
were as same as stated in Section 2.1.6. 
2.5.6 RNA Isolation and Quantitative RT-PCR 
At 10 and 20 days of culture, RNA of fibroblast cell sheet was isolated and used to 
characterize the gene copy number with RT-PCR. Briefly, specimens were taken out 
from bioreactor or culture dishes and place in non-treat Petri dishes and washed twice 
by PBS and cut into pieces before transferred from TCP to 1.5ml and homogenized 
with tissue homogenizer (TH-220, Omni International, Inc, US). The total RNA of cell 
sheet seed scaffolds was isolated by using RNeasy Mini Kit (Qiagen, USA) following 
the supplier’s instructions. 
The RNA samples were reverse transcribed into cDNA according to the 
manufacturer’s protocol (iScript cDNA synthesis Kit, BioRad). The “housekeeping” 
gene, glyceraldehydes-3-phosphate dehydrogenase (GAPDH) which presents in all 
cells was used to normalize the data and utilized as a marker that has an unchanged or 
constant level of expression in all samples. Quantitative PCR was conducted to 
determine the gene expression level of tenascin-C, type I and III type collagen, which 
were identified as phenotypic markers. Primers specific for type I collagen, type III 
collagen, tenascin-C and GAPDH were obtained from published literature (Cooper et 
al. 2006; Liu et al. 2008). The details of the primers are given in Table 2.3. 
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Quantitative PCR was performed on an iCycler instrument (BioRad, USA). The 
thermal parameters were described in Section 2.17. A melt curve was subsequently 
performed to analyze the products generated, which began at 50°C and increased to 
95°C in 0.5°C increments. At least three replicates were performed on each sample and 
each experimental gene was tested by three PCR runs. Data were analyzed by iQ5 
supplied by the vendor (BioRad, USA) as stated in Section 2.1.7. 















2.5.7 Mechanical Testing 
After 20 days of in vitro tissue culture, 3 specimens from each material group as well 
as culture condition group were used for biomechanical testing were taken out from 
bioreactor or tissue culture chambers. All the specimens were washed with PBS. Then 
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the specimens were mounted on the universal testing machine fitted with a 1000N load 
cell to test the mechanical properties of the specimens as described in Section 2.4.5. 
2.6 Statistical Analysis 
All data obtain were expressed as a mean ± standard deviation (SD). Single factor 
analysis of variance (ANOVA) technique was used to assess the statistical significance 
of results between groups at each assessment time point. Furthermore, single factor 
analysis of variance (ANOVA) technique was used to assess the statistical significance 
of results between each time point of one particular culture condition. The statistical 
analysis was performed at a confidence level of 95%. A value of p<0.05 was accepted 
as statistically significant. Furthermore, Fisher’s Least Significant Difference (LSD) 
was applied to compare the difference between different culture condition as well as 
different time point. The calculated p value of each set of experiment was shown in 
Appendix A.8. 
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Chapter 3. Results 
3.1 Dosage Response of Ascorbic Acid on Cell Sheet Formation 
In this study, fibroblasts cultured with medium containing 10% FBS with additional of 
0µg/ml, 50µg/ml, 100µg/ml ascorbic acid was used to study the effect of ascorbic acid 
concentration on fibroblast cell sheet formation. 
3.1.1 Cell Viability of Different Ascorbic Acid Stimulated Cell Sheet  
 
Figure 3.1 Assessment of cell viability over time under different ascorbic acid 
concentration treatment by alamarblue metabolic assay (n=6) 
 
The kinetics of cell proliferation rate under different ascorbic acid treatment is shown 
in Figure 3.1. Analysis of percent reduction of Alamar BlueTM revealed that fibroblast 
cultured with higher amount of ascorbic acid showed increase cell viability at each 
assessment time point (p<0.05). During the first 2 weeks of culture, a significant 
increase in cell viability was observed. The percent reduction of Alamar BlueTM 
increased from 53.65±0.78% to 65.24±0.83%, from 60.98±0.32% to 69.79±0.63% and 
from 64.38±0.94% to 72.89±0.95% for cell sheet treated with standard medium 
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containing 0μg/ml, 50μg/ml and 100μg/ml ascorbic acid respectively after 14 days of 
culture. 
However, after 14 days of culture, there was no significant increase in percent 
reduction for all cell sheets as culture time increase. The percent reduction of Alamar 
BlueTM only increased from 65.24±0.83% at day 14 to 65.19±0.49% at day 35 for cell 
sheet culture in absence of ascorbic acid, from 69.79±0.63% at day 14 to 70.54±0.23% 
at day 35 for 50μg/ml ascorbic acid stimulated cell sheet, and from 72.89±0.95% at 
day 14 to 74.79±0.44% at day 35 for cell sheet culture in presence of 100μg/ml 
ascorbic acid. 
3.1.2 Collagen Content of Different Ascorbic Acid Stimulated Cell Sheet 
 
Figure 3. 2 Effect of ascorbic acid concentration on collagen production over time of 
skin fibroblast cell sheet (n=6) 
Total collagen contents of fibroblast cell sheets at each time points were shown in 
Figure 3.2. Analysis of collagen content showed that the collagen content of fibroblast 
cell sheet increased with culture time. The collagen content of fibroblast cell sheet 
increased from 3.71±1.29μg at day 7 to 23.35±0.68μg at day 35 for cell sheet culture 
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in absence of ascorbic acid, from 5.63±0.63μg at day 7 to 31.33±1.82μg at day 35 for 
50μg/ml triggered cell sheet, and from 7.26±0.23μg at day 7 to 36.63±1.13μg at day 35 
for cell sheet culture with 100μg/ml ascorbic acid. 
3.1.3 Cell Sheet Thickness of Different Ascorbic Acid Stimulated Cell 
Sheet 
Table 3.1 Cell sheet thickness on day 35 by confocol method (n=6) 





Table 3.1 showed the measured average cell sheet thickness after 35 days of culture 
using confocal microscope method. The date showed that as ascorbic acid 
concentration increase, there was a significant increase in mean cell sheet thickness 
(p<0.05). 
Transverse sections (Figure 3.3) of cell sheet cultured with different amount of 
ascorbic acid showed that cell sheets comprised several layers of fibroblasts and the 
ECM synthesized by the fibroblasts. Table 3.2 showed the measured average cell sheet 
thickness after 35 days of culture from histology section. The cell sheet thickness of 
ascorbic acid cultured cell sheet and control group was varied from 30μm to 40μm, 




Figure 3.3 Histology of transverse section of fibroblast sheet after 5 weeks of culture (a, 
0µg/ml ascorbic acid, 200X; b, 50µg/ml ascorbic acid, 200X; c, 100µg/ml ascorbic 
acid, 200X) 
 
Table 3.2 Cell sheet thickness on day 35 by histology sections (n=6) 





3.1.4 Immunohistochemical Detection of Collagen Synthesis 
To evaluate the typical ECM components in fibroblast cell sheet, 
immnunohistochemistry technique was used to analyze type I, type III collagen 
distribution (Figure 3.4 and 3.5). Immnunohistochemistry analysis indicated that the 
ECM of fibroblast cell sheet was composed primarily of type I collagen and a small 
amount of type III collagen. Moreover, compared with fibroblast cell sheet cultured for 
10 days, higher level of collagen type I was detected after 5 weeks of culture in all 
sample groups. Furthermore, compared to fibroblast cultured without ascorbic acid, 
higher level of collagen type I was detected in specimens cultured in presence of 
ascorbic acid at both day 10 and day 35. However, there was no difference in type I 
  60
collagen expression between ascorbic acid triggered fibroblast cell sheets at both day 
10 and day 35. 
 
Figure 3.4 Immunohistochemistry evaluation of type I collagen in cell sheet cultured 
without ascorbic acid at day 10 (a) and day 35 (d), cell sheet cultured with 50µg/ml 
ascorbic acid at day 10 (b) and day 35 (e) and cell sheet cultured with 100µg/ml 
ascorbic acid at day 10 (c) and day 35 (f). 
 
Figure 3.5 Immunohistochemistry evaluation of type type III collagen in cell sheet 
without ascorbic acid at day 10 (a) and day 35 (d), cell sheet cultured with 50µg/ml 
ascorbic acid at day 10 (b) and day 35 (e) and cell sheet cultured with 100µg/ml 
ascorbic acid at day 10 (c) and day 35 (f). 
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Compared with type I collagen, low level of collagen type III was detected in (Figure 
3.5) at both day 10 and day 35 in all specimens. However, higher level of type III 
collagen was detected at day 35 than day 10 in all sample groups. Furthermore, cell 
sheet cultured with ascorbic acid express higher level of collagen type III at each 
assessment time point than fibroblast cell sheet cultured without ascorbic acid. But 
there was no difference in type III collagen expression between fibroblast cell sheets 
cultured with 50µg/ml and 100µg/ml ascorbic acid at both day 10 and day 35. 
 
3.1.5 Transcript Levels of Collagen Expression 
Comparison of mRNA transcript levels of type I and type III collagen genes were 
made between cell sheets cultured with different concentration of ascorbic acid. 
mRNA transcript expression of type I and type III collagen were evaluated by real-
time RT-PCR after 7, 21 and 35 days of culture (Figure 3.6). The real-time RT-PCR 
demonstrated significant gene expression profile difference between sample groups. In 
comparison with fibroblast cell sheet culture without ascorbic acid, the transcription 
levels of type I and type III collagen on cell sheet cultured with 50µg/ml and 100µg/ml 
ascorbic acid on each assessment time point were significantly upregulated (p<0.05). 
Furthermore, the transcript levels of both genes were upregulated in all sample groups 
with time (p<0.05). Compared with fibroblast cultured without ascorbic acid for 7 
days, transcription level of type I collagen was significantly increased by 1.40 and 1.49 
fold on cell sheet cultured with 50µg/ml and 100µg/ml ascorbic acid respectively after 
7 days of culture. Transcription level of type III collagen was increased by 1.18 and 
1.31 fold respectively on cell sheet cultured with 50µg/ml and 100µg/ml ascorbic acid. 
Compared with fibroblast cultured without ascorbic acid for 7 days, transcription level 
of type I collagen was significantly increased by 1.95, 2.34 and 2.79 fold on cell sheet 
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cultured with 0µg/ml, 50µg/ml and 100µg/ml ascorbic acid respectively after 21 days 
of culture and transcription level of type III collagen was increased by 1.64, 1.90 and 
2.15 fold on cell sheet cultured with 0µg/ml, 50µg/ml and 100µg/ml ascorbic acid 
respectively respectively. Compared with fibroblast cultured without ascorbic acid for 
7 days, the transcription level of type I collagen, was significantly increased by 2.72, 
3.78 and 4.02 fold cell sheet cultured with 0µg/ml, 50µg/ml and 100µg/ml ascorbic 
acid respectively after 5 weeks of culture and transcription level of type III collagen 
was increased by 1.92, 2.23 and 2.51 fold on cell sheet cultured with 0µg/ml, 50µg/ml 
and 100µg/ml ascorbic acid respectively. 
 
Figure 3.6 Expression of type I (a) and type III (b) collagen gene by cell sheet under 
different ascorbic acid concentration for 7, 21 and 35 days. Levels, quantified using 
real-time RT-PCR, are normalized to the housekeeping gene, GAPDH 
 
3.2 Dosage Response of Fetal Bovine Serum (FBS) on Cell Sheet 
Formation 
In this study, fibroblasts cultured with medium containing 10%, 15%, 20% and 25% 
FBS with additional of 50µg/ml ascorbic acid was used to study the effect of FBS on 
fibroblast cell sheet formation. 
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3.2.1 Varying FBS concentration on Cell Viability 
 
Figure 3.7 Assessment of cell viability over time under different FBS concentration 
treatment by alamarblue metabolic assay (n=6) 
 
The kinetics of cell viability with different FBS concentration is shown in Figure 3.7. 
Analysis of percent reduction of Alamar BlueTM revealed that fibroblast cultured with 
higher amount of FBS showed increase cell viability at each assessment time point 
(p<0.05). Moreover, during first 2 weeks, significant increase of cell viability of all 
sample groups was observed. Percent reduction of Alamar BlueTM of fibroblast cell 
sheet culture with 10%, 15%, 20% and 25% FBS increased from 60.98±0.32% to 
69.79±0.63%, 65.72±0.78% to 77.55±0.98%, 68.99±0.37% to 80.52±0.99% and 
72.25±0.84% to 85.95±1.32% respectively after 2 weeks of culture (p<0.05). However, 
after 14 days of culture, there was no significant increase in percent reduction for all 
cell sheets as increase in culture time. The percent reduction of Alamar BlueTM only 
increased from 69.79±0.63% at day 14 to 70.54±0.23% at day 35 for cell sheet culture 
with 10% FBS, from 77.55±0.98% at day 14 to 78.72±0.96% at day 35 for 50μg/ml for 
cell sheet culture with 15% FBS, from 80.52±0.99% at day 14 to 82.19±0.81% at day 
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35 for cell sheet culture with 20% FBS, and from 85.95±1.32% at day 14 to 
87.34±0.80% at day 35 for cell sheet culture with 25% FBS. 
3.2.2 Collagen Content of Different FBS Stimulated Cell Sheet 
 
Figure 3.8 Effect of FBS concentration on collagen production over time of skin 
fibroblast cell sheet (n=6) 
 
The collagen content of each time points of different amount of FBS stimulated cell 
sheet was shown in Figure 3.8. Analysis of collagen content showed that the collagen 
content of fibroblast cell sheet increased as increased in culture time. The collagen 
content increased from 5.63±0.63μg at day 7 to 31.33±1.82μg at day 35 for cell sheet 
culture with 10% FBS, from 8.97±0.89μg at day 7 to 74.23±2.04μg at day 35 for ell 
sheet culture with 15% FBS, from 14.23±0.62μg at day 7 to 93.40±8.80μg at day 35 
for ell sheet culture with 20% FBS, and from 25.41±3.16μg at day 7 to 114.61±2.31μg 
at day 35 for ell sheet culture with 25% FBS. 
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3.2.3 Cell Sheet Thickness of Different FBS Stimulated Cell Sheet 
Table 3.3 showed the measured average cell sheet thickness after 35 days culture of 
ascorbic acid. The date showed that as increase in FBS concentration, there was a 
significant increase in mean cell sheet thickness (p<0.05). 
Table 3.3 Cell sheet thickness on day 35 by confocol method (n=6) 
FBS Concentration (%) Average measured thickness (μm) 
10 38.50±1.52 
15 46.27±1.89  
20 48.84±1.38  
25 65.17±1.23  
 
Transverse sections (Figure 3.9) of cell sheet cultured with different FBS concentration 
showed that cell sheets comprised several layers of fibroblasts and ECM produced by 
the fibroblast. Table 3.4 showed the measured average cell sheet thickness after 35 
days of culture from histology section. The cell sheet thickness of ascorbic acid 
cultured cell sheet and control group was varied from 40μm to 70μm, which was 
consistent to cell sheet thickness obtained by confocol microscope method. 
Table 3.4 Cell Sheet thickness on day 35 by histology sections (n=6) 
FBS Concentration (%) Average measured thickness (μm) 
10 39.56±1.22 
15 47.78±1.19  
20 50.51±1.27  
25 66.35±1.34  
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Figure 3.9 Histology of transverse section of fibroblast sheet after 5 weeks of culture (a, 
10% FBS with 50µg/ml ascorbic acid; b, 15% FBS with 50µg/ml ascorbic acid; c, 20% 
FBS with 50µg/ml ascorbic acid; d, 25% FBS with 50µg/ml ascorbic acid) 
3.2.4 Immunohistochemical Detection of Collagen 
To evaluate the typical ECM components in fibroblast cell sheet, 
immnunohistochemistry technique was used to analyze type I, type III collagen 
distribution (Figure 3.10 and 3.11). Immnunohistochemistry analysis indicated that the 
ECM of fibroblast cell sheet was composed primarily of type I collagen and small 
amount of type III collagen. However, there was no difference in type I collagen 
expression between all sample groups at both day 10 and day 35. 
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Figure 3.10 Collagen type I analysis of cell sheet cultured with 10% FBS at day 10 (a) 
and day 35 (e), cell sheet cultured with 15% FBS at day 10 (b) and day 35 (f), cell 
sheet cultured with 20% FBS at day 10 (c) and day 35 (g) and cell sheet cultured with 
25% FBS at day 10 (d) and day 35 (h) 
 
Compared with type I collagen, low level of collagen type III was detected in (Figure 
3.11) at both day 10 and day 35 in all specimens. Moreover, higher level of type III 
collagen was detected at day 35 than day 10 in all sample groups. Furthermore, 
fibroblast cell sheet cultured with higher FBS concentration express higher level of 
collagen type III at day 10. But after 35 days of culture, there was no difference in type 
III collagen expression between all samples. 
 
Figure 3.11 Collagen type III analysis of cell sheet cultured with 10% FBS at day 10 (a) 
and day 35 (e), cell sheet cultured with 15% FBS at day 10 (b) and day 35 (f), cell 
sheet cultured with 20% FBS at day 10 (c) and day 35 (g) and cell sheet cultured with 
25% FBS at day 10 (d) and day 35 (h). 
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3.2.5 Transcript Levels of Collagen Expression 
Comparison of mRNA transcript levels of type I and type III collagen genes were 
made between cell sheets cultured with different concentration of FBS. mRNA 
transcript expression of type I and type III collagen were evaluated by real-time RT-
PCR after 7, 21 and 35 days of culture (Figure 3.12). The real-time RT-PCR 
demonstrated significant gene expression profile difference between sample groups. In 
comparison with fibroblast cell sheet culture with 10% FBS, the transcription levels of 
type I and type III collagen on cell sheet cultured with 15%, 20% and 25% FBS with 
additional 50µg/ml ascorbic acid on each assessment time point were significantly 
upregulated (p<0.05). Furthermore, the transcript levels of both genes were 
upregulated in all sample groups with time. Compared with fibroblast cultured with 
10% FBS for 7 days, transcription level of type I collagen was significantly increased 
by 1.79, 2.53 and 3.06 fold on cell sheet cultured with 15%, 20% and 25% FBS 
respectively after 7 days of culture. Transcription level of type III collagen was 
increased by 1.4, 1.9 and 2.43 fold on cell sheet cultured with 15%, 20% and 25% FBS 
respectively. Compared with fibroblast cultured with 10% FBS for 7 days, 
transcription level of type I collagen was significantly increased by 1.67, 3.89, 4.91 
and 5.61 fold on cell sheet cultured with 10%, 15%, 20% and 25% FBS respectively 
after 21 days of culture and transcription level of type III collagen was increased by 
1.65, 2.02, 2.84 and 3.25 fold on cell sheet cultured with 10%, 15%, 20% and 25% 
FBS respectively. Compared with fibroblast cultured with 10% FBS for 7 days, the 
transcription level of type I collagen was significantly increased by 2.70, 5.01, 6.88 
and 8.94 fold cell sheet cultured with 10%, 15%, 20% and 25% FBS respectively after 
5 weeks of culture and transcription level of type III collagen was increased by 1.93, 
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3.39, 4.88 and 5.86 fold on cell sheet cultured with 10%, 15%, 20% and 25% FBS 
respectively. 
 
Figure 3.12 Expression of type I (a) and type III (b) collagen gene by cell sheet under 
different FBS concentration for 7, 21 and 35 days. Levels, quantified using real-time 
RT-PCR, are normalized to the housekeeping gene, GAPDH 
3.3 Optimization of Fibroblast Cell Sheet Culture Condition 
3.3.1 Cell Viability on Different Culture Condition 
The kinetics of cell viability under different culture condition is shown in Figure 3.13. 
Cell viability assay showed similar trend that cell viability increased dramatically 
during fist 2 weeks of culture and remained plateau after that. Increase in ascorbic acid 
or FBS concentration resulted in increase cell viability at each assessment time point 
(p<0.05). However, fibroblast cell sheet cultured with 10% FBS and 100µg/ml 
ascorbic acid showed higher percent reduction of Alamar BlueTM  than fibroblast 
cultured with 15% FBS without ascorbic acid at each assessment time point. Fibroblast 
cultured with 15% FBS and 100µg/ml ascorbic acid showed higher percent reduction 
of Alamar BlueTM  than cell sheet cultured with 20% FBS and 0µg/ml ascorbic acid 
(p<0.05). Moreover, there is no significant difference in percent reduction of Alamar 
BlueTM  between fibroblast cultured with 10% FBS, 50µg/ml ascorbic acid and 
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fibroblast cultured with 15% FBS without ascorbic acid (p>0.05). There is also no 
difference in percent reduction of Alamar BlueTM  between fibroblast cultured with 
15% FBS, 50µg/ml ascorbic acid and cell sheet cultured with 20% FBS without 
ascorbic acid (p>0.05). 
 
Figure 3.13 Assessment of cell viability over time under different culture condition by 
alamarblue metabolic assay (n=6) 
 
3.3.2 Collagen Content of Cell Sheet under Different Culture Condition  
The collagen content of fibroblast cell sheet under different culture condition was 
shown in Figure 3.14. Fibroblast cell sheet showed steadily increase in collagen 
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content with time regardless of culture conditions (p<0.05). However, fibroblast cell 
sheets cultured with 10% FBS, 100µg/ml ascorbic acid showed higher collagen content 
than cell sheet cultured with 15% FBS without ascorbic acid (p<0.05). Fibroblast 
cultured with 15% FBS and 50µg/ml or 100µg/ml ascorbic acid showed higher 
collagen content than cell sheet cultured with 20% FBS without ascorbic acid (p<0.05). 
Furthermore, fibroblast cell sheets cultured with 10% FBS, 50µg/ml ascorbic acid 
showed similar collagen content as cell sheet cultured with 15% FBS without ascorbic 
acid (p>0.05). 
 
Figure 3.14 Collagen content of skin fibroblast cell sheet over time under different 
culture condition (n=6) 
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3.3.3 Normalized Collagen Content over Cell Viability 
Normalized collagen content of fibroblast cell sheet under different culture condition 
was shown in Figure 3.15. Normalized collagen content of fibroblast cell sheet showed 
steadily increase with culture time under all culture conditions (p<0.05). Cell sheet 
cultured with ascorbic acid showed higher normalized collagen content than cell sheet 
cultured without ascorbic acid under the same FBS concentration (p<0.05). 
Furthermore, cell sheet cultured cell sheet cultured with 15% FBS with ascorbic acid 
showed higher normalized collagen content than cell sheet cultured with 20% FBS 
without ascorbic acid (p<0.05). 
 
Figure 3.15 Normalized collagen content over percent reduction of Alamar BlueTM  at 
different time point 
 
3.3.4 Histology Study of Fibroblast Cell Sheet 
Transverse sections of cell sheet under different culture conditions are shown in Figure 
3.16. Fibroblast cell sheets were comprised of layers of fibroblast and ECM regardless 
of culture conditions. Furthermore, difference in cell sheet thickness was mainly due to 
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difference in collagen content. Fibroblast cell sheet with higher collagen content 
(Figure 3.16) resulted in thicker cell sheet. 
 
Figure 3.16 Histology section of cell sheet under different culture condition 
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3.3.5 RT-PCR Study of Transcript Levels of Collagen Expression 
 
 
Figure 3.17 Expression of type I (a) and type III (b) collagen gene on cell sheet under 
different culture condition for 7, 21 and 35 days. Levels, quantified using real-time 
RT-PCR, are normalized to the housekeeping gene, GAPDH 
Comparison of mRNA transcript levels of type I and type III collagen genes were 
made between cell sheets with different culture condition. mRNA transcript expression 
of type I and type III collagen were evaluated by real-time RT-PCR after 7, 21 and 35 
days of culture (Figure 3.17). The real-time RT-PCR demonstrated significant gene 
expression profile difference between sample groups (p<0.05). As FBS or ascorbic 
acid concentration increased, the gene expression of both type I and type III collagen 
was upregulated (p<0.05). Moreover, the gene expression of both type I and type III 
collagen was upregulated with culture time increase (p<0.05). However, there is no 
significant difference in type I and type III collagen gene expression between 
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fibroblast cell sheets cultured with 10% FBS, 100µg/ml ascorbic acid and cell sheet 
cultured with 15% FBS without ascorbic acid. Moreover, there is no significant 
difference in type I collagen gene expression between fibroblast cell sheets cultured 
with 15% FBS, 50µg/ml ascorbic acid and cell sheet cultured with 20% FBS without 
ascorbic acid. Fibroblast cultured with 15% FBS, 100µg/ml ascorbic acid showed 
higher type I and type III collagen gene expression than cell sheet cultured with 20% 
FBS without ascorbic acid. 
3.4 Degradation of Different Scaffold Material in Culture Medium 
3.4.1 FTIR Result 
The secondary structure of knitted silk scaffold and silk sponge modified knitted silk 
scaffold consists of the major conformations including random coils (silk I) and β-
sheet (silk II). FTIR spectroscopy was used to detect conformational changes that may 
occur during degradation process. Random coil shows absorption peak at 1665cm-1 
(amide I), 1540cm-1 (amide II) and 1265cm-1 (amide III) and the β-sheet shows 
absorption peak at 1624cm-1 (amide I), 1520cm-1 (amide II) and 1235cm-1 (amide III) 
(Um et al. 2003; Ayutsede et al. 2005; Barth 2007). 
Figure 3.18 shows the FTIR spectra of raw silk scaffold and knitted silk scaffolds at 
each degradation time point. There is no absorption peaks at 1665cm-1 in FTIR spectra 
of raw silk scaffold indicating no random coil structure in raw silk fibers. However, 
there are absorption peaks at 1653cm-1 in FTIR spectra of knitted silk scaffold at day 1, 
day 7 and day 14 indicating hydrophilic component in degummed silk fibroins. 
However, after 28 and 42 days immerged in culture medium, FTIR spectra exhibited 
no absorption peaks at 1653cm-1. Furthermore, there is no significant difference in the 
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major peaks between the FTIR spectra of knitted silk scaffold at day 28, day 42 and 
raw silk fibers. 
Figure 3.19 shows the FTIR spectra of silk sponge modified silk scaffold. FTIR 
spectra of silk sponge modified scaffold at day 1 and 7 also shows absorption peak at 
1653cm-1. Moreover, the absorption peak at 1653cm-1 no longer exhibited after 14 
days immerged in culture medium. There is also no significant difference in the major 
peaks between the FTIR spectra of knitted silk scaffold at day 14, day 28, day 42 and 
raw silk fibers. 
The FTIR spectra of knitted PLLA scaffold at different degradation time point is 
shown in Figure 3.19. No difference in the spectra was observed between PLLA fibers 
at different degradation time point. All FTIR spectra of PLLA fibers showed typical 
C=O vibration peak at 1754cm-1, C-C vibration peak at 1092cm-1 and C-O vibration 
peak at 1188cm-1 (Hildebrand et al. 1998). 
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Figure 3.18 The FTIR spectra of raw silk scaffold and degummed silk scaffold at 
different degradation time point 
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Figure 3.20 The FTIR spectra of knitted PLLA scaffold at different degradation time 
point 
3.4.2 Differential Scanning Calorimetry Result 
The thermograms of the knitted silk scaffold are shown in Figure 3.21. No difference 
in the DSC curve was seen between knitted silk scaffolds at different degradation time 
point. All samples exhibited one big endothermic peak around 100°C which attributed 
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to evaporation of the water, and an endothermic peak started around 300°C which 
attribute to the destruction of the silk fibroin. Furthermore, no exothermic peak 
appeared at 230°C, which indicated that a cold crystallization of β-sheet from the 
random coil occurred (Magoshi et al. 1977; Chen et al. 2006), was observed which 
indicating no random coil structure in all samples. 
 
Figure 3.21 DSC thermograph of raw silk fiber and degummed silk fiber after 1, 7, 14, 
28 and 42 days immerged in culture medium 
As shown in Figure 3.22, the thermogram of silk sponge without methanol treatment 
showed water evaporation endothermic peak around 100°C and fibroin destruction 
peak around 290°C. Furthermore, there was an exothermic peak appeared at 230°C, 
which indicated that a cold crystallization of β-sheet from the random coil occurred. 
However, there was no peak at 230°C in thermograms of silk sponge modified silk 
scaffold after methanol treatment (Figure 3.23). Furthermore, there is no significant 
difference in thermograms of silk sponge at different degradation time point. Moreover, 
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silk sponge modified knitted silk scaffolds at all degradation time point showed an 
endothermic silk fibroin destruction peak started around 300°C. 
 
Figure 3.22 DSC thermograph of silk sponge without methanol treatment 
 
 
Figure 3.23 DSC thermograph of raw silk fiber and silk sponge modified knitted silk 
scaffold after 1, 7, 14, 28 and 42 days immerged in culture medium 
 
The thermogram of knitted PLLA scaffold is shown in Figure 3.24. PLLA fibers at 
different time point all showed glass transition temperature (Tg) around 70°C and 
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melting temperature (Tm) around 185°C. The crystallinity of knitted PLLA fiber at 
different degradation time point was evaluated by the heat of fusion. By integrating the 
normalized area of the melting endotherm, determining the heat involved and rating it 
to the reference 100% crystalline polymer (93.6J/g (Leenslag et al. 1984)), the relative 
crystallinity of the PLLA fiber was assessed. The relative degree of cystallinity of 
PLLA fiber decreased from 65.67% to 56.16% after 2 weeks of in vitro degradation, 
and reached 53.50% after 28 days of degradation. 
 
Figure 3.24 DSC thermograph of knitted PLLA scaffold after 1, 7, 14 days immerged 
in culture medium 
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3.4.3 Gel Permeation Chromatograph Result 
The Bombyx mori silk fibroin consists of two proteins: a light chain and heavy chain in 
a 1:1 ratio. The molecular weight of heavy chain protein of silk fibroin is around 
390KDa and the molecular weight of light chain protein is around 25KDa (Fournier 
1979; Vepari et al. 2007). GPC measurements were used to observe the changes in 
molecular weight of light chain and heavy chain components of the silk fibroin 
throughout the degradation process. 
The GPC curves of knitted silk scaffolds are shown in Figure 3.25. It was found that 
silk fibroin consisted of mainly heavy chain dimer with molecular weight of 700KDa 
and light chain component with molecular weight of 21KDa as well as a small 
proportion of heavy chain component with peak retention time of 13.500min (arrow 
pointed in Figure 3.25). The molecular weight of the light chain protein decreased and 
the molecular weight distribution broaden during first 2 weeks degradation process. 
The weight average molecular weight (Greenwald et al.) of the light chain component 
dramatically decreased from an original 20990Da to 7693Da after 2 weeks of in vitro 
degradation. Moreover, the molecular weight distribution changed from 1.29 at day 1 
to 1.61 at day 14. After 28 days of in vitro degradation, the light chain protein was 
degraded and only degradation residues with Mw of 2814Da were detected. The Mw 
of the degradation residues decreased to 2483 after 42 days of in vitro degradation. 
However, the Mw of heavy chain dimer remained unchanged throughout the 
degradation period and the molecular weight of heavy chain slightly decreased as 
indicated by the decrease of peak retention time from 13.986min at day 14 to 
14.071min at day 42. 
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Figure 3.26 GPC trace of silk sponge modified knitted silk scaffold at different 
degradation times 
  86
The GPC curves of silk sponge modified knitted silk scaffolds are shown in Figure 
3.26. It was found that silk sponge consisted of mainly heavy chain dimer with Mw of 
700KDa and a small proportion of heavy chain with peak retention time of 13.500min. 
However, the light chain component of the silk fibroin in sponge was cleaved into two 
components with Mw of 19.6KDa and 4324Da respectively during the fabrication 
process. After 7 days immerged in culture medium, the Mw of these two components 
decreased to 18152Da and 3540Da, respectively. After 14 days of in vitro degradation, 
the light chain components were fully degraded and there was only degradation residue 
with Mw of 2558Da was detected. The Mw of the degradation residue further 
decreased from 2558Da to 2027Da after 42 days of degradation. Moreover, the Mw of 
heavy chain dimer remained unchanged throughout the degradation period and the 
molecular weight of heavy chain slightly decreased as indicated by the decrease of 
retention time from 13.777min at day 14 to 14.005min at day 42. 
 
Figure 3.27 GPC trace of knitted PLLA scaffold at different degradation times 
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The GPC curves of knitted silk scaffolds are shown in Figure 3.27. PLLA fibers 
showed a slight decrease in Mw. The Mw of the PLLA fibers decreased from an 
original value of 2.26×106Da to 2.02×106Da after 4 weeks of in vitro degradation. 
Furthermore, the peak tops of the GPC curve decreased from 14.298min at day 1 to 
14.581min at day 28. 




Figure 3.28 Mechanical properties of knitted PLLA (a), knitted silk (b) and silk sponge 
modified knitted silk scaffold (c) as a function of in vitro degradation time in culture 
medium 
 
The change in ultimate load and tensile stiffness of knitted PLLA, knitted silk and silk 
sponge modified knitted silk scaffold was shown in Figure 3.28. There was no 
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significant difference in failure load and tensile stiffness between knitted PLLA 
scaffolds at each assessment time point. The ultimate load of both knitted silk and silk 
sponge modified knitted silk scaffold decreased after 2 weeks of in vitro degradation 
and remain plateau after that (p<0.05). The decrease of ultimate load of silk sponge 
modified knitted scaffold (18.43%) was larger than knitted silk scaffold (12.80%). 
However, there was no difference in tensile stiffness between knitted silk scaffolds at 
different time point. Whereas, the tensile stiffness of silk sponge modified knitted silk 
scaffold decreased after 1 weeks of degradation and remained plateau after that 
(p<0.05). 
3.5 Effect of Scaffold Geometries on in vitro Tissue Culture 
3.5.1 Fibroblast Viability on Different Scaffold Geometries 
 
Figure 3.29 Assessment of cell viability over time on different scaffold format by 
alamarblue metabolic assay (n=6 for each geometry) 
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Figure 3.29 showed the percent reduction of Alamar BlueTM of cell sheet/scaffold 
hybrid of different geometry at each assessment time point. From the experimental 
date, there was no significant difference in percent reduction of Alamar BlueTM of 
different geometries at each time point and the percent reduction of Alamar BlueTM 
increased with culture time. The percent reduction of Alamar BlueTM increased from 
38.36±0.53%, 38.50±0.65% and 38.41±0.62% at day 1 to 47.34±0.54%, 
46.23±1.64% and 46.99±2.30% at day 7 for flat, folded and rolled format respectively. 
The percent reduction of Alamar BlueTM finally increased to 60.02±0.75%, 
63.28±0.66% and 62.26±0.67% after 28 days of culture for flat, folded and rolled 
format respectively. 
3.5.2 Collagen Content of Different Scaffold Geometries 




















 0ug/ml Ascorbic Acid
 50ug/ml Ascorbic Acid
 100ug/ml Ascorbic Acid
 
Figure 3.30 Collagen production over time of different geometries (n=6) 
The collagen content of cell sheet/scaffold hybrid of different geometry at each assay 
time point was shown in Figure 3.30. At each time point, there was no significant 
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difference in collagen content between geometries. Furthermore, with culture time, the 
collagen content of tissue analog of different geometry increased (p<0.05). The total 
collagen content after 7 day of culture was 12.76±1.21μg, 12.67±1.14μg, and 
12.09±1.81μg for flat, folded and rolled format respectively. After 14 days of culture, 
the collagen content increased to 37.12±0.81μg, 40.67±1.49μg, and 40.49±6.12μg for 
flat, folded and rolled format respectively. After 28 days of culture, the collagen 
content of flat, folded and rolled format reached 67.29±0.30μg, 66.42±1.91μg, and 
67.44±1.09μg respectively. 
3.5.3 Cell Survivability on Different Scaffold Geometries 
Figure 3.31 showed the fluorescent image of cell sheet seeded scaffolds of different 
geometries after day 28 days of culture. The fluorescence image showed that cell 
sheets adhered onto knitted PLLA scaffold. Moreover, fibroblast cell sheet coved the 
macro poses of knitted scaffold regardless of scaffold geometries. After 4 weeks of 
culture, fibroblast cell sheets on all three formats were viable as indicated by positive 
CMFDA staining under fluorescent microscopy. 
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Figure 3.31 Effect of scaffold geometry and culture period on cell content and matrix 
deposition. (a)-(b), (c)-(d), (e)-(f): Adhesion of cell sheet on rolled, folded and flat 
scaffold respectively after 28 days of culture 
 
3.5.4 Mechanical Testing of Cell Sheet-Knitted PLLA Scaffold Hybrid 
The mean ultimate load and tensile stiffness of scaffold only groups and tissue analogs 
of different geometry was shown in Figure 3.32. There was no significant difference in 
ultimate load and stiffness between different scaffold geometry after 28 days of in vitro 
culture. The mean ultimate load of cell sheet-scaffolds hybrid (n=6) was 24.78±2.22N, 
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23.48±2.41N and 23.94±2.96N for flat, folded and rolled format respectively. The 
tensile stiffness was 6.40±0.84N/mm, 6.55±0.45N/mm and 6.52±0.90N/mm for flat, 
folded and rolled format respectively. 
Moreover, the mean ultimate load and tensile stiffness of original knitted PLLA 
scaffold were 23.29±3.00N and 6.10±0.37N/mm respectively (n=6). After 28 days in 
culture medium, the mean ultimate load and tensile stiffness of original knitted PLLA 
scaffold were 22.56±2.65N and 5.83±0.80N/mm respectively (n=6). The ultimate load 
of cell sheet seeded scaffolds was slightly higher than that of both original scaffold and 
scaffold after 28 days of culture. However, there was no significant difference in 
ultimate load and tensile stiffness between different sample groups. 
 
Figure 3.32 Histogram comparing the mean (± SD) ultimate load (a) and tensile 
stiffness (b) of cell sheet-scaffold hybrid with scaffold alone after 4 weeks of culture 
 
3.6 Effect of Scaffold Material on in vitro Tissue Culture 
3.6.1 Cell Viability on Scaffold with Different Material 
The kinetics of cell sheet viability on knitted PLLA, knitted silk scaffold and silk 
sponge modified scaffold is shown in Figure 3.33 Analysis of percent reduction of 
Alamar BlueTM revealed that fibroblast cell sheet viability increase on all types of 
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scaffolds with culture time. Cell sheet on silk sponge modified knitted silk scaffold 
showed highest percent reduction of Alamar BlueTM among all types of scaffolds at 
each assessment time point (p<0.05). While cell sheet on knitted silk scaffold showed 
higher percent reduction of Alamar BlueTM at each assessment time point than knitted 
PLLA scaffold (p<0.05). The percent reduction of Alamar BlueTM singnificantly 
increased from 46.97±0.65%, 52.13±0.90% and 56.92±0.48% at day 1 to 58.64±0.56%, 
64.17±0.57% and 73.96±0.96% at day 10 for knitted PLLA, knitted silk and silk 
sponge modified knitted silk scaffold respectively (p<0.05). The percent reduction of 
Alamar BlueTM finally increased to 73.12± 0.31%, 80.10± 0.34% and 87.84± 0.78% at 
day 20 for knitted PLLA, knitted silk and silk sponge modified knitted silk scaffold 
respectively (p<0.05). 
 
Figure 3.33 Assessment of cell viability over time on scaffold of different material by 
alamarblue metabolic assay (n=6) 
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3.6.2 Collagen Content of Cell Sheet on different Scaffold Material 
The collagen content of different geometries of scaffolds at each assay time point was 
shown in Figure 3.34. The collagen content of fibroblast cell sheet of all types of 
scaffolds increased with culture time. Moreover, at each time point, cell sheet on silk 
sponge modified knitted silk scaffold showed highest amount of collagen among all 
three types of scaffolds (p<0.05); While cell sheet on knitted silk scaffold showed 
higher collagen content than cell sheet on knitted PLLA scaffold (p<0.05). The total 
collagen content after 6 day of culture was 30.82±3.41μg, 71.41±4.20μg and 
106.76±1.63μg for knitted PLLA, knitted silk and silk sponge modified knitted silk 
scaffold respectively. After 10 days of culture, the collagen content increased to 
77.82±1.59μg, 87.39±1.79μg, and 181.09±5.05μg for knitted PLLA, knitted silk and 
silk sponge modified knitted silk scaffold respectively (p<0.05). After 20 days of 
culture, the collagen content of knitted PLLA, knitted silk and silk sponge modified 
knitted silk scaffold reached 87.11±2.00μg, 104.06±2.31μg, and 190.52±2.36μg 
respectively (p<0.05). 
 
Figure 3.34 Collagen content over time on scaffold of different material (n=6) 
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3.6.3 Immunochemistry and Histology Study of Cell Sheet on Different 
Scaffold Material 
 
Figure 3.35 viable cells sheet on knitted PLLA scaffold and (b) viable cell sheet on 
knitted silk scaffold. (magnification: 12.5X)(a) viable cells sheet on knitted PLLA 
scaffold and (b) viable cell sheet on knitted silk scaffold. (magnification: 12.5X) 
 
 
Figure 3.36 Histology section of cell sheet on knitted PLLA scaffold (a), knitted silk 
scaffold (b), silk sponge modified knitted silk scaffold (c) and transverse sections for 
knitted PLLA scaffold (d), knitted silk scaffold (e), silk sponge modified knitted silk 
scaffold (f) after 20 days of culture (S:scaffold, SP: silk sponge) 
 
Figure 3.35 showed the fluorescent image of fibroblast sheet on knitted PLLA and 
knitted silk scaffold at day 20. The fluorescence image showed that cell sheets adhered 
onto both kinds of knitted scaffolds. After 20 days of culture, fibroblast cell sheet was 
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still alive and filled up the macroposes of knitted scaffold as indicated by positive 
CMFDA staining under fluorescent microscopy. 
Histology sections of cell sheet on scaffold with different materials are shown in 
Figure 3.36. H&E staining of the longitudinal sections (Figure 3.36(a)-(c)) showed 
formation of fibrous matrix with a large number of cells in matrix indicating the 
formation of connective tissue. The transverse section (Figure 3.36(d)-(f)) showed that 
a large number of cells present in connective tissue that filled and wrapped the scaffold 
which indicated that cell sheet integrated into knitted PLLA, knitted silk and silk 
sponge modified knitted silk scaffold. 
 
Figure 3.37 Immunohistochemistry of the fibroblast sheet-scaffold hybrid after 20 days 
of culture showing that cell sheet integrated into knitted scaffold system (original 
magnification: 200X; s: scaffold; (a)-(c) knitted PLLA scaffold; (d)-(f) knitted silk 
scaffold; (g)-(i) silk sponge modified knitted silk scaffold) 
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After 20 days of culture, the composite of cell sheet-scaffold hybrid of all types of 
scaffold material became a tissue like structure (Figure 3.37). Immunohistochemical 
analysis indicated that the matrix of neoligament tissue was composed primarily of 
collagen type I, small amount of type III collagen and tenascin-C. Furthermore, highest 
level of type I, type III collagen and tenascin-C was detected on cell sheet on silk 
sponge modified knitted silk scaffold. Higher level of type I, type III collagen and 
tenascin-C was detected on cell sheet on knitted silk scaffold than cell sheet on knitted 
PLLA scaffold. 
3.6.4 Transcript Levels of ECM Genes of Cell Sheets on Different Knitted 
Scaffold Systems 
Comparison of mRNA transcript levels of ligament/tendon related genes were made 
between cell sheets cultured on scaffold of different material. mRNA transcript 
expression of type I collagen, type III collagen, and tenascin-C were evaluated by real-
time RT-PCR after 10 and 20 days of culture (Figure 3.38). The real-time RT-PCR 
demonstrated significant gene expression profile difference between sample groups. In 
comparison with cell sheets on knitted PLLA scaffold, the transcription levels of type I 
collagen, type III collagen, and tenascin-C of cell sheets on knitted silk and sponge 
modified knitted silk scaffolds at both day 10 and 20 were significantly upregulated 
(p<0.05). Furthermore, the transcript levels of type I collagen, type III collagen, and 
tenascin-C genes were upregulated in all sample groups with time (p<0.05). When 
compared with knitted PLLA scaffold at 10 days, transcription level of type I collagen 
was significantly increased by 1.35 and 2.55 fold on knitted silk and silk sponge 
modified knitted silk scaffold respectively after 10 days of culture. Transcription level 
of type III collagen was increased by 1.11 and 1.57 fold on knitted silk and silk sponge 
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modified knitted silk scaffold respectively.  Transcription level of tenascin-C was 
increased by 1.47 and 2.34 fold on knitted silk and silk sponge modified knitted silk 
scaffold respectively. 
When compared with knitted PLLA scaffold at day 10, transcription level of type I 
collagen was significantly increased by 2.23, 2.55 and 3.11 fold on knitted PLLA, 
knitted silk and silk sponge modified knitted silk scaffold respectively. Transcription 
level of type III collagen was increased by 1.56, 1.57 and 2.27 fold on knitted PLLA, 
knitted silk and silk sponge modified knitted silk scaffold respectively.  Transcription 
level of tenascin-C was increased by 1.95, 2.34 and 2.79 fold on knitted PLLA, knitted 
silk and silk sponge modified knitted silk scaffold respectively. 
 
Figure 3.38 Expression type I collagen, type III collagen, and tenascin-C genes by cell 
sheet-scaffold hybrid for 10 and 20 days. Levels, quantified using real-time RT-PCR, 
are normalized to the housekeeping gene, GAPDH 
 
3.6.5 Mechanical Testing of Cell Sheet on Different Knitted Scaffold 
System 
The mean ultimate load and stiffness of cell sheet on knitted PLLA, knitted silk and 
silk sponge modified knitted silk scaffolds is shown in Figure 3.39. The mean ultimate 
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load of cell sheet-scaffolds hybrid (n=3) was 24.34±2.55N, 18.08±2.63N and 
30.17±3.61N for knitted PLLA, knitted silk and silk sponge modified knitted silk 
scaffold respectively. The stiffness was 6.17±0.62N/mm, 2.074±0.035N/mm and 
3.04±0.27N/mm for knitted PLLA, knitted silk and silk sponge modified knitted silk 
scaffold respectively. 
 
Figure 3.39 Histogram comparing the mean (± SD) ultimate load (a) and tensile 
stiffness (b) of cell sheet-scaffold hybrid with scaffold alone after 20 days of culture 
 
Moreover, the mean ultimate load of original knitted PLLA, knitted silk and silk 
sponge modified knitted silk scaffold was 23.29±3.00N, 18.70±2.98N and 
35.16±2.68N, respectively. The stiffness of knitted PLLA, knitted silk and silk sponge 
modified knitted silk scaffold was 6.10±0.37N/mm, 2.22±0.031N/mm and 
  100
3.79±0.32N/mm respectively. After 20 days immerged in culture medium, the mean 
ultimate load of knitted PLLA, knitted silk and silk sponge modified knitted silk 
scaffold was 22.78±2.32N, 15.80±1.52N and 28.78±2.56N, respectively. The stiffness 
of knitted PLLA, knitted silk and silk sponge modified knitted silk scaffold was 
6.07±0.72N/mm, 2.26±0.063N/mm and 3.32±0.67N/mm respectively. The failure load 
of knitted silk scaffold and sponge modified knitted silk scaffold groups possessed 
higher failure load than that of scaffolds only group after 20 days of immerged in 
culture medium. While the stiffness of these two groups was slightly lower than that of 
control groups. However, there was no significant difference in failure load and 
stiffness between knitted PLLA sample groups. 
3.7 Effect of Mechanical Stimulation on in vitro Tissue Culture 
3.7.1 Effect of Mechanical Stimulation on Cell Viability 
The kinetics of cell viability on knitted silk scaffold and silk sponge modified scaffold 
under static and bioreactor culture condition is shown in Figure 3.40. Analysis of 
percent reduction of Alamar BlueTM revealed that fibroblast cell sheet viability of both 
types of scaffolds increased with culture time regardless of culture condition. Cell 
sheet-scaffold hybrid cultured in bioreactor condition showed higher percent reduction 
of Alamar BlueTM than under static culture condition (p<0.05). However, cell sheet on 
silk sponge modified knitted silk scaffold under static culture condition showed higher 
percent reduction of Alamar BlueTM at each assessment time point than knitted silk 
scaffold under bioreactor culture condition. The percent reduction of Alamar BlueTM 
increased from 52.13±0. 0.91%, 53.94±0.69%, 56.92±0.48% and 58.59±0.61% at day 
1 to 64.17±0.57%, 65.20±0.64%, 73.96±0.96% and 76.73±0.75% at day 10 for knitted 
silk scaffold under static and bioreactor culture condition, and silk sponge modified 
  101
knitted silk scaffold under static and bioreactor culture condition respectively. The 
percent reduction of Alamar BlueTM increased to 80.10±0.34%, 83.27±0.80%, 
87.84±0.78% and 91.87±0.79% at day 20 for knitted silk scaffold under static and 
bioreactor culture condition, and silk sponge modified knitted silk scaffold under static 
and bioreactor culture condition respectively. 
 
Figure 3.40 Assessment of cell viability over time under different culture condition by 
alamarblue metabolic assay 
 
3.7.2 Effect of Mechanical Stimulation on Collagen Content 
The collagen content of cell sheet on knitted silk scaffold and silk sponge modified 
scaffold under static and bioreactor culture condition is shown in Figure 3.41. As 
increase in culture time, the collagen content of fibroblast cell sheet-scaffold hybrid 
increased regardless of culture conditions. Furthermore, cell sheet cultured in 
bioreactor showed higher collagen content than that of under static culture. Moreover, 
at each time point, cell sheet on silk sponge modified knitted silk scaffold under 
bioreactor culture condition showed highest amount of collagen among all sample 
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groups. Cell sheet on silk sponge modified knitted silk scaffold under static culture 
showed higher collagen content than cell sheet on knitted silk scaffold cultured in 
bioreactor. The total collagen content after 6 day of culture was 71.41±4.20μg, 
93.74±0.74μg, 106.76±1.63μg and 155.01±1.65μg for knitted silk scaffold under static 
and bioreactor culture condition, and silk sponge modified knitted silk scaffold under 
static and bioreactor culture condition respectively. After 10 days of culture, the 
collagen content increased to 87.39±1.79μg, 132.45±0.39μg, 181.09±5.05μg and 
201.41±2.26μg for knitted silk scaffold under static and bioreactor culture condition, 
and silk sponge modified knitted silk scaffold under static and bioreactor culture 
condition respectively. After 20 days of culture, the collagen content increased to 
104.06±2.31μg, 160.85±1.37μg, 190.52±2.36μg and 238.61±4.70μg for knitted silk 
scaffold under static and bioreactor culture condition, and silk sponge modified knitted 
silk scaffold under static and bioreactor culture condition respectively. 
 
Figure 3.41 Collagen content over time under different culture condition 
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3.7.3 Immunochemistry and Histology Study of Cell Sheet-Knitted 
Scaffold Hybrid under Different Culture Condition 
 
Figure 3.42 Immunohistochemistry of the fibroblast sheet-knitted silk scaffold hybrid 
under static culture condition (a-c) and under bioreactor condition (d-f) after (original 
magnification: 200X) 
 
Figure 3.43 Immunohistochemistry of the fibroblast sheet-silk sponge modified 
scaffold hybrid under static culture condition (a-c) and under bioreactor condition (d-f) 




Figure 3.44 Histology section of cell sheet on knitted silk scaffold under static culture 
condition(a) and under bioreactor culture condition (b) after 20 days of culture (arrow: 
load direction) 
 
Figure 3.45 Histology section of cell sheet on silk sponge modified knitted silk 
scaffold under static culture condition(a) and under bioreactor culture condition (b) 
after 20 days of culture (arrow: load direction) 
After 20 days of culture, the composite of cell sheet-scaffold hybrid became a tissue 
like structure (Figure 3.42 & Figure 3.43). Immunohistochemical analysis indicated 
that the matrix of neoligament tissue was composed primarily of collagen type I, small 
amount of type III collagen and tenascin-C. Moreover, cell sheet-scaffold hybrid 
cultured in bioreactor showed higher level of type I, type III collagen and tenascin-C 
expression than hybrid under static culture condition. 
Histology section of cell sheet on knitted scaffold under static and bioreactor culture 
condition is shown in Figure 3.44. Histology section of cell sheet on silk sponge 
modified knitted scaffold under static and bioreactor culture condition is shown in 
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Figure 3.45. H&E staining showed that after 20 days of culture under cyclic loading, 
the fibroblasts and the ECM secreted were oriented towards the stress direction. 
3.7.4 Effect of Mechanical Stimulation on Matrix Protein Expression of 
Cell Sheet-Knitted Scaffold Hybrid 
mRNA transcript expression of type I collagen, type III collagen, and tenascin-C for 
cell sheet on scaffold of different material under static and bioreactor culture condition 
were shown in Figure 3.46. The real-time RT-PCR demonstrated significant gene 
expression profile difference between sample groups. In comparison with knitted silk 
scaffold under static culture condition, the transcription levels of type I collagen, type 
III collagen, and tenascin-C on knitted silk under bioreactor culture condition, sponge 
modified knitted silk scaffold on both culture conditions were significantly upregulated 
(p<0.05). Furthermore, the transcript levels of both genes were upregulated in all 
sample groups with time. Compared with knitted silk scaffold after 10 days of static 
culture, transcription level of type I collagen on knitted silk scaffold culture in 
bioreactor, and silk sponge modified knitted silk scaffold under both static and 
bioreactor culture was significantly increased by 1.22, 2.55 and 3.11 fold respectively. 
The transcription level of type III collagen was significantly increased by 1.41, 1.57 
and 2.27 for knitted silk scaffold cultured in bioreactor, and sponge modified silk 
scaffold culture in both static condition and bioreactor respectively. The transcription 
level of tenascin-C was significantly increased by 1.49, 2.34 and 3.26 for knitted silk 
scaffold cultured in bioreactor, and sponge modified silk scaffold culture in both static 
condition and bioreactor respectively. 
Compared with knitted silk scaffold after 10 days of static culture, transcription level 
of type I collagen, was significantly increased by 1.57, 1.93, 3.97 and 5.10 fold on 
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knitted silk under static and bioreactor culture condition, and sponge modified knitted 
silk scaffold under static and bioreactor condition respectively after 20 days of culture. 
The transcription level of type III collagen was significantly increased by 1.73, 1.94, 
3.32 and 4.68 fold on knitted silk under static and bioreactor culture condition, and 
sponge modified knitted silk scaffold under static and bioreactor condition respectively 
after 20 days of culture. The transcription level of tenascin-C was significantly 
increased by 2.11, 2.79, 3.61 and 4.45 fold on knitted silk under static and bioreactor 
culture condition, and sponge modified knitted silk scaffold under static and bioreactor 
condition respectively after 20 days of culture. 
 
Figure 3.46 Expression of ligament/tendon related ECM gene by cell sheet-scaffold 
hybrid for 10 and 20 days under different culture condition. Levels, quantified using 
real-time RT-PCR, are normalized to the housekeeping gene, GAPDH 
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3.7.5 Effect of Mechanical Stimulation on Mechanical Properties of Cell 
Sheet-Knitted Scaffold Hybrid 
 
 
Figure 3.47 Histogram comparing the mean (± SD) ultimate load (a) and tensile 
stiffness (b) of cell sheet-scaffold hybrid with scaffold alone after 20 days of culture 
 
The mean ultimate load and stiffness of cell sheet-scaffolds hybrid under static and 
bioreactor culture condition is shown in Figure 3.47. The mean ultimate loads of cell 
sheet-scaffolds hybrid were 19.75±4.36N and 30.82±1.05N for knitted silk and silk 
sponge modified knitted silk scaffold cultured in bioreactor, respectively. The stiffness 
was 0.94±0.057N/mm and 2.48±0.34N/mm for knitted silk and silk sponge modified 
knitted silk scaffold culture in bioreactor respectively. 
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Moreover, after 20 days under cyclic loading, the mean ultimate load and tensile 
stiffness became 15.8±1.52N and 2.26± 0.063N/mm respectively for knitted silk 
scaffold. The mean ultimate load and tensile stiffness became 27.69±1.10N and 
2.28±0.51N/mm respectively for silk sponge modified knitted silk scaffold. The failure 
load and tensile strength of scaffold only group culture in bioreactor was lower than 
those of original scaffold as well as scaffold immerged in culture medium statically. 
However, the cell sheet-scaffold hybrid cultured in bioreactor showed increase in 
failure load compared with those of hybrid cultured statically. The tensile stiffness of 
cell sheet-scaffold hybrid cultured in bioreactor decreased dramatically as compared 
with hybrid cultured statically. The tensile stiffness of cell sheet-scaffold hybrid under 
bioreactor culture condition was slight higher than that of scaffold only group cultured 
in bioreactor. 
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Chapter 4. Discussion 
4.1 Dose Response of Ascorbic Acid Concentration on Cell Sheet 
Formation 
Fibroblast cell sheet has been used for tissue engineering applications (Takezawa et al. 
1993; Michel et al. 1999; Ito et al. 2005). Ascorbic acid/ascorbates are commonly 
added into culture medium to culture fibroblast cell sheet due to their ability to 
stimulate collagen synthesis (Blanck et al. 1975; Spanheimer et al. 1985; Chan et al. 
1990; Anderson et al. 1991). In the present study, fibroblasts were cultured with 
different concentrations of ascorbic acid in order to investigate the dose response of 
ascorbic acid on fibroblast cell sheet formation process. As previous studies indicated 
an inhibitory response of fibroblast proliferation to ascorbic acid supplementation with 
half-maximal inhibition at 1mM concentration (Denk et al. 1998; Peterszegi et al. 
2002), the highest concentration of ascorbic acid used in our studies was 100µg/ml. 
Fibroblasts kept proliferating after confluence and formed cell sheet on culture dishes 
after 5 weeks of culture. Histology sections showed that fibroblast cell sheet comprised 
of multilayer of cells and ECM synthesized by the cells. Moreover, the mean measured 
cell sheet thickness varied from 30μm to 40μm which was consistent with the cell 
sheet thickness obtained by confocol microscope. Furthermore, fibroblasts cultured 
with higher amount of ascorbic acid resulted in thicker cell sheets. 
From cell viability assay, it was observed that fibroblast cultured in presence of 
ascorbic acid showed increase in cell metabolism than control group at each 
assessment time point. These results correlated well with previous studies (Chan et al. 
1990; Alcaín et al. 1994; Peterszegi et al. 2002). However, in contrast to previous 
finding (Peterszegi et al. 2002), fibroblast cultured with higher amount of ascorbic acid 
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showed increased cell metabolism. Furthermore, after 14 days of culture, percent 
reduction of Alamar BlueTM remained plateau regardless of the culture condition. It can 
be speculated that cell sheet formation is a two-stage process. At the first stage, mainly 
during the first 2 weeks of culture, due to sufficient nutrient supply, fibroblasts 
proliferate and the cell number increases dramatically. After that, due to limited 
nutrient diffusion efficiency, fibroblast proliferation rate slows down. As the result, 
after 2 weeks of culture, the cell number in culture dish reach maximum level and 
remains unchanged. 
However, fibroblast cell sheets of all groups showed sustained increase in collagen 
content as culture time increased. Furthermore, cell sheet cultured with higher amount 
of ascorbic acid showed higher collagen content. These findings are consistent with 
previous studies that ascorbic acid could promote collagen biosynthesis and collagen 
matrix assembly (Blanck et al. 1975; Grinnell et al. 1989; Anderson et al. 1991; Guo et 
al. 2007). Moreover, since the difference in cell sheet thickness between sample groups 
was less than 5µm which was less than the thickness of mono cell layer (Bettega et al. 
1998) and there was no significant difference in number of cell layers between sample 
groups, the difference in cell sheet thickness is mainly attributed to the difference in 
collagen content rather than the difference in the number of cell layers between sample 
groups. Thus, cell sheet with higher collagen content was thicker. 
Moreover, immunohistochemical results were shown to correlate with collagen content 
assessment. Since cell sheet cultured with higher ascorbic acid produced more collagen 
and that the collagen content of all cell sheets increased as culture time increased, more 
type I and type III collagen were detected on ascorbic acid stimulated samples. The 
differences in type I and type III collagen expressions demonstrate that fibroblast cell 
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sheet is developing into a natural-like connective tissue typically consisting of 
predominant type I collagen and small amount of type III collagen. 
In this study, transcript levels of type I and type III collagen were also studied in 
present study. The results showed that fibroblast cell sheet cultured with higher 
ascorbic acid showed higher transcript levels of type I and type III collagen. These 
results correlated well with previous studies (Tajima et al. 1982; Lyons et al. 1984; 
Geesin et al. 1988; Kurata et al. 1991; Tajima et al. 1996) that ascorbic acid in culture 
medium stimulated type I and type III collagen gene expression. As indicated in 
previous finding (Geesin et al. 1988), translation activity of type I and type III collagen 
mRNA was not affected by the ascorbic acid in culture medium. Although ascorbic 
acid could stimulate collagen secretion by direct participating in proline hydroxylation, 
the saturation concentration is only about 1×10-5M which is much lower than the 
concentration used in our study (Blanck et al. 1975). It could be concluded that higher 
levels of type I and type III collagen detected in cell sheet cultured with higher amount 
of ascorbic acid was mainly due to increased transcript levels of protein mRNA. It has 
also shown that stimulation of collagen synthesis on cell sheet cultured with ascorbic 
acid was related to increased transcript levels of collagen mRNA. 
Although, Alamar BlueTM did not detect the actual cell number, Voytik-Harbin et al. 
(1998) indicated that swith up to 20000cell/well in 96-well format, there was a linear 
response of reduction of Alamar BlueTM and cell metabolic activity. As the result, it 
was suggested that cell sheet formation can be divided into two main stages: during the 
first stage, fibroblasts proliferated and formed cell sheet of multilayer of fibroblast. 
After certain amount of layers was formed (i.e. due to the nutrient supply and waste 
removal), the cell number within fibroblast cell sheet remains unchanged and more 
matrix protein will be produced. Adding ascorbic acid in culture medium is effective to 
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stimulate collagen synthesis and deposition from transcript level to post-transcript 
level. 
4.2 Dosage Response of FBS Concentration on Cell Sheet Formation 
Since FBS contains various growth factors and nutrient for in vitro cell culture, FBS is 
an important component of standard culture medium. Previous study (Kamci et al. 
1996) indicated that the wound closure rate of retinal pigment epithelial cell sheet 
depended on serum concentration in the culture medium. However, other researcher 
(Shalaw et al. 2006) pointed out that higher concentration of serum in culture medium 
only enhanced fibroblast proliferation but did not enhance collagen synthesis. The 
present study provided a detailed examination of the mechanism of induction by FBS 
of fibroblast metabolism and collagen biosynthesis. Furthermore, fibroblasts were 
culture with different concentration of FBS in order to investigate the dose response of 
FBS on fibroblast cell sheet formation. 
Similar to the findings in ascorbic acid dose response assay, fibroblasts kept 
proliferating after confluence and formed cell sheet on culture dishes after 5 weeks of 
culture regardless of FBS concentration. Histology sections showed that fibroblast cell 
sheet comprised of multilayer of cells and ECM synthesized by the cells. Moreover, 
the mean measured cell sheet thickness varied from 40μm to 70μm which was 
consistent with the cell sheet thickness obtained by confocol microscope. Furthermore, 
fibroblasts cultured with higher amount of FBS resulted in thicker cell sheets. 
Moreover, fibroblast cell sheet cultured with higher FBS concentration showed higher 
cell metabolism at each assessment time point. This finding was consistent with 
previous study that various growth factors in FBS could stimulate fibroblast 
proliferation (Shalaw et al. 2006; Shalaw et al. 2006). Similar to the findings in 
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ascorbic acid dose response assessment, percent reduction of Alamar BlueTM remained 
plateau regardless of the culture condition after 2 weeks of culture. It can be speculated 
that cell sheet formation process under different FBS concentration was also a two-
stage process. After 2 weeks of culture, the cell number is saturated and remains 
unchanged. 
In contrast to previous finding (Shalaw et al. 2006) that higher concentration of FBS 
did not enhance collagen synthesis, cell sheet cultured with higher concentration of 
FBS showed higher collagen content at each time point. The finding was consistent 
with previous study that various growth factor such as TGF-β, PDGF and FGF in 
culture medium could stimulate collagen synthesis (Geesin et al. 1991). 
The difference in collagen content of cell sheet cultured with different concentration of 
FBS was also shown in immunohistochemical staining. Higher level of type I and type 
III collagen was detected on cell sheet cultured with higher concentration of FBS after 
10 days of culture. However, due to the limitation in sensitivity of 
immunohistochemical staining, no significant difference in type I and type III collagen 
expression was detected after 5 weeks of culture. Furthermore, the differences in type I 
and type III collagen expressions demonstrate that fibroblast cell sheet is developing 
into a natural-like connective tissue typically consisting of predominant type I collagen 
and small amount of type III collagen. The difference in type I and type III collagen 
biosynthesis was detected at transcriptional level. Fibroblast cell sheet cultured with 
higher concentration of FBS showed higher transcriptional levels of type I and type III 
collagen. It was demonstrated that higher levels of type I and type III collagen detected 
in cell sheet cultured with higher amount of FBS was due to increased in collagen gene 
expression. 
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Furthermore, there was no significant difference in number of cell layers observed 
between different groups from histology sections. These data demonstrates that 
difference in cell sheet thickness is mainly due to difference in collagen content rather 
than difference in cell number between sample groups. As shown in collagen content 
test, cell sheet cultured with higher amount of FBS showed higher collagen content. 
Thus, cell sheet cultured with higher concentration of FBS was thicker. 
It can be speculated that cell sheet formation is a two-stage process regardless of FBS 
concentration. During the first stage, fibroblasts proliferated and formed cell sheet of 
multilayer of fibroblast. After certain amount of layers was formed (i.e. due to the 
nutrient supply and waste removal), the cell number within fibroblast cell sheet 
remains unchanged and more matrix protein will be produced. Higher concentration of 
FBS in culture medium is effective to promote collagen synthesis and deposition from 
transcript level to post-transcript level. 
4.3 Fibroblast Cell Sheet Culture Condition Optimization 
Previous dose response assessment showed that increase in ascorbic acid or FBS 
concentration in culture medium was efficient to promote cell metabolism and collagen 
synthesis from transcriptional to post-transcript level. However, the importance of FBS 
and ascorbic acid in promoting fibroblast cell sheet formation remains unclear. In the 
current study, several culture conditions were compared for their capacity to enhance 
fibroblast cell sheet formation in order to obtain the optimized culture condition for 
fibroblast cell sheet culture. Three important parameters: in vitro cellular viability, 
matrix production and mRNA transcript level of matrix protein was used to compare 
capacity of different culture condition on stimulating cell sheet formation. 
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Histology sections showed that after 5 weeks of culture, fibroblast formed cell sheet 
comprised of multilayer of fibroblast and ECM synthesized by the cells regardless of 
culture condition. Similar to ascorbic acid and FBS dose response assessment, the 
difference in cell sheet thickness was mainly due to the difference in collagen content 
of cell sheet cultured under different condition. Moreover, fibroblast cultured under all 
conditions showed similar cell viability profile. Cell metabolism increased during the 
first 2 weeks and remained plateau after that. While the collagen content of cell sheet 
under all culture conditions kept increasing with culture time. However, it was found 
that fibroblast cell sheets showed similar cell viability with different collagen content 
under some culture conditions (i.e. 15% FBS with 50µg/ml ascorbic acid and 20% 
FBS with 0µg/ml ascorbic acid). Thus, collagen content was normalized over cell 
metabolism for better assessment of the effect of culture condition on matrix 
production. After normalization, it was found that fibroblast culture in presence of 
ascorbic acid showed higher collagen content than that of cell sheet culture without 
ascorbic acid. Furthermore, under some conditions, fibroblast cell sheets showed lower 
level of matrix protein gene expression but higher collagen content (i.e. 15% FBS with 
50µg/ml ascorbic acid and 20% FBS with 0µg/ml ascorbic acid). It is mainly because 
ascorbic acid in culture medium not only influences collagen synthesis at 
transcriptional level but also influences at post-transcript level by regulating prolyl and 
lysyl hydroxylase activity (Murad et al. 1981) and direct participating in proline 
hydroxylation (Blanck et al. 1975). Thus, ascorbic acid in culture medium efficiently 
promoted proline hydroxylation and formed stable triple helical collagen. It is 
suggested from the results above that compared with various growth factors in FBS; 
ascorbic acid is the essential component in culture medium to promote cell sheet 
formation. It was also shown that there was only marginal increase in collagen content 
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and cell sheet thickness when comparing fibroblast cultured with 20% or 25% FBS 
with fibroblast cultured with 15% FBS and 100µg/ml ascorbic acid. Therefore, as after 
5 weeks cultured with 15% FBS with 100µg/ml ascorbic acid, fibroblast would form 
cell sheet with desirable thickness and function, 15% FBS with 100µg/ml ascorbic acid 
is chosen to be optimized culture condition for future fibroblast cell sheet culture. 
4.4 Degradation of Scaffold Materials in Culture Medium 
4.4.1 Silk Fiber and Silk Sponge 
A number of recent studies have explored a tissue engineering approach using silk 
fibroin scaffolds in various forms. Moreover, silk fibroin in various formats has been 
shown to support cell adhesion, proliferation, and differentiation in vitro and promote 
tissue repair in vivo (Min et al. 2004; Kim et al. 2005; Wang et al. 2006; Wang et al. 
2006; Vepari et al. 2007). Although researchers demonstrated degradation of silk when 
incubated with various of enzymes (Li et al. 2003; Arai et al. 2004; Horan et al. 2005; 
Kim et al. 2005), degradation behavior of silk fibroin during normal in vitro tissue 
culture process would be different due to lack of enzymes under in vitro culture 
condition. Furthermore, chemical and physical properties of the silk fibroin varied 
from species (Altman et al. 2003) and fabrication process (Vepari et al. 2007). In this 
study, conformation change, crystal structure as well as molecular weight of silk 
fibroin of silk fiber and silk sponge were examined to understand the effect of 
fabrication process on degradation behavior of silk fibroin. 
The Bombyx mori fibroin used to fabricate silk sponges and knitted scaffolds in this 
thesis mainly comprised of heavy chain dimer (Tanaka et al. 2001) about 750kDa and 
light chain around 25kDa (Fournier 1979). In contrast to previous study (Yamada et al. 
2001), the heavy chain of silk fibroin remained intact after dissolving in CaCl2-
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CH3CH2OH-H2O (molar ratio=1:2:8). However the light chain in both knitted silk 
scaffold and silk sponge samples was cleaved after dissolving as shown as a broad 
peak in GPC curves. Moreover, compared with fibroin in silk fiber, the Mw of light 
chain component in silk sponge was lower and molecular weight dispersion was 
broader. This is mainly because silk fibroin in sponge exposed to CaCl2-CH3CH2OH-
H2O solvent which cleaved the fibroin molecule (Yamada et al. 2001) during 
fabrication. The freeze-dry process may also affect the chemical properties of the silk 
fibroin in sponge. Moreover, silk fibroin in both knitted silk scaffold and silk sponge 
mainly consists of β-sheet structure. As indicated by DSC, half hour methanol 
treatment is sufficient to convert random coil structure to β-sheet structure in silk 
sponge. 
From GPC curve, it can be speculated that heavy chain dimmer of silk fibroin 
dissociated and became monomer with time in both silk fiber and sponge. Moreover, 
the heavy chain component of silk fibroin in both silk fiber and sponge was chemically 
stable in culture medium. The molecular weight of heavy chain slightly decreased after 
42 days immerged in culture medium as indicated by the increase in retention time. 
However, the light chain component of silk fibroin degraded faster than heavy chain 
component. The Mw of light chain in silk fiber decreased and molecular size 
dispersion became broader during first 14 days of degradation. After 28 days, the light 
chain of silk fibroin was fully degraded as only two small humps with Mw range from 
2000Da to 3000Da were found in the GPC curve of knitted silk scaffolds. Similar to 
light chain degradation in silk fiber, the molecular weight of the light chain component 
in silk sponge decreased sharply during first 14 days immerged in culture medium. As 
the light chain component in silk sponge was broken down during fabrication process, 
the degradation of light chain component in silk sponge was faster than that in silk 
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fiber. After 28 days, light chain was fully degraded and only residues with Mw range 
from 1500Da to 3000Da was left. These findings are different from previous research 
that the light chain component remains intact when incubated in PBS (Horan et al. 
2005). This may due to different solvent used to fabricate the sponge and prepare the 
samples. Although the solvent used in this study did not fully break down the polymer 
chain of the light chain component, the chemical properties of polymer chain changed 
thus the light chain component underwent degradation in culture medium. 
The FTIR spectra showed that there was a small proportion of random coil structure 
(1653cm-1 peak) in original silk fiber and silk sponge. However, the random coil 
structure was not confirmed by DSC as no exothermic peak around 230°C shown in 
DSC curves for both silk fiber and silk sponge. It can be speculated that there was no 
random coil structure in silk fiber and silk sponge after methanol treatment. The 
absorption peak at 1653cm-1 was attributed to some hydrophilic component rather than 
random coil structure in silk fibroin as the hydrophilic interaction between fibroin and 
water would shift the amide I absorption peak to higher wavenumber (Um et al. 2003). 
This absorption peak was also observed in FTIR spectra of silk fiber at day 7 and day 
14 of degradation. After 28 days of degradation, no such absorption peak was observed 
in silk fiber. However, no such absorption peak was observed in silk sponge only after 
14 days of degradation. This conformational change may due to the degradation of 
light chain component in silk fibroin as heavy chain component contained mainly β-
sheet crystal (Horan et al. 2005). As the light chain component in silk fibroin degraded, 
there was no more hydrophilic structure in silk fiber and sponge. Thus, no absorption 
peak at 1653cm-1 was observed after 28 days of in vitro degradation. Silk fibroin in 
both fiber and sponge were mainly in β-sheet as indicated by the strong β-sheet amide 
absorption peaks as well as thermograph obtained by DSC. 
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The mechanical properties of the knitted silk scaffold as well as silk sponge modified 
knitted silk scaffold were affected by the degradation of silk fibroin. As light chain 
component degraded rapidly within the first 2 weeks and fully degraded after 4 weeks 
of incubation, the ultimate load of knitted silk scaffold as well as silk sponge modified 
knitted silk scaffold decrease during the first 2 weeks after immerged in culture 
medium and remained unchanged after 28 days incubated in culture medium. Due to 
faster degradation of light chain in silk sponge, the change in mechanical strength of 
silk sponge modified knitted silk scaffold is larger than that of knitted silk scaffold 
after 7 days of degradation (11.4%, 8.5% changed in mechanical strength for sponge 
modified scaffold and knitted silk scaffold respectively). Because both the light chain 
component in sponge as well as in silk fiber was degraded, the total decrease in 
mechanical strength was larger in silk sponge modified knitted silk scaffold than that 
of knitted silk scaffold (20.5%, 17.2% changed in mechanical strength for sponge 
modified scaffold and knitted silk scaffold respectively). 
It is possible to speculate from above results that after degumming process, polar 
amino acid in light chain component formed hydrophilic interaction with water 
molecule and therefore absorption peak at 1653cm-1 was observed in FTIR spectra. 
Nonpolar amino acid in silk fibroin formed highly ordered β-sheet structure through 
hydrophobic interaction. The polar amino acid which formed hydrophilic interaction 
with water molecule would first undergo hydrolytic degradation thus fibroin chain was 
cleaved. After the light chain was fully degraded, only hydrophobic component in 
fibroin chain remained, thus only β-sheet absorption peaks were observed in FTIR 
spectra in both knitted silk scaffold and silk sponge. Due to faster degradation of light 
chain component in silk sponge, there was no 1653cm-1 absorption peak in day 14 
FTIR spectra of silk sponge while there was obvious absorption peak at 1653cm-1 
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observed in day 14 FTIR spectra of knitted silk scaffold. As β-sheet conformation is 
formed by hydrophobic interaction (Um et al. 2003; Vepari et al. 2007), the hydrolytic 
degradation process was slow. Therefore, the molecular weight of heavy chain 
decreased slowly throughout the degradation period. 
Although the light chain component of silk fibroin was fully degraded after 4 weeks of 
incubation, due to highly ordered β-sheet structure of heavy chain component, the silk 
scaffolds remain most of its mechanical strength and tensile stiffness after 42 days of 
in vitro degradation. These results suggest that silk scaffolds would be used for long-
term in vitro tissue culture. However, the mechanical strength of original scaffold 
should be stronger than the target tissue due to lost in mechanical strength due to fast 
degradation of light chain component. 
4.4.2 PLLA Fiber 
Hydrolytic degradation of PLLA is slow due to hydrophobic nature of the material 
(Leach et al. 1998). Therefore, knitted PLLA scaffold was shown to maintain its 
mechanical properties after 20 weeks of incubation in PBS (Ge et al. 2005). In the 
present study, conformational, structural change of PLLA was examined to understand 
the mechanism of induction by PLLA hydrolytic degradation on the change of 
mechanical properties of knitted scaffold. 
At each degradation time, typical C=O vibration peak at 1754cm-1, C-C vibration peak 
at 1092cm-1 and C-O vibration peak at 1188cm-1 was observed in FTIR spectra 
indicating no chemical reaction other than hydrolysis took place between PLLA 
scaffold and culture medium. 
Furthermore, DSC curves of the knitted scaffold showed that PLLA fibers used to knit 
scaffold was highly crystallized (65.67%). There was only slight decrease in 
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crystallinity after 4 weeks of in vitro degradation. Moreover, there was no significant 
difference in the melting temperature and glass transition temperature of PLLA fiber. 
From these data, it is suggested that the PLLA fiber maintained most of it crystal 
structure after 4 weeks of incubation in culture medium. The slight change in Tg and 
Tm also indicated that there was no significant change in Mw of PLLA fiber. 
The change in molecular weight of PLLA fibers was also studied by GPC. The data 
confirmed that the in vitro degradation of PLLA fiber was slow indicated by the slight 
decrease in Mw of PLLA fiber after 4 weeks of in vitro degradation. It is mainly 
because PLLA is hydrophobic material. Therefore, hydrolytic degradation process of 
PLLA scaffold was slow when immerged in culture medium. Moreover, as spun into 
fiber structure, the fiber was highly crystallized and the crystal structure slows down 
the hydrolytic degradation as hydrolytic reaction happens only on the surface of the 
PLLA crystal and the slow degradation of PLLA preserves the crystal structure of 
PLLA fiber. 
The slow degradation of PLLA preserved the crystal structure in PLLA fiber. Thus the 
mechanical strength and tensile stiffness of knitted PLLA scaffold were preserved after 
degradation process. 
4.5 Scaffold Geometry Effect on in vitro Tissue Culture 
Scaffold for ligament and tendon tissue engineering should not only be mechanical 
competent but also be pours enough for transportation of nutrients and metabolic waste. 
Although knitted scaffolds are shown to possess sufficient porosity (Zdrahala 1996; 
Ouyang et al. 2003; Sahoo et al. 2006), the cell survivability in most inner proportion 
of cell sheet/scaffold hybrid after rolling up remained unclear. In this study, cell 
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sheet/scaffold hybrids were either rolled up or folded to examine the survivability of 
cell sheet on different formats. 
Previous studies (Canavan et al. 2005) showed that mechanical dissociation were 
found to be damaging both to cells and ECM. However, from the fluorescent image of 
cell sheet seeded scaffold, the cell sheet adhered onto knitted scaffold and covered the 
macropores regardless of scaffold geometries. Moreover, cell metabolism and collagen 
content of cell sheet/scaffold hybrid showed steady increase as culture time increase. 
These finding indicated that knitted PLLA scaffold was a suitable substrate to support 
cell growth for in vitro culture of ligament and tendon tissue analog. 
Furthermore, there was no significant different in cell metabolism and collagen content 
between different scaffold format at each assessment time point. There was also no 
difference in cell morphology between geometries. It could be speculated that the 
porosity of knitted scaffold is sufficient for nutrient supply and metabolites 
transportation for cell growth on scaffold. Moreover, although mechanical removal 
would damage cell and ECM, fibroblast cell sheet comprised of multilayer of cells. 
Mechanical removal would only affect the top layer while most of the cells remained 
viable. Although temperature sensitive TCP helps to retain cell morphology when 
compared with mechanical removal method (Canavan et al. 2005), researchers found 
that it normally took relatively long detachment time to harvest cell sheet from 
temperature sensitive TCP which was not suitable for cell growth (Hyeong Kwon et al. 
2003). Researchers (da Silva et al. 2008) also pointed out that temperature sensitive 
TCP commonly used to culture single cell sheets are impermeable, which would 
decrease the rate of elimination of metabolic wastes and of nutrients supplying, since 
the construct side facing the culture surface would be wasted as a potential mass 
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transfer area. As fibroblast cell sheet is of multilayer of cells, mechanical removal 
would significantly reduce detachment time and help better retain cellular function. 
Furthermore, the ultimate load of all sample groups was slightly higher than that of 
original scaffold which indicated that the matrix protein produced by fibroblast cell 
sheet contributed to mechanical strength of the tissue analogs. Moreover, no significant 
difference in mechanical properties was observed between groups. It is mainly because 
the collagen content of different geometry was almost the same and it was the collagen 
produced by fibroblast contributed to the extra mechanical strength. However, there 
was no significant difference in the tensile stiffness between cell sheet-scaffold hybrids 
and original scaffold. It is mainly because after 28 days of culture, the crystal structure 
of knitted PLLA scaffold remained intact, and the crystal structure of PLLA fiber 
contributes to most of the mechanical strength and tensile stiffness of the cell sheet-
scaffold hybrid. As the collagen fibers was randomly deposited in cell sheet, cell sheet 
on scaffold only contribute to small proportion of mechanical strength of the hybrid 
but no significant impact on tensile stiffness of the hybrid. 
These results suggested that knitted scaffolds could be used to enhance the mechanical 
properties of cell sheets for ligament and tendon tissue engineering application. 
Furthermore, fibroblast cell sheet seeded knitted scaffold could be further formed 
different geometries with ideal size to match the anatomy structure of different 
ligament and tendon before implantation. 
4.6 Scaffold Material Effect on in vitro Tissue Culture 
Reconstruction of damaged ligament and tendon is one of the major concerns in sports 
medicine and orthopedic practice. Tissue engineering strategy for its repair is faced 
with the challenge of selecting the optimal biomaterial and the development of an 
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appropriate scaffold design. The purpose of this study was to engineer a three-
dimensional scaffold for ligament and tendon tissue engineering and choose the most 
suitable scaffold material for cell seeding and would promote fibroblast cell sheet 
proliferation and ligament analog formation. 
In previous studies (Ouyang et al. 2003; Ge et al. 2005), knitted scaffold was proved to 
possessed good internal communicating space and favor deposition of collagenous 
connective tissue matrix, which is crucial for ligament and tendon reconstruction. 
Previous scaffold geometry effect study (chapter 4.5) also proved that fibroblast cell 
sheet could integrate into knitted scaffold to form tissue analog and the porosity of 
knitted scaffold is sufficient to support cell sheet growth on knitted scaffold system. 
Moreover, scaffold material influences cell behavior significantly (Sato et al. 2000; 
Ouyang et al. 2002). Protein based material (silk) and synthetic material (PLLA) are 
selected to compare their capacity of promoting in vitro neo-tissue formation. 
Furthermore, freeze-dried method was used to modify knitted silk scaffold. In 
comparison with the knitted scaffold, by introducing microporous silk sponges into the 
openings of a knitted scaffold using freeze-dried method, the reduced pore size and the 
larger surface area-volume ratio of the silk sponge modified knitted silk scaffold 
facilitated cell attachment and provided sufficient area for cell sheet attachment. 
In the present study, fibroblast cell sheet attached onto knitted PLLA, knitted silk 
scaffold as well as silk sponge modified knitted silk scaffold and cover the macropores 
of the scaffolds. Histology study also showed that after 20 days of in vitro culture, 
fibroblast cell sheet integrated into all types of scaffolds and formed fibrous matrix 
with a large number of cells in matrix which indicated the formation of connective 
tissue. Furthermore, with time, a distinct increase in cell metabolism and matrix 
synthesis, as reflected by the final collagen content, was shown for all sample groups. 
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It is possible to speculate that as silk sponges is structural stable with controllable 
degradation and interconnected pores, cell sheet cultured on silk sponge modified 
knitted silk scaffold was promising to obtain sufficient nutrient and actively transport 
metabolites for proliferation and matrix protein synthesis. 
However, clear differences were noted between the scaffold types with respect to cell 
viability, total collagen production. Fibroblast cell sheet on silk sponge modified 
knitted silk scaffold showed highest cell metabolism, whereas cell sheet on knitted silk 
scaffold showed higher cell metabolism than cell sheet on knitted PLLA scaffold 
throughout the whole in vitro culture period. Furthermore, the total collagen content 
was highest for the cell sheet on silk sponge modified knitted silk scaffold and lowest 
in cell sheet on knitted PLLA scaffold. 
The complex anatomy of the human ligament and tendon is dependent on the 
interaction, orientation and relationship between matrix proteins and cells. Fibroblast 
cell sheet when grown on the scaffolds retain the expression of these proteins that exert 
important functions in ligament and tendon. In particular, we observed that fibroblast 
cell sheet cultured on knitted scaffolds modulate the expression of some important 
matrix components of the construct of the ligament and tendon. The key matrix 
components of the constructs include type I and type III collagen which are the major 
matrix components of the natural ligament/tendon and tenascin-C, one of the early 
marker for ligament and tendon organogenesis and embryogenesis (Chiquet et al. 1984; 
Jarvinen et al. 2000). Ligament and tendon marker proteins level and localization were 
determined by immunohistochemical staining. The results revealed that the matrix 
components of cell sheet-scaffold hybrid include abundant collagen type I and small 
amount of type III which are the major component of the natural tissue and small 
amount of tenascin-C which indicating that cell sheet-scaffold hybrid was developed 
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into ligament/tendon-like tissue. These findings were consistent with previous study 
(Ouyang et al. 2005) that knitted scaffold could be used to reinforce and support the 
growth of cell sheet into ligament/tendon analogs. Moreover, the deposition of the 
ECM rich in type I and type III collagen as well as tenascin-C on the silk sponge 
modified knitted silk scaffold compared with other two types of knitted scaffolds 
which was correlated with total collagen content test result that cell sheet on silk 
sponge modified scaffold had highest collagen content. 
Moreover, transcript levels of ligament/tendon marker proteins were studied in present 
study. The results showed that fibroblast cell sheet on silk sponge modified knitted silk 
scaffold showed highest transcript level of these ligament/tendon related ECM gene 
markers, whereas these gene markers of cell sheet were upregulated on knitted silk 
scaffold compared with knitted PLLA scaffold. It has demonstrated that higher level of 
all marker proteins detected in silk sponge modified knitted silk scaffold was due to 
increased transcript levels of protein mRNA. It has also shown that stimulation of 
collagen synthesis on silk sponge modified knitted scaffold was related to increased 
transcript levels of collagen mRNA. These results are consistent with previous study 
(Liu et al. 2008) that compared with knitted silk scaffold cell viability, matrix protein 
synthesis was upregulated on silk sponge. It may be due to the unique three-
dimensional geometry of silk sponge. As a non-woven structure, sponge shows 
increased surface area and rougher topography for cell attachment and tissue ingrowth. 
As the result, fibroblast cell sheet on silk sponge modified scaffold showed higher 
level of cell viability and collagen bio-synthesis. 
Furthermore, for engineering of load-bearing tissue like ligaments and tendons, the 
maintenance of mechanical properties of the scaffold until the new generated tissue 
becomes mechanically competent is an important requirement for scaffold design. Due 
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to degradation properties of scaffold material, after 20 days of in vitro culture, the 
failure load of both cell sheet-silk scaffold hybrid groups were lower than that of 
original scaffold whereas there was slight increase in failure load in PLLA scaffold 
groups (p>0.05). However, the failure load of cell sheet-knitted silk scaffold and cell 
sheet-sponge modified scaffold groups was higher than that of scaffold only groups 
after 20 days of culture while the tensile stiffness was lower (p<0.05). It is possible 
that the increase in tensile load may have been caused by the constituent cells and the 
abundant ECM secreted by them. Moreover, cell sheet on silk scaffold remodel silk 
fibers and silk sponge structure according to degradation of silk fiber and silk sponge. 
As collagen secreted by fibroblast was randomly deposited on knitted silk scaffold, the 
stiffness of the cell sheet-silk hybrid was lower than that of silk scaffold only groups. 
In contrast to previous study (Liu et al. 2008), silk sponge modification significantly 
increased the tensile load (increased 94%) and stiffness (increased 70%) of knitted silk 
scaffold in present study. That may be because silk sponge acted like a glue to link 
individual silk filament together and 80 silk filaments were held into one whole bundle, 
thus increased the tensile strength and stiffness of the whole scaffold. 
It was suggested that as a protein based material, silk scaffold showed higher cell 
affinity and stimulate cell proliferated and collagen biosynthesis at transcript level 
compared with knitted PLLA scaffold. Furthermore, silk sponge modification was 
efficient to increase failure load and tensile stiffness of knitted silk scaffold. Moreover, 
by cover the macropores with silk sponge, there is more anchor point for cell sheet 
attachment thus result in higher cell viability and ligament/tendon marker proteins 
expression level. In conclusion, silk sponge modified knitted silk scaffold is the most 
suitable scaffold among three for ligament and tendon tissue engineering. 
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4.7 Cyclic Loading Effect on in vitro Tissue Culture 
Tissue engineering of cell/material constructs offers a potential source of improved 
materials for ligament and tendon repair. Ideally, such constructs should possess 
sufficient mechanical properties to support rapid restoration of joint mobility and 
loading in order to prevent formation of tissue adhesions and limit atrophy of 
surrounding muscle and bone. Two strategies are currently under investigation, 
immediate implantation of cell/scaffold hybrids with subsequent in vivo remodeling 
and in vitro mechanical pre-conditioning cell/scaffold hybrids prior to implantation. 
Regardless of approach, there remains a fundamental need for improved knowledge of 
the effect of external loading on fibroblast cell sheet growth and the effect of scaffold 
geometry on mechanotransduction. 
In this study, ligament and tendon analogs have been fabricated by assembly fibroblast 
cell sheet onto knitted silk scaffold or silk sponge modified knitted silk scaffold. Lab-
developed bioreactor was used to apply cyclic strain to the cell-sheet scaffold hybrid. 
Cyclic strain was found to increase cell viability as well as collagen content on both 
knitted silk scaffold and silk sponge modified knitted silk scaffold throughout the 
culture period. These findings were consistent with previous studies (Zeichen et al. 
2000; Inanc et al. 2006) that cyclic strain could influence cellular metabolism thus 
influence cell proliferation, matrix protein synthesis. Histology study also showed that 
after 20 days of in vitro culture, fibroblast cell sheet integrated into all types of 
scaffolds and formed fibrous matrix with a large number of cells in matrix which 
indicated the formation of connective tissue. Furthermore, cell sheets cultured in 
bioreactor showed higher degree of cell and matrix protein alignment when compared 
with samples cultured statically. This finding was consistent with previous study 
(Neidlinger-Wilke et al. 2001; Grenier et al. 2005; Henshaw et al. 2006) that fibroblast 
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cultured under cyclic strain demonstrated linear cell arrangement of cells and parallel 
collagen fibril architecture. 
Moreover, localization of ligament and tendon marker protein such as type I, type III 
collagen and tenascin-C was determined by immunohistochemical staining. The results 
revealed that the matrix components of cell sheet-scaffold hybrid include abundant 
collagen type I and small amount of type III which are the major component of the 
natural tissue and small amount of tenascin-C which indicating that cell sheet-scaffold 
hybrid was developed into ligament/tendon-like tissue. Furthermore, the samples 
cultured in bioreactor showed higher level of ligament/tendon matrix marker proteins 
such as collagen type I, type III and tenascin-C than samples cultured statically. 
Moreover, the increase in marker proteins expression was proven by RT-PCR study. 
The RT-PCR results showed that fibroblast cell sheet-scaffold hybrid cultured in 
bioreactor showed higher transcript level of these ligament/tendon related ECM gene 
markers than specimens cultured statically. It has also proved that stimulation of 
collagen synthesis under bioreactor culture condition was related to increased 
transcript levels of collagen mRNA. These findings were consistent with previous 
studies (Garvin et al. 2003; Noth et al. 2005; Webb et al. 2006) that cyclic strain would 
influence cellular metabolism thus subsequently influence matrix gene expression, 
matrix protein synthesis. Moreover, tenascin-C was upregulated in mechanically 
loaded tissue and during healing process in musculoskeletal tissues (Jarvinen et al. 
2000; Chiquet et al. 2003; Heckmann et al. 2007). The significant increased in 
tenascin-C expression of bioreactor samples indicated that cell sheet-scaffold hybrid 
formed ligament/tendon like matrix and mechanical stimulation effectively accelerate 
neo-tissue formation process. 
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Moreover, cell sheet on silk sponge modified knitted silk scaffold under bioreactor 
culture condition showed an increment in percent reduction of Alamar BlueTM of 
56.8% after 20 days of culture, while the increment of knitted silk scaffold was 54.3%. 
This finding indicated a higher increment in cell metabolism on sponge modified 
scaffold throughout the in vitro culture process. The collagen content of cell sheet 
seeded silk sponge modified knitted silk scaffold under bioreactor culture condition 
was also higher than that of cell sheet seeded knitted silk scaffold cultured in 
bioreactor. Immunohistochemical staining and RT-PCR also showed that the 
expression levels of ligament/tendon marker proteins were higher on cell sheet seeded 
silk sponge modified knitted silk scaffold under bioreactor culture condition than those 
of cell sheet seeded knitted silk scaffold cultured in bioreactor. It may be due to the 
unique three-dimensional geometry of silk sponge. As more anchor points for cell 
sheet adhesion, biomechanical signals are sent to receptors on cell surface via the cell 
adhesion sites and stimulate the expression of genes responsible for the synthesis and 
secretion of the key ligament and tendon ECM component. Furthermore, cyclic 
stretching may increase mass transport efficiency of sponge modified scaffold and 
resulted in higher cell viability as well as more ECM protein expression. 
After 20 days of in vitro culture, the failure load of cell sheet-scaffold hybrid was 
higher than that of scaffold only groups. The increase in tensile load may have been 
caused by the constituent cells and the abundant ECM secreted by them. Mechanical 
testing also demonstrated that cyclic strain resulted in increased ultimate load of tissue 
analogs. This is mainly because the samples with mechanical stimulation showed 
higher collagen content and higher degree of collagen fibril alignment. However, the 
tensile stiffness of samples cultured in bioreactor was extremely lower than that of 
samples cultured statically. This may due to cyclic strain effect. Cyclic strain 
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accelerated silk degradation in culture medium and cause stress-relaxation of the 
material. As the result, scaffolds incubated under cyclic loading showed lower 
mechanical strength and tensile stiffness compared with scaffolds cultured statically. 
Although cyclic loading stimulated ECM synthesis, deposition and alignment, the 
tensile stiffness of collagen fibril on scaffold was lower than original scaffold. Thus 
cell sheet-scaffold hybrid cultured in bioreactor showed higher failure load with lower 
tensile stiffness when compared with specimen culture statically. 
It was suggested that cyclic loading stimulate cell proliferated, matrix gene expression 
and matrix protein synthesis. Furthermore, silk sponge modification is efficient to 
increase anchor points for cell sheet attachment to knitted scaffold system, thus cell 
sheet on sponge modified scaffold may be more sensitive to cyclic strain and stimulate 
matrix protein synthesis. In conclusion, assembly fibroblast cell sheet onto silk sponge 
modified knitted silk scaffold and subsequently cultured in bioreactor which provide 
cyclic strain is a suitable strategy for in vitro ligament and tendon reconstruction. 
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Chapter 5. Conclusion 
In this research, fibroblast cell sheet was cultured and fibroblast cell sheet was 
reinforced with knitted silk scaffold system for in vitro ligament and tendon 
reconstruction. 
Cell Sheet Characterization 
It is shown that fibroblast cultured in presence of ascorbic acid could form cell sheet 
with multilayer of fibroblast and randomly aligned collagen fibrils. With ascorbic acid 
or FBS concentration increase, fibroblast showed higher cell metabolism and ECM 
proteins (type I and type III collagen) expression at both gene and protein levels. 
Furthermore, 15% FBS with additional 100µg/ml ascorbic acid could be the optimized 
culture condition to obtain desirable fibroblast cell sheet for further usage. 
Scaffold Degradation Study 
Degradation study demonstrated that silk fibroin in both silk fiber and sponge 
remained in β-sheet structure and heavy chain component of silk fibroin showed slow 
in vitro degradation while the light chain was fully degraded after 4 weeks. The light 
chain degraded faster in silk sponge. Mechanical properties of scaffold are weakened 
as the result of material degradation. 
Geometry Effect Study 
We have shown that scaffold geometries have no impact on in vitro tissue culture as 
fibroblast cell sheet showed similar cell metabolism and collagen content on different 
formats. These results suggest the porosity of the knitted scaffold system is sufficient 
for cell survival. Therefore, knitted scaffolds could be used to enhance the mechanical 
properties of cell sheets. 
Scaffold Material Effect Study 
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We have shown that it is possible to modify the knitted scaffold by incorporating a silk 
sponge structure. Compared with knitted scaffold, sponge modification promoted 
proliferation, ECM synthesis based on the results obtained from Alamar Blue, collagen 
assay, and expression of ligament-related ECM markers (e.g. type I and type III 
collagen and tenascin-C) at both gene and protein levels. Mechanical testing results 
also confirmed better cellular function with fibroblast cell sheet on sponge modified 
scaffold. Based on the results obtained, it suggests the suitability of the sponge 
modified knitted silk scaffold used along with fibroblast cell sheet for the development 
of a tissue-engineered ligament/tendon. 
Mechanical Stimulation Effect Study 
In this part of thesis, we have shown that it is possible to stimulate in vitro tissue 
culture by using bioreactor to culture cell sheet/scaffold hybrids. Compared with static 
cultured, cyclic loading promoted proliferation, function of fibroblast cell sheet based 
on the results obtained from Alamar Blue, collagen assay, and expression of ligament-
related ECM markers (e.g. type I and type  IIIcollagen and tenascin-C) at both gene 
and protein levels. Mechanical testing results also confirmed better cellular function 
with fibroblast cell sheet culture under mechanical stimulus. These data suggests that 
bioreactor which providing cyclic strain to tissue analog is essential for the in vitro 
development of fibroblast cell sheet into tissue-engineered ligament/tendon. 
Future Works 
However, in this research, skin fibroblast was used to culture cell sheet. It is yet 
unclear whether skin fibroblast can be cultured into ligament or tendon cell lineage as 
there are been no specific protein markers for ligament or tendon fibroblast discovered 
so far. Further study on cellular difference between skin fibroblast and ligament or 
tendon fibroblast would contribute to better understanding of tissue formation under in 
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vitro culture environment. Furthermore, in this thesis, Alamar BlueTM was used to 
determine cell viability. However, Alamar BlueTM assay did not reveal the actual cell 
number of the cell sheets. This weakened the expression of data, both of cells and 
values normalized to cells. With accurate cell counting method like DNA content 
measurement, it would contribute to better understanding of cell proliferation under 
different culture condition as well as collagen production normalized to cells. 
Since fibroblast is terminated differentiated cell, fibroblast shows poor self-renew 
ability. BMSC, an adult stem cell, shows potential to differentiate into ligament and 
tendon lineage. Since BMSC shows high cell proliferation rate and can be cultured into 
cell sheets with additional of ascorbic acid, BMSC would be another cell source to 
form cell sheet for ligament and tendon applications. Moreover, study of the in vivo 
response of in vitro cultured tissue analogs would provide useful information on 
efficiency of tissue replacement and contribute to the understanding of natural healing 
process of the damage tissue. 
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Appendix A. Protocols for experiments 
A.1 Cell Proliferation Rate and Activity Test by Alamar BlueTM Assay 
Cell proliferation and activity were quantitatively evaluated by Alamar BlueTM assay, a 
one-step non-radioactive assay (Ansar Ahmed et al. 1994). As the internal environment 
of the proliferating cell is more reduced than that of non-proliferation cells, Alamar 
BlueTM, which can be reduced by metabolic intermediates of the proliferating cells, is a 
useful tool in monitoring the reducing environment of the proliferating cell because 
Alamar BlueTM reduction is accompanied by a measurable shift in color. As Alamar 
BlueTM accepts electrons from the metabolic intermediates, it changes from the 
oxidized indigo blue, non-fluorescing state to the reduced fluorescent pink state. One 
way to quantitatively monitor Alamar BlueTM reduction is by measuring absorbance 
spectrophotometrically. The maximum absorbance wavelengths of reduced and 
oxidized forms of Alamar BlueTM are 570 and 600 nm, respectively. In monitoring 
Alamar BlueTM reduction spectrophotometrically, reduction is expressed as a 
percentage (% Reduced). However, due to the absorption spectra overlap of the 
oxidized and the reduced form of Alamar BlueTM, a formula is used to calculate the 
percentage of reduction: 
2 1 1 2
' '
1 2 2 1
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(εredλ1) = 155677 (Molar extinction coefficient of reduced Alamar BlueTM at 570nm) 
(εredλ2) = 14652 (Molar extinction coefficient of reduced Alamar BlueTM at 600nm) 
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(εoxλ1) = 80586 (Molar extinction coefficient of oxidized Alamar BlueTM at 570nm) 
(εoxλ2) = 117216 (Molar extinction coefficient of oxidized Alamar BlueTM at 600nm) 
(Aλ1) = Absorbance of test wells at 570nm 
(Aλ2) = Absorbance of test wells at 600nm 
(A’λ1) = Absorbance of negative control wells which contain medium plus Alamar 
BlueTM but to which no cells have been added at 570nm 
(A’λ2) = Absorbance of negative control wells which contain medium plus Alamar 
BlueTM but to which no cells have been added at 600nm 
Cells were cultured with standard culture medium, which was used to trigger cell sheet 
forming, supplemented with 10% (v/v) Alamar BlueTM at 37°C with 5% humidified 
CO2 for 3 hours. After incubation, the medium with Alamar BlueTM was transferred 
into a 96-well plate and the color change of Alamar BlueTM was recorded down 
spectrophotometrically (Sunrise, Sunrise Instruments). 
A.2 ECM Production by Sircol Collagen Assay Kit 
As a parameter of matrix synthesis, collagen contents of the cell sheets and cell sheet 
seeded scaffolds were quantitatively detected by SircolTM Collagen Assay Kit 
(Biocolor Ltd, Northern Ireland). The SircolTM dye regent contains Sirius Red, which 
is an anionic dye with sulphonic acid side groups, can react with [Gly-X-Y]n tripeptide 
sequence found within the triple helix sequence of mammalian collagens. The Sircol 
dye bonded collagens are dissolved in Alkali reagent. The change in color, which 
reflects the concentration of collagen, is monitored spectrophotometrically. The 
collagen content is calculated by calibrating the standard curve. 
To obtain standards values and a reagent blank, 25, 50, and 100µL of Standard 
Collagen (rat-tail; 0.5 mg/ml standard in 0.5ml acetic acid) and 200µL of fresh culture 
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medium respectively, were taken in duplicate 1.5 ml centrifuge tubes. Distilled water 
was added to make a total volume of 200µl. For test samples, 200µL of culture 
medium from three strained samples and three unstrained samples were taken in 
separate labeled micro centrifuge tubes. 1 ml of the Sircol Dye Reagent was added and 
the contents of the tube mixed by inversion, and then in a mechanical mixer for 30 min. 
After that centrifuged at 13,000 rpm for 10 minutes, the supernatant was decanted 
away, and any excess supernatant was removed by an absorbent paper. Then, 1 ml of 
Alkali reagent was added, and the tubes were vortexed for 5 min. 200µL of the 
solution obtained was aliquot into separate wells of a 96-well microplate (3 well per 
sample), and the absorbance values of the samples were measured with a microplate 
reader at a wavelength of 540nm. 
A.3 Cell Survivability 
In order to assess the viable cells within cell sheet and the viable cells on scaffolds, 5-
chloromethylfluorescein diacetate (Figure A.1(a)) (CMFDA, ITS Science & Medical 
Pte. Ltd.) was used to stain the living cells. CMFDA is fluorescent chloromethyl 
derivative that can freely diffuse through the membranes of live cells. Once inside the 
cell, the cytosolic esterases cleave the acetate groups of CMFDA, releasing the 
fluorescent product, 5-chloromethylfluorescein (Figure A.1(b)). Cells loaded with 
CMFDA are fluorescent for at least 24 hours that can visualize using both confocal 














Figure A.1 (a) Chemical structure of CMFDA; (b) Chemical Structure of 5-
chloromethylfluorescein 
 
At each assessment time points, the medium of samples were aspirated and replaced by 
medium containing only DMEM and 10mmol/L CMFDA. The samples were then 
incubated at 37°C with 5% humidified CO2 for 30 minutes. Following CMFDA lading, 
the staining medium was aspirated and replace with standard culture medium and the 
samples were incubated at 37°C with 5% humidified CO2 for 1 hour. After incubation, 
the samples were washed by phosphate buffer saline (PBS) and fixed by 4% 
formaldehyde. The stained samples were further checked under fluorescent microscope 
or confocal laser scanning microscope. 
A.4 Immunohistochemistry Study 
The detection kit used in this research constituted a labeled Streptavidin-biotin 
immunoenzymatic antigen detection system. This technique involved the sequential 
incubation of the specimen with an unconjugated primary antibody specific to the 
target antigen, a biotinylated secondary antibody which reacted with the primary 
antibodies, enzyme-labeled streptavidin and substrate-chromogen. The primary 
antibodies used were mouse anti-human collagen type I, mouse anti-human collagen 
(a)  (b) 
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type III or anti-human tenascin-C for the detection of collagen Type I, type III or 
tenasic-C respectively. 
Cell sheet or cell sheet seed scaffolds were washed twice with PBS and then fix in 4% 
formaldehyde and transferred into 15% sucrose solution until the specimens sinks. The 
scaffolds were further section into 5μm thickness using cryostat (Figure A.2). All 
slides or cell sheet were divided into three group: one group will be stained with the 
antibody for collagen type I, one with collagen type III, one with tenascin-C and the 
last group without any primary antibody (Table A.1). All antibodies were dissolved in 
water to form 1µg/µl stock solution. 
Table A.1 Grouping of specimens for immunohistochemistry 
Group Treatments 
1 
Treated with mouse anti-human collagen type I primary antibody, 
followed by anti mouse secondary antibody 
2 
Treated with mouse anti-human collagen type III primary antibody, 
followed by anti mouse secondary antibody 
3 
Treated with mouse anti-human tenacin-C primary antibody, followed 
by anti mouse secondary antibody 
Blank 
Treated with PBS (instead of a primary antibody), followed by anti 
mouse secondary antibody 
 
 
All three groups of cell sheet and histological sections were rinsed with IHC buffer 
solution. Then all the samples were treated with blocking reagent for 10 minutes. After 
that, specimens from group 1 and group 2 were labeled with primary monoclonal anti-
collagen type I, type III or tenascin-C antibodies at a 1:200 dilution and left at room 
temperature for 10 minutes. Subsequently, the sections from all three groups were 
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treated with biotinylated secondary antibodies for 10 minutes and further treated with 
streptavidin horseradish peroxidase (HRP) at room temperature for 10 minutes and 
followed by incubation with a DAB solution (1:25 ratio of DAB Chromogen A (3,3’-
Diaminobenzidine) and DAB Chromogen B (hydrogen peroxide)) for 10 minutes at 
room temperature. Finally, the samples were treated with Hematoxylin Counter Stain 
for 10 minutes. Immunosections and were analyzed by light microscope. 
 
Figure A.2 Cryostat (Leica CM 3050 S) 
A.5 Histology 
Cell sheet thickness and cell morphology on different scaffold systems were studied 
with the aid of Hematoxylin & Eosin staining. All specimens were washed with PBS 
and then fixed in 4% Formalin for one day. This was then followed by the dehydration 
process where the samples would go through 50%, 70%, 90% and 100% (twice) 
ethanol on an hourly basis. The samples were soaked in a solution of ethanol and 
toluene (volume ratio of 50:50) overnight and then in 100% toluene for 24 hours. The 
scaffolds were then paraffin embedded by transferring the samples through progressive 
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grades of paraffin baths. The paraffin blocked samples were sectioned by microtome 
(Figure A.3) into 10µm thickness and then mounted on microscope slides. 
Histology was performed on both the transverse and longitudinal sections of the 
scaffolds. All the paraffin-embedded slides sections were dewaxed by transferring 
them sequentially to xylene (twice), xylene and toluene (volume ratio of 50:50), 100% 
(twice), 90%, 70% and 50% ethanol for 1 minute at each stage. The slides were then 
watered under tap water and stained with Haematoxylin stain for 2-3 minute. After that 
slides were differentiated in dilute HCL solution for 5-10 seconds. The slides were 
washed with water again and followed by Eosin stain for 30-45 seconds. After staining 
with H&E, all slides were dehydrate by transferring them sequentially to 70%, 90%, 
100% alcohol (twice), xylene + 100 % alcohol (50:50, volume) and 100% xylene 
(twice) for 1 minute at each stage. Then xylene based mounting medium (permount) 
was applied on the slide and cover with coverslip. In H&E staining, the fibrin glue and 
ECM were stained red by Eosin while the cell nuclei became dark purplish blue by the 
Haematoxylin. 
 
Figure A.3 Microtome to section paraffin block 
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A.6 Mechanical Testing 
All the specimens were washed with PBS. Then the specimens were mounted on the a 
universal testing machine, UTM (Figure A.4) fitted with a 1000N load cell. 
Mechanical properties were measured by loading the sample to failure at room 
temperature. It has an accuracy of at least 1% of reading up to a maximum of 2N. After 
the mounting, phosphate buffer solution was dropped onto the specimens to keep them 
wet. At a test speed of 10mm/min, a tensile load was applied. Ultimate load was 
obtained from load-elongation curve of each specimen. While tensile stiffness was 
calculated from the linear region of the load-elongation curve. 
 
Figure A.4 Universal testing machine (UTM) (Instron® 3345 Tester) 
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A.7 Data Analysis for mechanical testing  
The peak load and stiffness of the scaffolds in elastic region need to be obtained from 
the data points recorded from the instron machine. The peak load was found by 
plotting the graph of load (N) versus extension (mm) of the scaffold. 
The stiffness in the elastic region was found by the following method: 
1. The data for the load and extension up to the first peak (load) were extracted. 
2. The gradients between successive points were calculated i.e. g1 and g2 in figure 
E. 
3. The difference in gradients calculated as a percentage of the first gradient. 
i.e.( g2 - g1 )/ g1  × 100 %. 
4. The graph of x2 versus the difference in successive gradients was plotted 
(Figure A.6). From the graph x2 versus the difference in successive gradients, 
the region of best linearity was signed out. 
5. If more than one region of linearity were found, the regions were compared 
using the correlation method to single out the more linear region. 
6. The region  selected was tested with the correlation formula to ensure a square 
of correlation factor of more than 0.99 (1.0 being a perfectly fitting straight 
line) 
7. With the best linear region, a straight line was fitted using linear regression 
(least square method) and the gradient of the line would be the stiffness of the 
elastic region (Figure A.7). 
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Figure A.5 Calculation of gradient between two successive points 
 
 
Figure A.6 Graph of percentage gradient changeversus extension. 
 
Figure A.7 The best fitted straight line (blue) of most linear region. 
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A.8 Statistical Analysis of Experimental Data 
A.8.1 Dosage Response of Ascorbic Acid on Cell Sheet Formation 

















Thickness1 LSD 1 2 -5.00000* .69205 .000 -6.4751 -3.5249
3 -8.00000* .69205 .000 -9.4751 -6.5249
2 3 -3.00000* .69205 .001 -4.4751 -1.5249
Thickness2 LSD 1 2 -5.35000* .77590 .000 -7.0038 -3.6962
3 -8.14000* .77590 .000 -9.7938 -6.4862
2 3 -2.79000* .77590 .003 -4.4438 -1.1362
*. The mean difference is significant at the 0.05 level. 
**. Thickness 1: confocal method; Thickness2: histology method 
***. Condition 1:10%FBS with 0μg/ml ascorbic acid; Condition 2: 10%FBS with 50μg/ml; Condition 3: 
10%FBS with 100μg/ml 
 
ANOVA analysis of cell sheet thickness obtained by different method 
  Sum of Squares df Mean Square F Sig. 
NoAA* Between Groups 1.512 1 1.512 1.092 .321
AA50* Between Groups 3.371 1 3.371 1.775 .212
AA100* Between Groups 2.167 1 2.167 1.371 .269
*. No AA: 10%FBS with 0μg/ml ascorbic acid; AA50: 10%FBS with 50μg/ml; AA100: 10%FBS with 
100μg/ml 
 
ANOVA analysis of gene expression under different culture condition at each time point 
  Sum of Squares df Mean Square F Sig. 
Col1day7 Between Groups .816 2 .408 15.580 .000
Col1Day21 Between Groups 2.120 2 1.060 18.831 .000
Col1Day35 Between Groups 5.742 2 2.871 57.539 .000
Col3Day7 Between Groups .291 2 .145 7.534 .005
Col3Day21 Between Groups .780 2 .390 7.778 .005





Multiple Comparisons of gene expression at different time point under each culture condition 
Dependent 
Variable** (I) D (J) D 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
C1Col1 LSD 7 21 -.9500000* .1128421 .000 -1.190517 -.709483
35 -1.7200000* .1128421 .000 -1.960517 -1.479483
21 35 -.7700000* .1128421 .000 -1.010517 -.529483
C2Col1 LSD 7 21 -.9400000* .1368698 .000 -1.231731 -.648269
35 -2.3800000* .1368698 .000 -2.671731 -2.088269
21 35 -1.4400000* .1368698 .000 -1.731731 -1.148269
C3Col1 LSD 7 21 -1.3000000* .1125463 .000 -1.539887 -1.060113
35 -2.5300000* .1125463 .000 -2.769887 -2.290113
21 35 -1.2300000* .1125463 .000 -1.469887 -.990113
C1Col3 LSD 7 21 -.6400000* .1021437 .000 -.857714 -.422286
35 -.9200000* .1021437 .000 -1.137714 -.702286
21 35 -.2800000* .1021437 .015 -.497714 -.062286
C2Col3 LSD 7 21 -.7200000* .1193035 .000 -.974289 -.465711
35 -1.0500000* .1193035 .000 -1.304289 -.795711
21 35 -.3300000* .1193035 .014 -.584289 -.075711
C3Col3 LSD 7 21 -.8400000* .1313604 .000 -1.119988 -.560012
35 -1.2000000* .1313604 .000 -1.479988 -.920012
21 35 -.3600000* .1313604 .015 -.639988 -.080012
*. The mean difference is significant at the 0.05 level. 
**. C1: 10%FBS with 0μg/ml ascorbic acid; C2: 10%FBS with 50μg/ml; C3: 10%FBS with 100μg/ml 
A.8.2 Dosage Response of FBS on Cell Sheet Formation 








Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
CFM LSD 1 2 -8.2200000* .7253160 .000 -9.732983 -6.707017
3 -10.9500000* .7253160 .000 -12.462983 -9.437017
4 -26.7900000* .7253160 .000 -28.302983 -25.277017
2 3 -2.7300000* .7253160 .001 -4.242983 -1.217017
4 -18.5700000* .7253160 .000 -20.082983 -17.057017
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3 4 -15.8400000* .7253160 .000 -17.352983 -14.327017
Histo LSD 1 2 -7.7700000* .8803314 .000 -9.606339 -5.933661
3 -10.3400000* .8803314 .000 -12.176339 -8.503661
4 -26.6700000* .8803314 .000 -28.506339 -24.833661
2 3 -2.5700000* .8803314 .008 -4.406339 -.733661
4 -18.9000000* .8803314 .000 -20.736339 -17.063661
3 4 -16.3300000* .8803314 .000 -18.166339 -14.493661
*. The mean difference is significant at the 0.05 level. 
**. 1: 10% FBS with 50µg/ml ascorbic acid; 2: 15% FBS with 50µg/ml ascorbic acid; 3: 20% FBS with 
50µg/ml ascorbic acid; 4: 25% FBS with 50µg/ml ascorbic acid 
***. CFM: confocal microscope method; Histo: histology method 
 
ANOVA analysis of cell sheet thickness obtained by different method 
  Sum of Squares df Mean Square F Sig. 
FBS10 Between Groups 3.371 1 3.371 1.775 .212
FBS15 Between Groups 6.840 1 6.840 2.743 .129
FBS20 Between Groups 8.367 1 8.367 4.757 .054
FBS25 Between Groups 4.177 1 4.177 2.525 .143
 
 
Multiple Comparisons of gene expression under different culture condition at each time point 
Dependent Variable (I) C** (J) C**
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Col1day7 LSD 1 2 -.7900000* .1160101 .000 -1.031993 -.548007
3 -1.5300000* .1160101 .000 -1.771993 -1.288007
4 -2.0600000* .1160101 .000 -2.301993 -1.818007
2 3 -.7400000* .1160101 .000 -.981993 -.498007
4 -1.2700000* .1160101 .000 -1.511993 -1.028007
3 4 -.5300000* .1160101 .000 -.771993 -.288007
Col1Day21 LSD 1 2 -2.2200000* .1340087 .000 -2.499537 -1.940463
3 -3.2400000* .1340087 .000 -3.519537 -2.960463
4 -3.9400000* .1340087 .000 -4.219537 -3.660463
2 3 -1.0200000* .1340087 .000 -1.299537 -.740463
4 -1.7200000* .1340087 .000 -1.999537 -1.440463
3 4 -.7000000* .1340087 .000 -.979537 -.420463
Col1Day35 LSD 1 2 -2.3100000* .1328847 .000 -2.587193 -2.032807
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3 -4.1800000* .1328847 .000 -4.457193 -3.902807
4 -6.2400000* .1328847 .000 -6.517193 -5.962807
2 3 -1.8700000* .1328847 .000 -2.147193 -1.592807
4 -3.9300000* .1328847 .000 -4.207193 -3.652807
3 4 -2.0600000* .1328847 .000 -2.337193 -1.782807
Col3Day7 LSD 1 2 -.4000000* .0945604 .000 -.597250 -.202750
3 -.9000000* .0945604 .000 -1.097250 -.702750
4 -1.4300000* .0945604 .000 -1.627250 -1.232750
2 3 -.5000000* .0945604 .000 -.697250 -.302750
4 -1.0300000* .0945604 .000 -1.227250 -.832750
3 4 -.5300000* .0945604 .000 -.727250 -.332750
Col3Day21 LSD 1 2 -.3700000* .1088577 .003 -.597073 -.142927
3 -1.1900000* .1088577 .000 -1.417073 -.962927
4 -1.6000000* .1088577 .000 -1.827073 -1.372927
2 3 -.8200000* .1088577 .000 -1.047073 -.592927
4 -1.2300000* .1088577 .000 -1.457073 -1.002927
3 4 -.4100000* .1088577 .001 -.637073 -.182927
Col3Day35 LSD 1 2 -1.4600000* .1262933 .000 -1.723443 -1.196557
3 -2.9500000* .1262933 .000 -3.213443 -2.686557
4 -3.9300000* .1262933 .000 -4.193443 -3.666557
2 3 -1.4900000* .1262933 .000 -1.753443 -1.226557
4 -2.4700000* .1262933 .000 -2.733443 -2.206557
3 4 -.9800000* .1262933 .000 -1.243443 -.716557
*. The mean difference is significant at the 0.05 level. 
**. 1: 10% FBS with 50µg/ml ascorbic acid; 2: 15% FBS with 50µg/ml ascorbic acid; 3: 20% FBS with 
50µg/ml ascorbic acid; 4: 25% FBS with 50µg/ml ascorbic acid 
 
Multiple Comparisons of gene expression at different time point under each culture condition 
Dependent 
Variable** (I) D (J) D 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
C1Col1 LSD 7 21 -.6700000* .1056724 .000 -.895235 -.444765
35 -1.7000000* .1056724 .000 -1.925235 -1.474765
21 35 -1.0300000* .1056724 .000 -1.255235 -.804765
C2Col1 LSD 7 21 -2.1000000* .1171419 .000 -2.349682 -1.850318
35 -3.2200000* .1171419 .000 -3.469682 -2.970318
21 35 -1.1200000* .1171419 .000 -1.369682 -.870318
  166
C3Col1 LSD 7 21 -2.3800000* .1300854 .000 -2.657271 -2.102729
35 -4.3500000* .1300854 .000 -4.627271 -4.072729
21 35 -1.9700000* .1300854 .000 -2.247271 -1.692729
C4Col1 LSD 7 21 -2.5500000* .1536952 .000 -2.877594 -2.222406
35 -5.8800000* .1536952 .000 -6.207594 -5.552406
21 35 -3.3300000* .1536952 .000 -3.657594 -3.002406
C1Col3 LSD 7 21 -.6500000* .1116045 .000 -.887879 -.412121
35 -.9300000* .1116045 .000 -1.167879 -.692121
21 35 -.2800000* .1116045 .024 -.517879 -.042121
C2Col3 LSD 7 21 -.6200000* .0984886 .000 -.829923 -.410077
35 -1.9900000* .0984886 .000 -2.199923 -1.780077
21 35 -1.3700000* .0984886 .000 -1.579923 -1.160077
C3Col3 LSD 7 21 -.9400000* .0976388 .000 -1.148112 -.731888
35 -2.9800000* .0976388 .000 -3.188112 -2.771888
21 35 -2.0400000* .0976388 .000 -2.248112 -1.831888
C4Col3 LSD 7 21 -.8200000* .1315295 .000 -1.100348 -.539652
35 -3.4300000* .1315295 .000 -3.710348 -3.149652
21 35 -2.6100000* .1315295 .000 -2.890348 -2.329652
*. The mean difference is significant at the 0.05 level. 
**. C1: 10% FBS with 50µg/ml ascorbic acid; C2: 15% FBS with 50µg/ml ascorbic acid; C3: 20% FBS 
with 50µg/ml ascorbic acid; C4: 25% FBS with 50µg/ml ascorbic acid 
A.8.3 Dosage Response of Ascorbic Acid on Cell Sheet Formation 








Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Day1 LSD 1 2 -7.3288857* .5174894 .000 -8.375607 -6.282165
3 -10.7276595* .5174894 .000 -11.774381 -9.680938
4 -9.0794991* .5174894 .000 -10.126220 -8.032778
5 -12.0711389* .5174894 .000 -13.117860 -11.024418
6 -14.9484935* .5174894 .000 -15.995215 -13.901772
7 -14.0724830* .5174894 .000 -15.119204 -13.025762
8 -15.3377328* .5174894 .000 -16.384454 -14.291012
9 -17.9643132* .5174894 .000 -19.011034 -16.917592
  167
10 -18.6054411* .5488804 .000 -19.715657 -17.495226
2 3 -3.3987738* .5174894 .000 -4.445495 -2.352053
4 -1.7506134* .5174894 .002 -2.797335 -.703892
5 -4.7422532* .5174894 .000 -5.788974 -3.695532
6 -7.6196078* .5174894 .000 -8.666329 -6.572887
7 -6.7435973* .5174894 .000 -7.790318 -5.696876
8 -8.0088471* .5174894 .000 -9.055568 -6.962126
9 -10.6354275* .5174894 .000 -11.682149 -9.588706
10 -11.2765555* .5488804 .000 -12.386771 -10.166340
3 4 1.6481605* .5174894 .003 .601439 2.694882
5 -1.3434794* .5174894 .013 -2.390201 -.296758
6 -4.2208339* .5174894 .000 -5.267555 -3.174113
7 -3.3448235* .5174894 .000 -4.391545 -2.298102
8 -4.6100733* .5174894 .000 -5.656794 -3.563352
9 -7.2366537* .5174894 .000 -8.283375 -6.189933
10 -7.8777816* .5488804 .000 -8.987997 -6.767566
4 5 -2.9916399* .5174894 .000 -4.038361 -1.944919
6 -5.8689944* .5174894 .000 -6.915716 -4.822273
7 -4.9929839* .5174894 .000 -6.039705 -3.946263
8 -6.2582338* .5174894 .000 -7.304955 -5.211513
9 -8.8848142* .5174894 .000 -9.931535 -7.838093
10 -9.5259421* .5488804 .000 -10.636158 -8.415727
5 6 -2.8773545* .5174894 .000 -3.924076 -1.830633
7 -2.0013441* .5174894 .000 -3.048065 -.954623
8 -3.2665939* .5174894 .000 -4.313315 -2.219873
9 -5.8931743* .5174894 .000 -6.939895 -4.846453
10 -6.5343022* .5488804 .000 -7.644518 -5.424087
6 7 .8760104 .5174894 .098 -.170711 1.922732
8 -.3892394 .5174894 .456 -1.435961 .657482
9 -3.0158198* .5174894 .000 -4.062541 -1.969099
10 -3.6569477* .5488804 .000 -4.767163 -2.546732
7 8 -1.2652498* .5174894 .019 -2.311971 -.218529
9 -3.8918302* .5174894 .000 -4.938551 -2.845109
  168
10 -4.5329581* .5488804 .000 -5.643174 -3.422743
8 9 -2.6265804* .5174894 .000 -3.673302 -1.579859
10 -3.2677083* .5488804 .000 -4.377924 -2.157493
9 10 -.6411279 .5488804 .250 -1.751343 .469088
Day3 LSD 1 2 -5.1666030* .5088063 .000 -6.194939 -4.138267
3 -10.5362558* .5088063 .000 -11.564592 -9.507920
4 -5.7009387* .5088063 .000 -6.729275 -4.672603
5 -13.1065316* .5088063 .000 -14.134867 -12.078196
6 -13.9731457* .5088063 .000 -15.001482 -12.944810
7 -12.7485023* .5088063 .000 -13.776838 -11.720166
8 -15.0812458* .5088063 .000 -16.109582 -14.052910
9 -17.2880413* .5088063 .000 -18.316377 -16.259705
10 -20.9662023* .5088063 .000 -21.994538 -19.937866
2 3 -5.3696527* .5088063 .000 -6.397989 -4.341317
4 -.5343357 .5088063 .300 -1.562672 .494000
5 -7.9399286* .5088063 .000 -8.968264 -6.911593
6 -8.8065426* .5088063 .000 -9.834879 -7.778207
7 -7.5818993* .5088063 .000 -8.610235 -6.553563
8 -9.9146427* .5088063 .000 -10.942979 -8.886307
9 -12.1214383* .5088063 .000 -13.149774 -11.093102
10 -15.7995993* .5088063 .000 -16.827935 -14.771263
3 4 4.8353170* .5088063 .000 3.806981 5.863653
5 -2.5702758* .5088063 .000 -3.598612 -1.541940
6 -3.4368899* .5088063 .000 -4.465226 -2.408554
7 -2.2122466* .5088063 .000 -3.240582 -1.183911
8 -4.5449900* .5088063 .000 -5.573326 -3.516654
9 -6.7517855* .5088063 .000 -7.780121 -5.723450
10 -10.4299465* .5088063 .000 -11.458282 -9.401611
4 5 -7.4055929* .5088063 .000 -8.433929 -6.377257
6 -8.2722069* .5088063 .000 -9.300543 -7.243871
7 -7.0475636* .5088063 .000 -8.075899 -6.019228
8 -9.3803070* .5088063 .000 -10.408643 -8.351971
9 -11.5871026* .5088063 .000 -12.615438 -10.558767
10 -15.2652635* .5088063 .000 -16.293599 -14.236928
  169
5 6 -.8666141 .5088063 .096 -1.894950 .161722
7 .3580293 .5088063 .486 -.670307 1.386365
8 -1.9747142* .5088063 .000 -3.003050 -.946378
9 -4.1815097* .5088063 .000 -5.209846 -3.153174
10 -7.8596707* .5088063 .000 -8.888007 -6.831335
6 7 1.2246433* .5088063 .021 .196307 2.252979
8 -1.1081001* .5088063 .035 -2.136436 -.079764
9 -3.3148957* .5088063 .000 -4.343232 -2.286560
10 -6.9930566* .5088063 .000 -8.021392 -5.964721
7 8 -2.3327434* .5088063 .000 -3.361079 -1.304408
9 -4.5395390* .5088063 .000 -5.567875 -3.511203
10 -8.2176999* .5088063 .000 -9.246036 -7.189364
8 9 -2.2067956* .5088063 .000 -3.235131 -1.178460
10 -5.8849565* .5088063 .000 -6.913292 -4.856621
9 10 -3.6781610* .5088063 .000 -4.706497 -2.649825
Day7 LSD 1 2 -4.6399084* .4853676 .000 -5.620873 -3.658944
3 -10.4705067* .4853676 .000 -11.451471 -9.489542
4 -5.6207541* .4853676 .000 -6.601719 -4.639790
5 -13.8509741* .4853676 .000 -14.831939 -12.870010
6 -14.5449782* .4853676 .000 -15.525943 -13.564014
7 -12.2393502* .4853676 .000 -13.220315 -11.258386
8 -16.0016722* .4853676 .000 -16.982637 -15.020708
9 -19.7275064* .4853676 .000 -20.708471 -18.746542
10 -21.2437341* .4853676 .000 -22.224699 -20.262770
2 3 -5.8305983* .4853676 .000 -6.811563 -4.849634
4 -.9808457 .4853676 .050 -1.961810 .000119
5 -9.2110657* .4853676 .000 -10.192030 -8.230101
6 -9.9050698* .4853676 .000 -10.886034 -8.924105
7 -7.5994418* .4853676 .000 -8.580406 -6.618477
8 -11.3617638* .4853676 .000 -12.342728 -10.380799
9 -15.0875979* .4853676 .000 -16.068562 -14.106633
10 -16.6038257* .4853676 .000 -17.584790 -15.622861
3 4 4.8497526* .4853676 .000 3.868788 5.830717
5 -3.3804674* .4853676 .000 -4.361432 -2.399503
  170
6 -4.0744715* .4853676 .000 -5.055436 -3.093507
7 -1.7688435* .4853676 .001 -2.749808 -.787879
8 -5.5311655* .4853676 .000 -6.512130 -4.550201
9 -9.2569996* .4853676 .000 -10.237964 -8.276035
10 -10.7732274* .4853676 .000 -11.754192 -9.792263
4 5 -8.2302200* .4853676 .000 -9.211184 -7.249256
6 -8.9242241* .4853676 .000 -9.905189 -7.943260
7 -6.6185961* .4853676 .000 -7.599561 -5.637632
8 -10.3809181* .4853676 .000 -11.361883 -9.399954
9 -14.1067523* .4853676 .000 -15.087717 -13.125788
10 -15.6229800* .4853676 .000 -16.603944 -14.642016
5 6 -.6940041 .4853676 .161 -1.674969 .286960
7 1.6116239* .4853676 .002 .630659 2.592588
8 -2.1506981* .4853676 .000 -3.131663 -1.169734
9 -5.8765323* .4853676 .000 -6.857497 -4.895568
10 -7.3927600* .4853676 .000 -8.373724 -6.411796
6 7 2.3056280* .4853676 .000 1.324664 3.286593
8 -1.4566940* .4853676 .005 -2.437659 -.475730
9 -5.1825282* .4853676 .000 -6.163493 -4.201564
10 -6.6987559* .4853676 .000 -7.679720 -5.717791
7 8 -3.7623220* .4853676 .000 -4.743287 -2.781358
9 -7.4881562* .4853676 .000 -8.469121 -6.507192
10 -9.0043839* .4853676 .000 -9.985348 -8.023419
8 9 -3.7258341* .4853676 .000 -4.706799 -2.744870
10 -5.2420619* .4853676 .000 -6.223026 -4.261097
9 10 -1.5162277* .4853676 .003 -2.497192 -.535263
Day14 LSD 1 2 -4.5509259* .5694049 .000 -5.701736 -3.400116
3 -7.6560436* .5694049 .000 -8.806854 -6.505233
4 -3.7613044* .5694049 .000 -4.912115 -2.610494
5 -12.3138244* .5694049 .000 -13.464635 -11.163014
6 -14.7007844* .5694049 .000 -15.851595 -13.549974
7 -12.1935112* .5694049 .000 -13.344321 -11.042701
8 -15.2875148* .5694049 .000 -16.438325 -14.136705
9 -19.5129644* .5694049 .000 -20.663775 -18.362154
  171
10 -20.7174995* .5694049 .000 -21.868310 -19.566689
2 3 -3.1051178* .5694049 .000 -4.255928 -1.954307
4 .7896214 .5694049 .173 -.361189 1.940432
5 -7.7628986* .5694049 .000 -8.913709 -6.612088
6 -10.1498586* .5694049 .000 -11.300669 -8.999048
7 -7.6425854* .5694049 .000 -8.793396 -6.491775
8 -10.7365890* .5694049 .000 -11.887399 -9.585779
9 -14.9620386* .5694049 .000 -16.112849 -13.811228
10 -16.1665737* .5694049 .000 -17.317384 -15.015763
3 4 3.8947392* .5694049 .000 2.743929 5.045549
5 -4.6577808* .5694049 .000 -5.808591 -3.506971
6 -7.0447408* .5694049 .000 -8.195551 -5.893931
7 -4.5374676* .5694049 .000 -5.688278 -3.386657
8 -7.6314712* .5694049 .000 -8.782282 -6.480661
9 -11.8569208* .5694049 .000 -13.007731 -10.706111
10 -13.0614559* .5694049 .000 -14.212266 -11.910646
4 5 -8.5525200* .5694049 .000 -9.703330 -7.401710
6 -10.9394800* .5694049 .000 -12.090290 -9.788670
7 -8.4322068* .5694049 .000 -9.583017 -7.281396
8 -11.5262104* .5694049 .000 -12.677021 -10.375400
9 -15.7516600* .5694049 .000 -16.902470 -14.600850
10 -16.9561951* .5694049 .000 -18.107005 -15.805385
5 6 -2.3869600* .5694049 .000 -3.537770 -1.236150
7 .1203132 .5694049 .834 -1.030497 1.271124
8 -2.9736904* .5694049 .000 -4.124501 -1.822880
9 -7.1991400* .5694049 .000 -8.349950 -6.048330
10 -8.4036751* .5694049 .000 -9.554485 -7.252865
6 7 2.5072732* .5694049 .000 1.356463 3.658084
8 -.5867304 .5694049 .309 -1.737541 .564080
9 -4.8121800* .5694049 .000 -5.962990 -3.661370
10 -6.0167151* .5694049 .000 -7.167525 -4.865905
7 8 -3.0940036* .5694049 .000 -4.244814 -1.943193
9 -7.3194532* .5694049 .000 -8.470264 -6.168643
10 -8.5239883* .5694049 .000 -9.674799 -7.373178
  172
8 9 -4.2254496* .5694049 .000 -5.376260 -3.074639
10 -5.4299847* .5694049 .000 -6.580795 -4.279174
9 10 -1.2045351* .5694049 .041 -2.355345 -.053725
Day21 LSD 1 2 -4.7937502* .5499733 .000 -5.905288 -3.682213
3 -7.7458227* .5499733 .000 -8.857360 -6.634285
4 -4.2194648* .5499733 .000 -5.331002 -3.107927
5 -12.6120848* .5499733 .000 -13.723622 -11.500547
6 -15.2726648* .5499733 .000 -16.384202 -14.161127
7 -12.8165379* .5499733 .000 -13.928075 -11.705001
8 -16.1103581* .5499733 .000 -17.221896 -14.998821
9 -19.5639748* .5499733 .000 -20.675512 -18.452437
10 -22.4108784* .5499733 .000 -23.522416 -21.299341
2 3 -2.9520725* .5499733 .000 -4.063610 -1.840535
4 .5742854 .5499733 .303 -.537252 1.685823
5 -7.8183346* .5499733 .000 -8.929872 -6.706797
6 -10.4789146* .5499733 .000 -11.590452 -9.367377
7 -8.0227878* .5499733 .000 -9.134325 -6.911250
8 -11.3166079* .5499733 .000 -12.428145 -10.205070
9 -14.7702247* .5499733 .000 -15.881762 -13.658687
10 -17.6171282* .5499733 .000 -18.728666 -16.505591
3 4 3.5263579* .5499733 .000 2.414820 4.637895
5 -4.8662621* .5499733 .000 -5.977800 -3.754725
6 -7.5268421* .5499733 .000 -8.638380 -6.415305
7 -5.0707152* .5499733 .000 -6.182253 -3.959178
8 -8.3645354* .5499733 .000 -9.476073 -7.252998
9 -11.8181521* .5499733 .000 -12.929690 -10.706615
10 -14.6650557* .5499733 .000 -15.776593 -13.553518
4 5 -8.3926200* .5499733 .000 -9.504157 -7.281083
6 -11.0532000* .5499733 .000 -12.164737 -9.941663
7 -8.5970731* .5499733 .000 -9.708611 -7.485536
8 -11.8908933* .5499733 .000 -13.002431 -10.779356
9 -15.3445100* .5499733 .000 -16.456047 -14.232973
10 -18.1914136* .5499733 .000 -19.302951 -17.079876
5 6 -2.6605800* .5499733 .000 -3.772117 -1.549043
  173
7 -.2044531 .5499733 .712 -1.315991 .907084
8 -3.4982733* .5499733 .000 -4.609811 -2.386736
9 -6.9518900* .5499733 .000 -8.063427 -5.840353
10 -9.7987936* .5499733 .000 -10.910331 -8.687256
6 7 2.4561269* .5499733 .000 1.344589 3.567664
8 -.8376933 .5499733 .136 -1.949231 .273844
9 -4.2913100* .5499733 .000 -5.402847 -3.179773
10 -7.1382136* .5499733 .000 -8.249751 -6.026676
7 8 -3.2938202* .5499733 .000 -4.405358 -2.182283
9 -6.7474369* .5499733 .000 -7.858974 -5.635899
10 -9.5943405* .5499733 .000 -10.705878 -8.482803
8 9 -3.4536167* .5499733 .000 -4.565154 -2.342079
10 -6.3005203* .5499733 .000 -7.412058 -5.188983
9 10 -2.8469036* .5499733 .000 -3.958441 -1.735366
Day28 LSD 1 2 -4.8305026* .5174024 .000 -5.876212 -3.784793
3 -7.7808747* .5174024 .000 -8.826584 -6.735165
4 -4.8275727* .5174024 .000 -5.873282 -3.781863
5 -13.2824027* .5174024 .000 -14.328112 -12.236693
6 -15.3460327* .5174024 .000 -16.391742 -14.300323
7 -12.9786356* .5174024 .000 -14.024345 -11.932926
8 -15.8609836* .5174024 .000 -16.906693 -14.815274
9 -20.5517027* .5174024 .000 -21.597412 -19.505993
10 -22.4829725* .5174024 .000 -23.528682 -21.437263
2 3 -2.9503720* .5174024 .000 -3.996081 -1.904663
4 .0029300 .5174024 .996 -1.042779 1.048639
5 -8.4519000* .5174024 .000 -9.497609 -7.406191
6 -10.5155300* .5174024 .000 -11.561239 -9.469821
7 -8.1481329* .5174024 .000 -9.193842 -7.102424
8 -11.0304809* .5174024 .000 -12.076190 -9.984772
9 -15.7212000* .5174024 .000 -16.766909 -14.675491
10 -17.6524698* .5174024 .000 -18.698179 -16.606761
3 4 2.9533020* .5174024 .000 1.907593 3.999011
5 -5.5015280* .5174024 .000 -6.547237 -4.455819
6 -7.5651580* .5174024 .000 -8.610867 -6.519449
  174
7 -5.1977609* .5174024 .000 -6.243470 -4.152052
8 -8.0801089* .5174024 .000 -9.125818 -7.034400
9 -12.7708280* .5174024 .000 -13.816537 -11.725119
10 -14.7020978* .5174024 .000 -15.747807 -13.656389
4 5 -8.4548300* .5174024 .000 -9.500539 -7.409121
6 -10.5184600* .5174024 .000 -11.564169 -9.472751
7 -8.1510629* .5174024 .000 -9.196772 -7.105354
8 -11.0334109* .5174024 .000 -12.079120 -9.987702
9 -15.7241300* .5174024 .000 -16.769839 -14.678421
10 -17.6553998* .5174024 .000 -18.701109 -16.609691
5 6 -2.0636300* .5174024 .000 -3.109339 -1.017921
7 .3037671 .5174024 .560 -.741942 1.349476
8 -2.5785809* .5174024 .000 -3.624290 -1.532872
9 -7.2693000* .5174024 .000 -8.315009 -6.223591
10 -9.2005698* .5174024 .000 -10.246279 -8.154861
6 7 2.3673971* .5174024 .000 1.321688 3.413106
8 -.5149509 .5174024 .326 -1.560660 .530758
9 -5.2056700* .5174024 .000 -6.251379 -4.159961
10 -7.1369398* .5174024 .000 -8.182649 -6.091231
7 8 -2.8823480* .5174024 .000 -3.928057 -1.836639
9 -7.5730671* .5174024 .000 -8.618776 -6.527358
10 -9.5043369* .5174024 .000 -10.550046 -8.458628
8 9 -4.6907191* .5174024 .000 -5.736428 -3.645010
10 -6.6219889* .5174024 .000 -7.667698 -5.576280
9 10 -1.9312698* .5174024 .001 -2.976979 -.885561
Day35 LSD 1 2 -5.3461370* .8381834 .000 -7.040169 -3.652105
3 -9.5969684* .8381834 .000 -11.291000 -7.902937
4 -5.5723880* .8381834 .000 -7.266420 -3.878356
5 -13.5261280* .8381834 .000 -15.220160 -11.832096
6 -16.0833780* .8381834 .000 -17.777410 -14.389346
7 -13.7031980* .8381834 .000 -15.397230 -12.009166
8 -16.9990965* .8381834 .000 -18.693128 -15.305065
9 -19.6184080* .8381834 .000 -21.312440 -17.924376
10 -22.1422002* .8381834 .000 -23.836232 -20.448168
  175
2 3 -4.2508314* .8381834 .000 -5.944863 -2.556800
4 -.2262511 .8381834 .789 -1.920283 1.467781
5 -8.1799911* .8381834 .000 -9.874023 -6.485959
6 -10.7372411* .8381834 .000 -12.431273 -9.043209
7 -8.3570611* .8381834 .000 -10.051093 -6.663029
8 -11.6529595* .8381834 .000 -13.346991 -9.958928
9 -14.2722711* .8381834 .000 -15.966303 -12.578239
10 -16.7960632* .8381834 .000 -18.490095 -15.102031
3 4 4.0245803* .8381834 .000 2.330549 5.718612
5 -3.9291597* .8381834 .000 -5.623191 -2.235128
6 -6.4864097* .8381834 .000 -8.180441 -4.792378
7 -4.1062297* .8381834 .000 -5.800261 -2.412198
8 -7.4021281* .8381834 .000 -9.096160 -5.708096
9 -10.0214397* .8381834 .000 -11.715471 -8.327408
10 -12.5452318* .8381834 .000 -14.239264 -10.851200
4 5 -7.9537400* .8381834 .000 -9.647772 -6.259708
6 -10.5109900* .8381834 .000 -12.205022 -8.816958
7 -8.1308100* .8381834 .000 -9.824842 -6.436778
8 -11.4267084* .8381834 .000 -13.120740 -9.732677
9 -14.0460200* .8381834 .000 -15.740052 -12.351988
10 -16.5698121* .8381834 .000 -18.263844 -14.875780
5 6 -2.5572500* .8381834 .004 -4.251282 -.863218
7 -.1770700 .8381834 .834 -1.871102 1.516962
8 -3.4729684* .8381834 .000 -5.167000 -1.778937
9 -6.0922800* .8381834 .000 -7.786312 -4.398248
10 -8.6160721* .8381834 .000 -10.310104 -6.922040
6 7 2.3801800* .8381834 .007 .686148 4.074212
8 -.9157184 .8381834 .281 -2.609750 .778313
9 -3.5350300* .8381834 .000 -5.229062 -1.840998
10 -6.0588221* .8381834 .000 -7.752854 -4.364790
7 8 -3.2958984* .8381834 .000 -4.989930 -1.601867
9 -5.9152100* .8381834 .000 -7.609242 -4.221178
10 -8.4390021* .8381834 .000 -10.133034 -6.744970
8 9 -2.6193116* .8381834 .003 -4.313343 -.925280
  176
10 -5.1431037* .8381834 .000 -6.837135 -3.449072
9 10 -2.5237921* .8381834 .004 -4.217824 -.829760
*. The mean difference is significant at the 0.05 level. 
**. 1: 10% FBS without ascorbic acid; 2: 10% FBS with 50µg/ml ascorbic acid; 3: 10% FBS with 100µg/ml 
ascorbic acid; 4: 15% FBS without ascorbic acid; 5: 15% FBS with 50µg/ml ascorbic acid; 6: 15% FBS 
with 100µg/ml ascorbic acid; 7: 20% FBS without ascorbic acid; 8: 20% FBS with 50µg/ml ascorbic acid; 
9: 20% FBS with 100µg/ml ascorbic acid; 10: 25% FBS with 50µg/ml ascorbic acid 
 
Multiple Comparisons of cell viability at different time point under each culture condition 




Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Condition1 LSD 1 3 -5.6096302* .3414484 .000 -6.309056 -4.910205
7 -8.0241984* .3414484 .000 -8.723624 -7.324773
14 -11.5881581* .3414484 .000 -12.287583 -10.888733
21 -11.6293177* .3414484 .000 -12.328743 -10.929892
28 -11.7604899* .3414484 .000 -12.459915 -11.061065
35 -11.5458445* .3414484 .000 -12.245270 -10.846419
3 7 -2.4145682* .3414484 .000 -3.113994 -1.715143
14 -5.9785279* .3414484 .000 -6.677953 -5.279103
21 -6.0196875* .3414484 .000 -6.719113 -5.320262
28 -6.1508597* .3414484 .000 -6.850285 -5.451434
35 -5.9362143* .3414484 .000 -6.635640 -5.236789
7 14 -3.5639597* .3414484 .000 -4.263385 -2.864534
21 -3.6051193* .3414484 .000 -4.304545 -2.905694
28 -3.7362914* .3414484 .000 -4.435717 -3.036866
35 -3.5216461* .3414484 .000 -4.221071 -2.822221
14 21 -.0411596 .3414484 .905 -.740585 .658266
28 -.1723318 .3414484 .618 -.871757 .527094
35 .0423136 .3414484 .902 -.657112 .741739
21 28 -.1311722 .3414484 .704 -.830598 .568253
35 .0834732 .3414484 .809 -.615952 .782899
28 35 .2146454 .3414484 .535 -.484780 .914071
Condition2 LSD 1 3 -3.4473475* .3209838 .000 -4.104853 -2.789842
7 -5.3352212* .3209838 .000 -5.992727 -4.677716
14 -8.8101983* .3209838 .000 -9.467704 -8.152693
21 -9.0941822* .3209838 .000 -9.751688 -8.436677
  177
28 -9.2621068* .3209838 .000 -9.919612 -8.604601
35 -9.5630958* .3209838 .000 -10.220601 -8.905590
3 7 -1.8878737* .3209838 .000 -2.545379 -1.230368
14 -5.3628507* .3209838 .000 -6.020356 -4.705345
21 -5.6468347* .3209838 .000 -6.304340 -4.989329
28 -5.8147593* .3209838 .000 -6.472265 -5.157254
35 -6.1157483* .3209838 .000 -6.773254 -5.458243
7 14 -3.4749771* .3209838 .000 -4.132483 -2.817472
21 -3.7589610* .3209838 .000 -4.416466 -3.101456
28 -3.9268856* .3209838 .000 -4.584391 -3.269380
35 -4.2278746* .3209838 .000 -4.885380 -3.570369
14 21 -.2839839 .3209838 .384 -.941489 .373522
28 -.4519086 .3209838 .170 -1.109414 .205597
35 -.7528975* .3209838 .026 -1.410403 -.095392
21 28 -.1679246 .3209838 .605 -.825430 .489581
35 -.4689136 .3209838 .155 -1.126419 .188592
28 35 -.3009890 .3209838 .356 -.958494 .356517
Condition3 LSD 1 3 -5.4182264* .4846234 .000 -6.410932 -4.425520
7 -7.7670456* .4846234 .000 -8.759752 -6.774340
14 -8.5165422* .4846234 .000 -9.509248 -7.523836
21 -8.6474809* .4846234 .000 -9.640187 -7.654775
28 -8.8137050* .4846234 .000 -9.806411 -7.820999
35 -10.4151533* .4846234 .000 -11.407859 -9.422447
3 7 -2.3488192* .4846234 .000 -3.341525 -1.356113
14 -3.0983157* .4846234 .000 -4.091022 -2.105610
21 -3.2292544* .4846234 .000 -4.221961 -2.236548
28 -3.3954786* .4846234 .000 -4.388185 -2.402772
35 -4.9969269* .4846234 .000 -5.989633 -4.004221
7 14 -.7494965 .4846234 .133 -1.742203 .243210
21 -.8804352 .4846234 .080 -1.873141 .112271
28 -1.0466594* .4846234 .040 -2.039365 -.053953
35 -2.6481077* .4846234 .000 -3.640814 -1.655402
14 21 -.1309387 .4846234 .789 -1.123645 .861767
28 -.2971628 .4846234 .545 -1.289869 .695543
  178
35 -1.8986112* .4846234 .001 -2.891317 -.905905
21 28 -.1662241 .4846234 .734 -1.158930 .826482
35 -1.7676725* .4846234 .001 -2.760379 -.774966
28 35 -1.6014483* .4846234 .003 -2.594154 -.608742
Condition4 LSD 1 3 -2.2310699* .7228899 .005 -3.711843 -.750297
7 -4.5654535* .7228899 .000 -6.046226 -3.084681
14 -6.2699635* .7228899 .000 -7.750736 -4.789191
21 -6.7692835* .7228899 .000 -8.250056 -5.288511
28 -7.5085635* .7228899 .000 -8.989336 -6.027791
35 -8.0387335* .7228899 .000 -9.519506 -6.557961
3 7 -2.3343836* .7228899 .003 -3.815156 -.853611
14 -4.0388936* .7228899 .000 -5.519666 -2.558121
21 -4.5382136* .7228899 .000 -6.018986 -3.057441
28 -5.2774936* .7228899 .000 -6.758266 -3.796721
35 -5.8076636* .7228899 .000 -7.288436 -4.326891
7 14 -1.7045100* .7228899 .026 -3.185283 -.223737
21 -2.2038300* .7228899 .005 -3.684603 -.723057
28 -2.9431100* .7228899 .000 -4.423883 -1.462337
35 -3.4732800* .7228899 .000 -4.954053 -1.992507
14 21 -.4993200 .7228899 .495 -1.980093 .981453
28 -1.2386000 .7228899 .098 -2.719373 .242173
35 -1.7687700* .7228899 .021 -3.249543 -.287997
21 28 -.7392800 .7228899 .315 -2.220053 .741493
35 -1.2694500 .7228899 .090 -2.750223 .211323
28 35 -.5301700 .7228899 .469 -2.010943 .950603
Condition5 LSD 1 3 -6.6450229* .4921863 .000 -7.653221 -5.636825
7 -9.8040336* .4921863 .000 -10.812232 -8.795836
14 -11.8308436* .4921863 .000 -12.839042 -10.822646
21 -12.1702636* .4921863 .000 -13.178462 -11.162066
28 -12.9717536* .4921863 .000 -13.979952 -11.963556
35 -13.0008336* .4921863 .000 -14.009032 -11.992636
3 7 -3.1590107* .4921863 .000 -4.167209 -2.150813
14 -5.1858207* .4921863 .000 -6.194019 -4.177623
21 -5.5252407* .4921863 .000 -6.533439 -4.517043
  179
28 -6.3267307* .4921863 .000 -7.334929 -5.318533
35 -6.3558107* .4921863 .000 -7.364009 -5.347613
7 14 -2.0268100* .4921863 .000 -3.035008 -1.018612
21 -2.3662300* .4921863 .000 -3.374428 -1.358032
28 -3.1677200* .4921863 .000 -4.175918 -2.159522
35 -3.1968000* .4921863 .000 -4.204998 -2.188602
14 21 -.3394200 .4921863 .496 -1.347618 .668778
28 -1.1409100* .4921863 .028 -2.149108 -.132712
35 -1.1699900* .4921863 .025 -2.178188 -.161792
21 28 -.8014900 .4921863 .115 -1.809688 .206708
35 -.8305700 .4921863 .103 -1.838768 .177628
28 35 -.0290800 .4921863 .953 -1.037278 .979118
Conditon6 LSD 1 3 -4.6342824* .3996302 .000 -5.452888 -3.815677
7 -7.6206832* .3996302 .000 -8.439289 -6.802078
14 -11.3404491* .3996302 .000 -12.159054 -10.521844
21 -11.9534891* .3996302 .000 -12.772094 -11.134884
28 -12.1580291* .3996302 .000 -12.976634 -11.339424
35 -12.6807291* .3996302 .000 -13.499334 -11.862124
3 7 -2.9864008* .3996302 .000 -3.805006 -2.167795
14 -6.7061667* .3996302 .000 -7.524772 -5.887561
21 -7.3192067* .3996302 .000 -8.137812 -6.500601
28 -7.5237467* .3996302 .000 -8.342352 -6.705141
35 -8.0464467* .3996302 .000 -8.865052 -7.227841
7 14 -3.7197659* .3996302 .000 -4.538371 -2.901161
21 -4.3328059* .3996302 .000 -5.151411 -3.514201
28 -4.5373459* .3996302 .000 -5.355951 -3.718741
35 -5.0600459* .3996302 .000 -5.878651 -4.241441
14 21 -.6130400 .3996302 .136 -1.431645 .205565
28 -.8175800 .3996302 .050 -1.636185 .001025
35 -1.3402800* .3996302 .002 -2.158885 -.521675
21 28 -.2045400 .3996302 .613 -1.023145 .614065
35 -.7272400 .3996302 .079 -1.545845 .091365
28 35 -.5227000 .3996302 .202 -1.341305 .295905
Condition7 LSD 1 3 -4.2856495* .6780323 .000 -5.674536 -2.896763
  180
7 -6.1910656* .6780323 .000 -7.579952 -4.802180
14 -9.7091863* .6780323 .000 -11.098072 -8.320300
21 -10.3733726* .6780323 .000 -11.762259 -8.984486
28 -10.6666424* .6780323 .000 -12.055529 -9.277756
35 -11.1765595* .6780323 .000 -12.565446 -9.787673
3 7 -1.9054161* .6780323 .009 -3.294302 -.516530
14 -5.4235368* .6780323 .000 -6.812423 -4.034651
21 -6.0877231* .6780323 .000 -7.476609 -4.698837
28 -6.3809929* .6780323 .000 -7.769879 -4.992107
35 -6.8909100* .6780323 .000 -8.279796 -5.502024
7 14 -3.5181207* .6780323 .000 -4.907007 -2.129235
21 -4.1823070* .6780323 .000 -5.571193 -2.793421
28 -4.4755768* .6780323 .000 -5.864463 -3.086691
35 -4.9854939* .6780323 .000 -6.374380 -3.596608
14 21 -.6641863 .6780323 .336 -2.053072 .724700
28 -.9574561 .6780323 .169 -2.346342 .431430
35 -1.4673732* .6780323 .039 -2.856259 -.078487
21 28 -.2932698 .6780323 .669 -1.682156 1.095616
35 -.8031869 .6780323 .246 -2.192073 .585699
28 35 -.5099171 .6780323 .458 -1.898803 .878969
Condition8 LSD 1 3 -5.3531431* .6513872 .000 -6.687449 -4.018837
7 -8.6881379* .6513872 .000 -10.022444 -7.353832
14 -11.5379401* .6513872 .000 -12.872246 -10.203634
21 -12.4019430* .6513872 .000 -13.736249 -11.067637
28 -12.2837406* .6513872 .000 -13.618047 -10.949434
35 -13.2072081* .6513872 .000 -14.541514 -11.872902
3 7 -3.3349947* .6513872 .000 -4.669301 -2.000688
14 -6.1847970* .6513872 .000 -7.519103 -4.850491
21 -7.0487998* .6513872 .000 -8.383106 -5.714494
28 -6.9305975* .6513872 .000 -8.264904 -5.596291
35 -7.8540650* .6513872 .000 -9.188371 -6.519759
7 14 -2.8498023* .6513872 .000 -4.184109 -1.515496
21 -3.7138051* .6513872 .000 -5.048111 -2.379499
28 -3.5956028* .6513872 .000 -4.929909 -2.261296
  181
35 -4.5190703* .6513872 .000 -5.853377 -3.184764
14 21 -.8640029 .6513872 .195 -2.198309 .470303
28 -.7458005 .6513872 .262 -2.080107 .588506
35 -1.6692680* .6513872 .016 -3.003574 -.334962
21 28 .1182023 .6513872 .857 -1.216104 1.452509
35 -.8052652 .6513872 .227 -2.139571 .529041
28 35 -.9234675 .6513872 .167 -2.257774 .410839
Condition9 LSD 1 3 -4.9333583* .6357266 .000 -6.235585 -3.631131
7 -9.7873916* .6357266 .000 -11.089618 -8.485165
14 -13.1368093* .6357266 .000 -14.439036 -11.834582
21 -13.2289793* .6357266 .000 -14.531206 -11.926752
28 -14.3478793* .6357266 .000 -15.650106 -13.045652
35 -13.1999393* .6357266 .000 -14.502166 -11.897712
3 7 -4.8540333* .6357266 .000 -6.156260 -3.551806
14 -8.2034510* .6357266 .000 -9.505678 -6.901224
21 -8.2956210* .6357266 .000 -9.597848 -6.993394
28 -9.4145210* .6357266 .000 -10.716748 -8.112294
35 -8.2665810* .6357266 .000 -9.568808 -6.964354
7 14 -3.3494177* .6357266 .000 -4.651645 -2.047191
21 -3.4415877* .6357266 .000 -4.743815 -2.139361
28 -4.5604877* .6357266 .000 -5.862715 -3.258261
35 -3.4125477* .6357266 .000 -4.714775 -2.110321
14 21 -.0921700 .6357266 .886 -1.394397 1.210057
28 -1.2110700 .6357266 .067 -2.513297 .091157
35 -.0631300 .6357266 .922 -1.365357 1.239097
21 28 -1.1189000 .6357266 .089 -2.421127 .183327
35 .0290400 .6357266 .964 -1.273187 1.331267
28 35 1.1479400 .6357266 .082 -.154287 2.450167
Condition10 LSD 1 3 -7.9703913* .8995266 .000 -9.816067 -6.124715
7 -10.6624914* .8995266 .000 -12.508168 -8.816815
14 -13.7002165* .8995266 .000 -15.545893 -11.854540
21 -15.4347550* .8995266 .000 -17.280431 -13.589079
28 -15.6380212* .8995266 .000 -17.483697 -13.792345
35 -15.0826035* .8995266 .000 -16.928280 -13.236927
  182
3 7 -2.6921001* .8480818 .004 -4.432220 -.951980
14 -5.7298251* .8480818 .000 -7.469945 -3.989705
21 -7.4643636* .8480818 .000 -9.204484 -5.724243
28 -7.6676299* .8480818 .000 -9.407750 -5.927510
35 -7.1122122* .8480818 .000 -8.852332 -5.372092
7 14 -3.0377251* .8480818 .001 -4.777845 -1.297605
21 -4.7722636* .8480818 .000 -6.512384 -3.032143
28 -4.9755298* .8480818 .000 -6.715650 -3.235410
35 -4.4201121* .8480818 .000 -6.160232 -2.679992
14 21 -1.7345385 .8480818 .051 -3.474659 .005582
28 -1.9378048* .8480818 .030 -3.677925 -.197685
35 -1.3823871 .8480818 .115 -3.122507 .357733
21 28 -.2032662 .8480818 .812 -1.943386 1.536854
35 .3521515 .8480818 .681 -1.387969 2.092272
28 35 .5554177 .8480818 .518 -1.184702 2.295538
*. The mean difference is significant at the 0.05 level. 
**. 1: 10% FBS without ascorbic acid; 2: 10% FBS with 50µg/ml ascorbic acid; 3: 10% FBS with 100µg/ml 
ascorbic acid; 4: 15% FBS without ascorbic acid; 5: 15% FBS with 50µg/ml ascorbic acid; 6: 15% FBS 
with 100µg/ml ascorbic acid; 7: 20% FBS without ascorbic acid; 8: 20% FBS with 50µg/ml ascorbic acid; 
9: 20% FBS with 100µg/ml ascorbic acid; 10: 25% FBS with 50µg/ml ascorbic acid 
 








Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
ColDay7 LSD 1 2 -1.9198322* .4221854 .000 -2.800495 -1.039169
3 -3.5452644* .4221854 .000 -4.425928 -2.664601
2 3 -1.6254322* .4221854 .001 -2.506095 -.744769
4 -.6209037 .4221854 .157 -1.501567 .259760
3 4 1.0045285* .4221854 .027 .123865 1.885192
ColDay14 LSD 1 2 -2.5461280* .5044965 .000 -3.598489 -1.493767
3 -6.5744369* .5044965 .000 -7.626798 -5.522075
2 3 -4.0283089* .5044965 .000 -5.080670 -2.975947
4 -.8153705 .5044965 .122 -1.867732 .236991
3 4 3.2129384* .5044965 .000 2.160577 4.265300
ColDay21 LSD 1 2 -3.0569743* .5033530 .000 -4.106950 -2.006998
3 -5.6857475* .5033530 .000 -6.735723 -4.635772
  183
2 3 -2.6287731* .5033530 .000 -3.678749 -1.578797
4 -2.2870263* .5033530 .000 -3.337002 -1.237050
3 4 .3417468 .5033530 .505 -.708229 1.391723
ColDay28 LSD 1 2 -5.4607540* 1.2596758 .000 -8.088392 -2.833116
3 -8.5336305* 1.2596758 .000 -11.161268 -5.905993
2 3 -3.0728765* 1.2596758 .024 -5.700514 -.445239
4 -.9602593 1.2596758 .455 -3.587897 1.667378
3 4 2.1126172 1.2596758 .109 -.515020 4.740255
ColDay35 LSD 1 2 -7.9870190* .8537309 .000 -9.767871 -6.206167
3 -13.2881663* .8537309 .000 -15.069018 -11.507315
2 3 -5.3011473* .8537309 .000 -7.081999 -3.520296
4 .1719805 .8537309 .842 -1.608871 1.952832
3 4 5.4731278* .8537309 .000 3.692276 7.253979
ColDay7 LSD 4 5 -2.7189462* .9275882 .008 -4.653861 -.784031
6 -7.1274932* .9275882 .000 -9.062408 -5.192578
5 6 -4.4085470* .9275882 .000 -6.343462 -2.473632
7 -1.8894584 .9275882 .055 -3.824373 .045457
6 7 2.5190886* .9275882 .013 .584174 4.454004
ColDay14 LSD 4 5 -13.0581400* 2.9461591 .000 -19.203720 -6.912560
6 -21.2167845* 2.9461591 .000 -27.362365 -15.071204
5 6 -8.1586445* 2.9461591 .012 -14.304225 -2.013064
7 1.4879374 2.9461591 .619 -4.657643 7.633518
6 7 9.6465819* 2.9461591 .004 3.501002 15.792162
ColDay21 LSD 4 5 -17.8460438* 1.5799070 .000 -21.141672 -14.550415
6 -21.7112818* 1.5799070 .000 -25.006910 -18.415653
5 6 -3.8652380* 1.5799070 .024 -7.160866 -.569610
7 7.3140269* 1.5799070 .000 4.018399 10.609655
6 7 11.1792649* 1.5799070 .000 7.883637 14.474893
ColDay28 LSD 4 5 -20.4375322* 1.2810190 .000 -23.109691 -17.765373
6 -25.9831175* 1.2810190 .000 -28.655276 -23.310959
5 6 -5.5455853* 1.2810190 .000 -8.217744 -2.873426
7 9.9987187* 1.2810190 .000 7.326560 12.670878
6 7 15.5443040* 1.2810190 .000 12.872145 18.216463
ColDay35 LSD 4 5 -43.0653697* 1.7437677 .000 -46.702805 -39.427934
  184
6 -56.9205290* 1.7437677 .000 -60.557965 -53.283093
5 6 -13.8551593* 1.7437677 .000 -17.492595 -10.217724
7 22.0582935* 1.7437677 .000 18.420858 25.695729
6 7 35.9134528* 1.7437677 .000 32.276017 39.550888
ColDay7 7 8 -3.3708668* .7776107 .001 -5.028305 -1.713429
9 -6.4786920* .7776107 .000 -8.136130 -4.821254
8 9 -3.1078253* .7776107 .001 -4.765263 -1.450387
ColDay14 7 8 -15.6892888* .8061698 .000 -17.407599 -13.970979
9 -18.8271454* .8061698 .000 -20.545456 -17.108835
8 9 -3.1378566* .8061698 .001 -4.856167 -1.419546
ColDay21 7 8 -16.7766632* .9512491 .000 -18.804203 -14.749124
9 -18.8426832* .9512491 .000 -20.870223 -16.815144
8 9 -2.0660200* .9512491 .046 -4.093560 -.038480
ColDay28 7 8 -18.4698646* 1.0454873 .000 -20.698268 -16.241461
9 -20.8651943* 1.0454873 .000 -23.093598 -18.636791
8 9 -2.3953298* 1.0454873 .037 -4.623733 -.166926
ColDay35 7 8 -41.2270989* 3.3191895 .000 -48.301784 -34.152414
9 -57.3047354* 3.3191895 .000 -64.379420 -50.230050
8 9 -16.0776365* 3.3191895 .000 -23.152322 -9.002951
ColDay7 1 4 -2.5407358* .8419483 .009 -4.335306 -.746165
7 -7.1491404* .8419483 .000 -8.943711 -5.354570
4 7 -4.6084045* .8419483 .000 -6.402975 -2.813834
ColDay14 1 4 -3.3614985* .3619386 .000 -4.132952 -2.590045
7 -14.9317011* .3619386 .000 -15.703155 -14.160247
4 7 -11.5702026* .3619386 .000 -12.341656 -10.798749
ColDay21 1 4 -5.3440007* .9522530 .000 -7.373680 -3.314321
7 -15.8760176* .9522530 .000 -17.905697 -13.846338
4 7 -10.5320169* .9522530 .000 -12.561696 -8.502338
ColDay28 1 4 -6.4210133* 1.0581031 .000 -8.676307 -4.165720
7 -16.8598268* 1.0581031 .000 -19.115120 -14.604534
4 7 -10.4388135* 1.0581031 .000 -12.694107 -8.183520
ColDay35 1 4 -7.8150385* .9723051 .000 -9.887458 -5.742619
7 -28.8221147* .9723051 .000 -30.894534 -26.749695
4 7 -21.0070762* .9723051 .000 -23.079496 -18.934657
  185
ColDay7 2 5 -3.3398498 2.3803868 .176 -8.305250 1.625550
8 -8.6001750* 2.3803868 .002 -13.565575 -3.634775
10 -19.7768508* 2.3803868 .000 -24.742251 -14.811451
5 8 -5.2603252* 2.3803868 .039 -10.225725 -.294925
10 -16.4370010* 2.3803868 .000 -21.402401 -11.471601
8 10 -11.1766758* 2.3803868 .000 -16.142076 -6.211276
ColDay14 2 5 -13.8735105* 3.3246000 .000 -20.808505 -6.938516
8 -28.0748618* 3.3246000 .000 -35.009856 -21.139868
10 -38.6534818* 3.3246000 .000 -45.588476 -31.718488
5 8 -14.2013513* 3.3246000 .000 -21.136345 -7.266357
10 -24.7799713* 3.3246000 .000 -31.714965 -17.844977
8 10 -10.5786200* 3.3246000 .005 -17.513614 -3.643626
ColDay21 2 5 -20.1330702* 3.0974688 .000 -26.594277 -13.671864
8 -29.5957065* 3.0974688 .000 -36.056913 -23.134500
10 -45.5335383* 3.0974688 .000 -51.994745 -39.072332
5 8 -9.4626363* 3.0974688 .006 -15.923843 -3.001430
10 -25.4004682* 3.0974688 .000 -31.861675 -18.939262
8 10 -15.9378318* 3.0974688 .000 -22.399038 -9.476625
ColDay28 2 5 -21.3977915* 2.6609317 .000 -26.948398 -15.847185
8 -29.8689374* 2.6609317 .000 -35.419544 -24.318331
10 -50.0012813* 2.6609317 .000 -55.551888 -44.450675
5 8 -8.4711459* 2.6609317 .005 -14.021752 -2.920540
10 -28.6034898* 2.6609317 .000 -34.154096 -23.052884
8 10 -20.1323439* 2.6609317 .000 -25.682950 -14.581738
ColDay35 2 5 -42.8933892* 3.4168304 .000 -50.020772 -35.766006
8 -62.0621945* 3.4168304 .000 -69.189578 -54.934811
10 -83.2815680* 3.4168304 .000 -90.408951 -76.154185
5 8 -19.1688054* 3.4168304 .000 -26.296189 -12.041422
10 -40.3881788* 3.4168304 .000 -47.515562 -33.260796
8 10 -21.2193735* 3.4168304 .000 -28.346757 -14.091990
ColDay7 3 6 -6.1229646* .3372630 .000 -6.841824 -5.404106
9 -10.0825681* .3372630 .000 -10.801427 -9.363709
6 9 -3.9596034* .3372630 .000 -4.678462 -3.240744
ColDay14 3 6 -18.0038461* 1.0045233 .000 -20.144937 -15.862755
  186
9 -27.1844096* 1.0045233 .000 -29.325500 -25.043319
6 9 -9.1805634* 1.0045233 .000 -11.321654 -7.039473
ColDay21 3 6 -21.3695350* 1.5119624 .000 -24.592207 -18.146863
9 -29.0329534* 1.5119624 .000 -32.255625 -25.810282
6 9 -7.6634183* 1.5119624 .000 -10.886090 -4.440747
ColDay28 3 6 -23.8705003* 1.2963679 .000 -26.633643 -21.107358
9 -29.1913906* 1.2963679 .000 -31.954533 -26.428248
6 9 -5.3208903* 1.2963679 .001 -8.084033 -2.557748
ColDay35 3 6 -51.4474012* 1.5269986 .000 -54.702122 -48.192681
9 -72.8386837* 1.5269986 .000 -76.093404 -69.583963
6 9 -21.3912825* 1.5269986 .000 -24.646003 -18.136562
*. The mean difference is significant at the 0.05 level. 
**. 1: 10% FBS without ascorbic acid; 2: 10% FBS with 50µg/ml ascorbic acid; 3: 10% FBS with 100µg/ml 
ascorbic acid; 4: 15% FBS without ascorbic acid; 5: 15% FBS with 50µg/ml ascorbic acid; 6: 15% FBS 
with 100µg/ml ascorbic acid; 7: 20% FBS without ascorbic acid; 8: 20% FBS with 50µg/ml ascorbic acid; 
9: 20% FBS with 100µg/ml ascorbic acid; 10: 25% FBS with 50µg/ml ascorbic acid 
 
Multiple Comparisons of collagen content at different time point under each culture condition 
Dependent 





J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Condition1 LSD 7 14 -3.8368327* .6542646 .000 -5.184316 -2.489349
21 -7.2420217* .6542646 .000 -8.589505 -5.894538
28 -11.4465512* .6542646 .000 -12.794034 -10.099068
35 -19.6317943* .6542646 .000 -20.979278 -18.284311
14 21 -3.4051890* .6542646 .000 -4.752672 -2.057706
28 -7.6097185* .6542646 .000 -8.957202 -6.262235
35 -15.7949617* .6542646 .000 -17.142445 -14.447478
21 28 -4.2045295* .6542646 .000 -5.552013 -2.857046
35 -12.3897727* .6542646 .000 -13.737256 -11.042289
28 35 -8.1852432* .6542646 .000 -9.532726 -6.837760
Condition2 LSD 7 14 -4.4631285* .6856932 .000 -5.875340 -3.050917
21 -8.3791638* .6856932 .000 -9.791375 -6.966952
28 -14.9874730* .6856932 .000 -16.399685 -13.575261
35 -25.6989812* .6856932 .000 -27.111193 -24.286770
14 21 -3.9160353* .6856932 .000 -5.328247 -2.503824
28 -10.5243445* .6856932 .000 -11.936556 -9.112133
  187
35 -21.2358527* .6856932 .000 -22.648064 -19.823641
21 28 -6.6083092* .6856932 .000 -8.020521 -5.196098
35 -17.3198173* .6856932 .000 -18.732029 -15.907606
28 35 -10.7115082* .6856932 .000 -12.123720 -9.299297
Condition3 LSD 7 14 -6.8660052* .9301813 .000 -8.781749 -4.950261
21 -9.3825048* .9301813 .000 -11.298249 -7.466760
28 -16.4349173* .9301813 .000 -18.350662 -14.519173
35 -29.3746963* .9301813 .000 -31.290441 -27.458952
14 21 -2.5164996* .9301813 .012 -4.432244 -.600755
28 -9.5689122* .9301813 .000 -11.484656 -7.653168
35 -22.5086911* .9301813 .000 -24.424435 -20.592947
21 28 -7.0524125* .9301813 .000 -8.968157 -5.136668
35 -19.9921915* .9301813 .000 -21.907936 -18.076447
28 35 -12.9397790* .9301813 .000 -14.855523 -11.024035
Condition4 LSD 7 14 -4.6575953* .7987078 .000 -6.302565 -3.012626
21 -10.0452865* .7987078 .000 -11.690256 -8.400317
28 -15.3268287* .7987078 .000 -16.971798 -13.681859
35 -24.9060970* .7987078 .000 -26.551067 -23.261127
14 21 -5.3876912* .7987078 .000 -7.032661 -3.742722
28 -10.6692333* .7987078 .000 -12.314203 -9.024264
35 -20.2485017* .7987078 .000 -21.893471 -18.603532
21 28 -5.2815422* .7987078 .000 -6.926512 -3.636573
35 -14.8608105* .7987078 .000 -16.505780 -13.215841
28 35 -9.5792683* .7987078 .000 -11.224238 -7.934299
Condition5 LSD 7 14 -14.9967892* 3.1224420 .000 -21.427579 -8.565999
21 -25.1723842* 3.1224420 .000 -31.603174 -18.741594
28 -33.0454147* 3.1224420 .000 -39.476204 -26.614625
35 -65.2525205* 3.1224420 .000 -71.683310 -58.821731
14 21 -10.1755950* 3.1224420 .003 -16.606385 -3.744805
28 -18.0486255* 3.1224420 .000 -24.479415 -11.617836
35 -50.2557313* 3.1224420 .000 -56.686521 -43.824942
21 28 -7.8730305* 3.1224420 .018 -14.303820 -1.442241
35 -40.0801363* 3.1224420 .000 -46.510926 -33.649347
28 35 -32.2071058* 3.1224420 .000 -38.637896 -25.776316
  188
Condition6 LSD 7 14 -18.7468867* 1.3288856 .000 -21.483778 -16.009996
21 -24.6290752* 1.3288856 .000 -27.365966 -21.892184
28 -34.1824530* 1.3288856 .000 -36.919344 -31.445562
35 -74.6991328* 1.3288856 .000 -77.436024 -71.962242
14 21 -5.8821885* 1.3288856 .000 -8.619080 -3.145297
28 -15.4355663* 1.3288856 .000 -18.172457 -12.698675
35 -55.9522462* 1.3288856 .000 -58.689137 -53.215355
21 28 -9.5533778* 1.3288856 .000 -12.290269 -6.816487
35 -50.0700577* 1.3288856 .000 -52.806949 -47.333167
28 35 -40.5166798* 1.3288856 .000 -43.253571 -37.779789
Condition7 LSD 7 14 -11.6193934* 1.1049781 .000 -13.895138 -9.343648
21 -15.9688989* 1.1049781 .000 -18.244644 -13.693154
28 -21.1572376* 1.1049781 .000 -23.432983 -18.881493
35 -41.3047686* 1.1049781 .000 -43.580514 -39.029024
14 21 -4.3495055* 1.1049781 .001 -6.625251 -2.073760
28 -9.5378443* 1.1049781 .000 -11.813589 -7.262099
35 -29.6853753* 1.1049781 .000 -31.961120 -27.409630
21 28 -5.1883387* 1.1049781 .000 -7.464084 -2.912594
35 -25.3358697* 1.1049781 .000 -27.611615 -23.060125
28 35 -20.1475310* 1.1049781 .000 -22.423276 -17.871786
Condition8 LSD 7 14 -23.9378153* 2.3493042 .000 -28.776298 -19.099333
21 -29.3746953* 2.3493042 .000 -34.213178 -24.536213
28 -36.2562354* 2.3493042 .000 -41.094718 -31.417753
35 -79.1610007* 2.3493042 .000 -83.999483 -74.322518
14 21 -5.4368800* 2.3493042 .029 -10.275363 -.598397
28 -12.3184201* 2.3493042 .000 -17.156903 -7.479937
35 -55.2231854* 2.3493042 .000 -60.061668 -50.384703
21 28 -6.8815401* 2.3493042 .007 -11.720023 -2.043057
35 -49.7863054* 2.3493042 .000 -54.624788 -44.947823
28 35 -42.9047653* 2.3493042 .000 -47.743248 -38.066283
Condition9 LSD 7 14 -23.9678467* 1.3496328 .000 -26.747467 -21.188226
21 -28.3328901* 1.3496328 .000 -31.112511 -25.553269
28 -35.5437399* 1.3496328 .000 -38.323361 -32.764119
35 -92.1308120* 1.3496328 .000 -94.910433 -89.351191
  189
14 21 -4.3650434* 1.3496328 .003 -7.144664 -1.585423
28 -11.5758932* 1.3496328 .000 -14.355514 -8.796272
35 -68.1629653* 1.3496328 .000 -70.942586 -65.383344
21 28 -7.2108498* 1.3496328 .000 -9.990471 -4.431229
35 -63.7979219* 1.3496328 .000 -66.577543 -61.018301
28 35 -56.5870720* 1.3496328 .000 -59.366693 -53.807451
Condition10 LSD 7 14 -23.3397595* 4.1315592 .000 -31.848865 -14.830654
21 -34.1358513* 4.1315592 .000 -42.644957 -25.626746
28 -48.3116148* 4.1315592 .000 -56.820720 -39.802509
35 -89.2036983* 4.1315592 .000 -97.712804 -80.694593
14 21 -10.7960918* 4.1315592 .015 -19.305197 -2.286986
28 -24.9718553* 4.1315592 .000 -33.480961 -16.462750
35 -65.8639388* 4.1315592 .000 -74.373044 -57.354833
21 28 -14.1757635* 4.1315592 .002 -22.684869 -5.666658
35 -55.0678470* 4.1315592 .000 -63.576952 -46.558742
28 35 -40.8920835* 4.1315592 .000 -49.401189 -32.382978
*. The mean difference is significant at the 0.05 level. 
**. 1: 10% FBS without ascorbic acid; 2: 10% FBS with 50µg/ml ascorbic acid; 3: 10% FBS with 100µg/ml 
ascorbic acid; 4: 15% FBS without ascorbic acid; 5: 15% FBS with 50µg/ml ascorbic acid; 6: 15% FBS 
with 100µg/ml ascorbic acid; 7: 20% FBS without ascorbic acid; 8: 20% FBS with 50µg/ml ascorbic acid; 
9: 20% FBS with 100µg/ml ascorbic acid; 10: 25% FBS with 50µg/ml ascorbic acid 
 









Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Day7 LSD 1 2 -.4107400* .1303951 .007 -.688671 -.132809
3 -.6708300* .1303951 .000 -.948761 -.392899
2 3 -.2600900 .1303951 .065 -.538021 .017841
Day14 LSD 1 2 -.4804600* .1540557 .007 -.808822 -.152098
3 -1.2957300* .1540557 .000 -1.624092 -.967368
2 3 -.8152700* .1540557 .000 -1.143632 -.486908
Day21 LSD 1 2 -.5337300* .0909095 .000 -.727499 -.339961
3 -.9972300* .0909095 .000 -1.190999 -.803461
2 3 -.4635000* .0909095 .000 -.657269 -.269731
Day28 LSD 1 2 -1.0262100* .3511443 .011 -1.774656 -.277764
3 -1.5268300* .3511443 .001 -2.275276 -.778384
  190
2 3 -.5006200 .3511443 .174 -1.249066 .247826
Day35 LSD 1 2 -1.4293900* .2018489 .000 -1.859621 -.999159
3 -2.1871000* .2018489 .000 -2.617331 -1.756869
2 3 -.7577100* .2018489 .002 -1.187941 -.327479
Day7 LSD 4 5 -.4295900* .1883912 .034 -.822567 -.036613
6 -1.3720400* .1883912 .000 -1.765017 -.979063
7 -.8970700* .1883912 .000 -1.290047 -.504093
5 6 -.9424500* .1883912 .000 -1.335427 -.549473
7 -.4674800* .1883912 .022 -.860457 -.074503
6 7 .4749700* .1883912 .020 .081993 .867947
Day14 LSD 4 5 -2.5062500* .3190300 .000 -3.171735 -1.840765
6 -3.9897400* .3190300 .000 -4.655225 -3.324255
7 -2.1951500* .3190300 .000 -2.860635 -1.529665
5 6 -1.4834900* .3190300 .000 -2.148975 -.818005
7 .3111000 .3190300 .341 -.354385 .976585
6 7 1.7945900* .3190300 .000 1.129105 2.460075
Day21 LSD 4 5 -3.4128600* .3186707 .000 -4.077595 -2.748125
6 -3.8256000* .3186707 .000 -4.490335 -3.160865
7 -1.8105700* .3186707 .000 -2.475305 -1.145835
5 6 -.4127400 .3186707 .210 -1.077475 .251995
7 1.6022900* .3186707 .000 .937555 2.267025
6 7 2.0150300* .3186707 .000 1.350295 2.679765
Day28 LSD 4 5 -3.6890400* .2388142 .000 -4.187198 -3.190882
6 -4.6185700* .2388142 .000 -5.116728 -4.120412
7 -1.7167100* .2388142 .000 -2.214868 -1.218552
5 6 -.9295300* .2388142 .001 -1.427688 -.431372
7 1.9723300* .2388142 .000 1.474172 2.470488
6 7 2.9018600* .2388142 .000 2.403702 3.400018
Day35 LSD 4 5 -8.1998100* .2531760 .000 -8.727926 -7.671694
6 -10.6240600* .2531760 .000 -11.152176 -10.095944
7 -3.5814100* .2531760 .000 -4.109526 -3.053294
5 6 -2.4242500* .2531760 .000 -2.952366 -1.896134
7 4.6184000* .2531760 .000 4.090284 5.146516
6 7 7.0426500* .2531760 .000 6.514534 7.570766
  191
Day7 LSD 7 8 -.6023700 .6986364 .402 -2.091478 .886738
9 -4.7480134* .6986364 .000 -6.237122 -3.258905
8 9 -4.1456434* .6986364 .000 -5.634752 -2.656535
Day14 LSD 7 8 -2.7499100* .2170468 .000 -3.212534 -2.287286
9 -3.2722400* .2170468 .000 -3.734864 -2.809616
8 9 -.5223300* .2170468 .029 -.984954 -.059706
Day21 LSD 7 8 -3.1917700* .2915002 .000 -3.813088 -2.570452
9 -3.2339400* .2915002 .000 -3.855258 -2.612622
8 9 -.0421700 .2915002 .887 -.663488 .579148
Day28 LSD 7 8 -3.5330100* .3706081 .000 -4.322942 -2.743078
9 -3.4741900* .3706081 .000 -4.264122 -2.684258
8 9 .0588200 .3706081 .876 -.731112 .848752
Day35 LSD 7 8 -8.1178900* .8936320 .000 -10.022621 -6.213159
9 -10.5905400* .8936320 .000 -12.495271 -8.685809
8 9 -2.4726500* .8936320 .014 -4.377381 -.567919
*. The mean difference is significant at the 0.05 level. 
**. 1: 10% FBS without ascorbic acid; 2: 10% FBS with 50µg/ml ascorbic acid; 3: 10% FBS with 100µg/ml 
ascorbic acid; 4: 15% FBS without ascorbic acid; 5: 15% FBS with 50µg/ml ascorbic acid; 6: 15% FBS 
with 100µg/ml ascorbic acid; 7: 20% FBS without ascorbic acid; 8: 20% FBS with 50µg/ml ascorbic acid; 
9: 20% FBS with 100µg/ml ascorbic acid; 10: 25% FBS with 50µg/ml ascorbic acid 
 
Multiple Comparisons of normalized collagen content at different time point under each culture 
condition 
Dependent 




Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
condition1 LSD 7 14 -.9219300* .1761502 .000 -1.284718 -.559142
21 -1.7868700* .1761502 .000 -2.149658 -1.424082
28 -2.8486200* .1761502 .000 -3.211408 -2.485832
35 -4.9459800* .1761502 .000 -5.308768 -4.583192
14 21 -.8649400* .1761502 .000 -1.227728 -.502152
28 -1.9266900* .1761502 .000 -2.289478 -1.563902
35 -4.0240500* .1761502 .000 -4.386838 -3.661262
21 28 -1.0617500* .1761502 .000 -1.424538 -.698962
35 -3.1591100* .1761502 .000 -3.521898 -2.796322
28 35 -2.0973600* .1761502 .000 -2.460148 -1.734572
condition2 LSD 7 14 -.9916500* .1846101 .000 -1.371862 -.611438
  192
21 -1.9098600* .1846101 .000 -2.290072 -1.529648
28 -3.4640900* .1846101 .000 -3.844302 -3.083878
35 -5.9646300* .1846101 .000 -6.344842 -5.584418
14 21 -.9182100* .1846101 .000 -1.298422 -.537998
28 -2.4724400* .1846101 .000 -2.852652 -2.092228
35 -4.9729800* .1846101 .000 -5.353192 -4.592768
21 28 -1.5542300* .1846101 .000 -1.934442 -1.174018
35 -4.0547700* .1846101 .000 -4.434982 -3.674558
28 35 -2.5005400* .1846101 .000 -2.880752 -2.120328
condition3 LSD 7 14 -1.5468300* .2504351 .000 -2.062611 -1.031049
21 -2.1132700* .2504351 .000 -2.629051 -1.597489
28 -3.7046200* .2504351 .000 -4.220401 -3.188839
35 -6.4622500* .2504351 .000 -6.978031 -5.946469
14 21 -.5664400* .2504351 .033 -1.082221 -.050659
28 -2.1577900* .2504351 .000 -2.673571 -1.642009
35 -4.9154200* .2504351 .000 -5.431201 -4.399639
21 28 -1.5913500* .2504351 .000 -2.107131 -1.075569
35 -4.3489800* .2504351 .000 -4.864761 -3.833199
28 35 -2.7576300* .2504351 .000 -3.273411 -2.241849
condition4 LSD 7 14 -1.0827200* .1909496 .000 -1.475988 -.689452
21 -2.3510800* .1909496 .000 -2.744348 -1.957812
28 -3.5226000* .1909496 .000 -3.915868 -3.129332
35 -5.7167600* .1909496 .000 -6.110028 -5.323492
14 21 -1.2683600* .1909496 .000 -1.661628 -.875092
28 -2.4398800* .1909496 .000 -2.833148 -2.046612
35 -4.6340400* .1909496 .000 -5.027308 -4.240772
21 28 -1.1715200* .1909496 .000 -1.564788 -.778252
35 -3.3656800* .1909496 .000 -3.758948 -2.972412
28 35 -2.1941600* .1909496 .000 -2.587428 -1.800892
condition5 LSD 7 14 -3.1593800* .3362654 .000 -3.851932 -2.466828
21 -5.3343500* .3362654 .000 -6.026902 -4.641798
28 -6.7820500* .3362654 .000 -7.474602 -6.089498
35 -13.4869800* .3362654 .000 -14.179532 -12.794428
14 21 -2.1749700* .3362654 .000 -2.867522 -1.482418
  193
28 -3.6226700* .3362654 .000 -4.315222 -2.930118
35 -10.3276000* .3362654 .000 -11.020152 -9.635048
21 28 -1.4477000* .3362654 .000 -2.140252 -.755148
35 -8.1526300* .3362654 .000 -8.845182 -7.460078
28 35 -6.7049300* .3362654 .000 -7.397482 -6.012378
condition6 LSD 7 14 -3.7004200* .2234327 .000 -4.160588 -3.240252
21 -4.8046400* .2234327 .000 -5.264808 -4.344472
28 -6.7691300* .2234327 .000 -7.229298 -6.308962
35 -14.9687800* .2234327 .000 -15.428948 -14.508612
14 21 -1.1042200* .2234327 .000 -1.564388 -.644052
28 -3.0687100* .2234327 .000 -3.528878 -2.608542
35 -11.2683600* .2234327 .000 -11.728528 -10.808192
21 28 -1.9644900* .2234327 .000 -2.424658 -1.504322
35 -10.1641400* .2234327 .000 -10.624308 -9.703972
28 35 -8.1996500* .2234327 .000 -8.659818 -7.739482
condition7 LSD 7 14 -2.3808000* .2974959 .000 -2.993504 -1.768096
21 -3.2645800* .2974959 .000 -3.877284 -2.651876
28 -4.3422400* .2974959 .000 -4.954944 -3.729536
35 -8.4011000* .2974959 .000 -9.013804 -7.788396
14 21 -.8837800* .2974959 .006 -1.496484 -.271076
28 -1.9614400* .2974959 .000 -2.574144 -1.348736
35 -6.0203000* .2974959 .000 -6.633004 -5.407596
21 28 -1.0776600* .2974959 .001 -1.690364 -.464956
35 -5.1365200* .2974959 .000 -5.749224 -4.523816
28 35 -4.0588600* .2974959 .000 -4.671564 -3.446156
condition8 LSD 7 14 -4.5283400* .6362008 .000 -5.838620 -3.218060
21 -5.8539800* .6362008 .000 -7.164260 -4.543700
28 -7.2728800* .6362008 .000 -8.583160 -5.962600
35 -15.9166200* .6362008 .000 -17.226900 -14.606340
14 21 -1.3256400* .6362008 .048 -2.635920 -.015360
28 -2.7445400* .6362008 .000 -4.054820 -1.434260
35 -11.3882800* .6362008 .000 -12.698560 -10.078000
21 28 -1.4189000* .6362008 .035 -2.729180 -.108620
35 -10.0626400* .6362008 .000 -11.372920 -8.752360
  194
28 35 -8.6437400* .6362008 .000 -9.954020 -7.333460
condition9 LSD 7 14 -5.1455800* .4016914 .000 -5.972879 -4.318281
21 -5.9910600* .4016914 .000 -6.818359 -5.163761
28 -7.3089700* .4016914 .000 -8.136269 -6.481671
35 -18.4841800* .4016914 .000 -19.311479 -17.656881
14 21 -.8454800* .4016914 .046 -1.672779 -.018181
28 -2.1633900* .4016914 .000 -2.990689 -1.336091
35 -13.3386000* .4016914 .000 -14.165899 -12.511301
21 28 -1.3179100* .4016914 .003 -2.145209 -.490611
35 -12.4931200* .4016914 .000 -13.320419 -11.665821
28 35 -11.1752100* .4016914 .000 -12.002509 -10.347911
condition10 LSD 7 14 -4.3288300* .5659089 .000 -5.494341 -3.163319
21 -6.1868400* .5659089 .000 -7.352351 -5.021329
28 -8.8388000* .5659089 .000 -10.004311 -7.673289
35 -16.7016900* .5659089 .000 -17.867201 -15.536179
14 21 -1.8580100* .5659089 .003 -3.023521 -.692499
28 -4.5099700* .5659089 .000 -5.675481 -3.344459
35 -12.3728600* .5659089 .000 -13.538371 -11.207349
21 28 -2.6519600* .5659089 .000 -3.817471 -1.486449
35 -10.5148500* .5659089 .000 -11.680361 -9.349339
28 35 -7.8628900* .5659089 .000 -9.028401 -6.697379
*. The mean difference is significant at the 0.05 level. 
**. 1: 10% FBS without ascorbic acid; 2: 10% FBS with 50µg/ml ascorbic acid; 3: 10% FBS with 100µg/ml 
ascorbic acid; 4: 15% FBS without ascorbic acid; 5: 15% FBS with 50µg/ml ascorbic acid; 6: 15% FBS 
with 100µg/ml ascorbic acid; 7: 20% FBS without ascorbic acid; 8: 20% FBS with 50µg/ml ascorbic acid; 
9: 20% FBS with 100µg/ml ascorbic acid; 10: 25% FBS with 50µg/ml ascorbic acid 
 
Multiple Comparisons of gene expression under different culture condition at each time point 
Dependent Variable (I) C** (J) C**
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Col1day7 LSD 1 2 -.4000000* .1134460 .001 -.627863 -.172137
3 -.4900000* .1134460 .000 -.717863 -.262137
4 -.5000000* .1134460 .000 -.727863 -.272137
5 -.7900000* .1134460 .000 -1.017863 -.562137
6 -1.1400000* .1134460 .000 -1.367863 -.912137
7 -.9500000* .1134460 .000 -1.177863 -.722137
  195
8 -1.5300000* .1134460 .000 -1.757863 -1.302137
9 -1.8100000* .1134460 .000 -2.037863 -1.582137
10 -2.0600000* .1134460 .000 -2.287863 -1.832137
2 3 -.0900000 .1134460 .431 -.317863 .137863
4 -.1000000 .1134460 .382 -.327863 .127863
5 -.3900000* .1134460 .001 -.617863 -.162137
6 -.7400000* .1134460 .000 -.967863 -.512137
7 -.5500000* .1134460 .000 -.777863 -.322137
8 -1.1300000* .1134460 .000 -1.357863 -.902137
9 -1.4100000* .1134460 .000 -1.637863 -1.182137
10 -1.6600000* .1134460 .000 -1.887863 -1.432137
3 4 -.0100000 .1134460 .930 -.237863 .217863
5 -.3000000* .1134460 .011 -.527863 -.072137
6 -.6500000* .1134460 .000 -.877863 -.422137
7 -.4600000* .1134460 .000 -.687863 -.232137
8 -1.0400000* .1134460 .000 -1.267863 -.812137
9 -1.3200000* .1134460 .000 -1.547863 -1.092137
10 -1.5700000* .1134460 .000 -1.797863 -1.342137
4 5 -.2900000* .1134460 .014 -.517863 -.062137
6 -.6400000* .1134460 .000 -.867863 -.412137
7 -.4500000* .1134460 .000 -.677863 -.222137
8 -1.0300000* .1134460 .000 -1.257863 -.802137
9 -1.3100000* .1134460 .000 -1.537863 -1.082137
10 -1.5600000* .1134460 .000 -1.787863 -1.332137
5 6 -.3500000* .1134460 .003 -.577863 -.122137
7 -.1600000 .1134460 .165 -.387863 .067863
8 -.7400000* .1134460 .000 -.967863 -.512137
9 -1.0200000* .1134460 .000 -1.247863 -.792137
10 -1.2700000* .1134460 .000 -1.497863 -1.042137
6 7 .1900000 .1134460 .100 -.037863 .417863
8 -.3900000* .1134460 .001 -.617863 -.162137
9 -.6700000* .1134460 .000 -.897863 -.442137
10 -.9200000* .1134460 .000 -1.147863 -.692137
  196
7 8 -.5800000* .1134460 .000 -.807863 -.352137
9 -.8600000* .1134460 .000 -1.087863 -.632137
10 -1.1100000* .1134460 .000 -1.337863 -.882137
8 9 -.2800000* .1134460 .017 -.507863 -.052137
10 -.5300000* .1134460 .000 -.757863 -.302137
9 10 -.2500000* .1134460 .032 -.477863 -.022137
Col1Day21 LSD 1 2 -.3900000* .1284912 .004 -.648082 -.131918
3 -.8400000* .1284912 .000 -1.098082 -.581918
4 -.7000000* .1284912 .000 -.958082 -.441918
5 -1.9400000* .1284912 .000 -2.198082 -1.681918
6 -2.5200000* .1284912 .000 -2.778082 -2.261918
7 -2.0800000* .1284912 .000 -2.338082 -1.821918
8 -3.0000000* .1284912 .000 -3.258082 -2.741918
9 -3.4200000* .1284912 .000 -3.678082 -3.161918
10 -3.6600000* .1284912 .000 -3.918082 -3.401918
2 3 -.4500000* .1284912 .001 -.708082 -.191918
4 -.3100000* .1284912 .020 -.568082 -.051918
5 -1.5500000* .1284912 .000 -1.808082 -1.291918
6 -2.1300000* .1284912 .000 -2.388082 -1.871918
7 -1.6900000* .1284912 .000 -1.948082 -1.431918
8 -2.6100000* .1284912 .000 -2.868082 -2.351918
9 -3.0300000* .1284912 .000 -3.288082 -2.771918
10 -3.2700000* .1284912 .000 -3.528082 -3.011918
3 4 .1400000 .1284912 .281 -.118082 .398082
5 -1.1000000* .1284912 .000 -1.358082 -.841918
6 -1.6800000* .1284912 .000 -1.938082 -1.421918
7 -1.2400000* .1284912 .000 -1.498082 -.981918
8 -2.1600000* .1284912 .000 -2.418082 -1.901918
9 -2.5800000* .1284912 .000 -2.838082 -2.321918
10 -2.8200000* .1284912 .000 -3.078082 -2.561918
4 5 -1.2400000* .1284912 .000 -1.498082 -.981918
6 -1.8200000* .1284912 .000 -2.078082 -1.561918
7 -1.3800000* .1284912 .000 -1.638082 -1.121918
8 -2.3000000* .1284912 .000 -2.558082 -2.041918
  197
9 -2.7200000* .1284912 .000 -2.978082 -2.461918
10 -2.9600000* .1284912 .000 -3.218082 -2.701918
5 6 -.5800000* .1284912 .000 -.838082 -.321918
7 -.1400000 .1284912 .281 -.398082 .118082
8 -1.0600000* .1284912 .000 -1.318082 -.801918
9 -1.4800000* .1284912 .000 -1.738082 -1.221918
10 -1.7200000* .1284912 .000 -1.978082 -1.461918
6 7 .4400000* .1284912 .001 .181918 .698082
8 -.4800000* .1284912 .000 -.738082 -.221918
9 -.9000000* .1284912 .000 -1.158082 -.641918
10 -1.1400000* .1284912 .000 -1.398082 -.881918
7 8 -.9200000* .1284912 .000 -1.178082 -.661918
9 -1.3400000* .1284912 .000 -1.598082 -1.081918
10 -1.5800000* .1284912 .000 -1.838082 -1.321918
8 9 -.4200000* .1284912 .002 -.678082 -.161918
10 -.6600000* .1284912 .000 -.918082 -.401918
9 10 -.2400000 .1284912 .068 -.498082 .018082
Col1Day35 LSD 1 2 -1.0600000* .1224064 .000 -1.305861 -.814139
3 -1.3000000* .1224064 .000 -1.545861 -1.054139
4 -1.2400000* .1224064 .000 -1.485861 -.994139
5 -2.2900000* .1224064 .000 -2.535861 -2.044139
6 -3.0200000* .1224064 .000 -3.265861 -2.774139
7 -2.1900000* .1224064 .000 -2.435861 -1.944139
8 -4.1600000* .1224064 .000 -4.405861 -3.914139
9 -5.4400000* .1224064 .000 -5.685861 -5.194139
10 -6.2200000* .1224064 .000 -6.465861 -5.974139
2 3 -.2400000 .1224064 .045 -.485861 .005861
4 -.1800000 .1224064 .148 -.425861 .065861
5 -1.2300000* .1224064 .000 -1.475861 -.984139
6 -1.9600000* .1224064 .000 -2.205861 -1.714139
7 -1.1300000* .1224064 .000 -1.375861 -.884139
8 -3.1000000* .1224064 .000 -3.345861 -2.854139
9 -4.3800000* .1224064 .000 -4.625861 -4.134139
10 -5.1600000* .1224064 .000 -5.405861 -4.914139
  198
3 4 .0600000 .1224064 .626 -.185861 .305861
5 -.9900000* .1224064 .000 -1.235861 -.744139
6 -1.7200000* .1224064 .000 -1.965861 -1.474139
7 -.8900000* .1224064 .000 -1.135861 -.644139
8 -2.8600000* .1224064 .000 -3.105861 -2.614139
9 -4.1400000* .1224064 .000 -4.385861 -3.894139
10 -4.9200000* .1224064 .000 -5.165861 -4.674139
4 5 -1.0500000* .1224064 .000 -1.295861 -.804139
6 -1.7800000* .1224064 .000 -2.025861 -1.534139
7 -.9500000* .1224064 .000 -1.195861 -.704139
8 -2.9200000* .1224064 .000 -3.165861 -2.674139
9 -4.2000000* .1224064 .000 -4.445861 -3.954139
10 -4.9800000* .1224064 .000 -5.225861 -4.734139
5 6 -.7300000* .1224064 .000 -.975861 -.484139
7 .1000000 .1224064 .418 -.145861 .345861
8 -1.8700000* .1224064 .000 -2.115861 -1.624139
9 -3.1500000* .1224064 .000 -3.395861 -2.904139
10 -3.9300000* .1224064 .000 -4.175861 -3.684139
6 7 .8300000* .1224064 .000 .584139 1.075861
8 -1.1400000* .1224064 .000 -1.385861 -.894139
9 -2.4200000* .1224064 .000 -2.665861 -2.174139
10 -3.2000000* .1224064 .000 -3.445861 -2.954139
7 8 -1.9700000* .1224064 .000 -2.215861 -1.724139
9 -3.2500000* .1224064 .000 -3.495861 -3.004139
10 -4.0300000* .1224064 .000 -4.275861 -3.784139
8 9 -1.2800000* .1224064 .000 -1.525861 -1.034139
10 -2.0600000* .1224064 .000 -2.305861 -1.814139
9 10 -.7800000* .1224064 .000 -1.025861 -.534139
Col3Day7 LSD 1 2 -.1500000 .0907010 .104 -.332178 .032178
3 -.3100000* .0907010 .001 -.492178 -.127822
4 -.4000000* .0907010 .000 -.582178 -.217822
5 -.6100000* .0907010 .000 -.792178 -.427822
6 -.9800000* .0907010 .000 -1.162178 -.797822
7 -.8100000* .0907010 .000 -.992178 -.627822
  199
8 -1.1800000* .0907010 .000 -1.362178 -.997822
9 -1.5100000* .0907010 .000 -1.692178 -1.327822
10 -1.7900000* .0907010 .000 -1.972178 -1.607822
2 3 -.1600000 .0907010 .084 -.342178 .022178
4 -.2500000* .0907010 .008 -.432178 -.067822
5 -.4600000* .0907010 .000 -.642178 -.277822
6 -.8300000* .0907010 .000 -1.012178 -.647822
7 -.6600000* .0907010 .000 -.842178 -.477822
8 -1.0300000* .0907010 .000 -1.212178 -.847822
9 -1.3600000* .0907010 .000 -1.542178 -1.177822
10 -1.6400000* .0907010 .000 -1.822178 -1.457822
3 4 -.0900000 .0907010 .326 -.272178 .092178
5 -.3000000* .0907010 .002 -.482178 -.117822
6 -.6700000* .0907010 .000 -.852178 -.487822
7 -.5000000* .0907010 .000 -.682178 -.317822
8 -.8700000* .0907010 .000 -1.052178 -.687822
9 -1.2000000* .0907010 .000 -1.382178 -1.017822
10 -1.4800000* .0907010 .000 -1.662178 -1.297822
4 5 -.2100000* .0907010 .025 -.392178 -.027822
6 -.5800000* .0907010 .000 -.762178 -.397822
7 -.4100000* .0907010 .000 -.592178 -.227822
8 -.7800000* .0907010 .000 -.962178 -.597822
9 -1.1100000* .0907010 .000 -1.292178 -.927822
10 -1.3900000* .0907010 .000 -1.572178 -1.207822
5 6 -.3700000* .0907010 .000 -.552178 -.187822
7 -.2000000* .0907010 .032 -.382178 -.017822
8 -.5700000* .0907010 .000 -.752178 -.387822
9 -.9000000* .0907010 .000 -1.082178 -.717822
10 -1.1800000* .0907010 .000 -1.362178 -.997822
6 7 .1700000 .0907010 .067 -.012178 .352178
8 -.2000000* .0907010 .032 -.382178 -.017822
9 -.5300000* .0907010 .000 -.712178 -.347822
10 -.8100000* .0907010 .000 -.992178 -.627822
7 8 -.3700000* .0907010 .000 -.552178 -.187822
  200
9 -.7000000* .0907010 .000 -.882178 -.517822
10 -.9800000* .0907010 .000 -1.162178 -.797822
8 9 -.3300000* .0907010 .001 -.512178 -.147822
10 -.6100000* .0907010 .000 -.792178 -.427822
9 10 -.2800000* .0907010 .003 -.462178 -.097822
Col3Day21 LSD 1 2 -.2600000* .1154123 .029 -.491812 -.028188
3 -.5100000* .1154123 .000 -.741812 -.278188
4 -.4300000* .1154123 .000 -.661812 -.198188
5 -.6800000* .1154123 .000 -.911812 -.448188
6 -1.2100000* .1154123 .000 -1.441812 -.978188
7 -.9700000* .1154123 .000 -1.201812 -.738188
8 -1.6300000* .1154123 .000 -1.861812 -1.398188
9 -1.8100000* .1154123 .000 -2.041812 -1.578188
10 -2.1000000* .1154123 .000 -2.331812 -1.868188
2 3 -.2500000* .1154123 .035 -.481812 -.018188
4 -.1700000 .1154123 .147 -.401812 .061812
5 -.4200000* .1154123 .001 -.651812 -.188188
6 -.9500000* .1154123 .000 -1.181812 -.718188
7 -.7100000* .1154123 .000 -.941812 -.478188
8 -1.3700000* .1154123 .000 -1.601812 -1.138188
9 -1.5500000* .1154123 .000 -1.781812 -1.318188
10 -1.8400000* .1154123 .000 -2.071812 -1.608188
3 4 .0800000 .1154123 .491 -.151812 .311812
5 -.1700000 .1154123 .147 -.401812 .061812
6 -.7000000* .1154123 .000 -.931812 -.468188
7 -.4600000* .1154123 .000 -.691812 -.228188
8 -1.1200000* .1154123 .000 -1.351812 -.888188
9 -1.3000000* .1154123 .000 -1.531812 -1.068188
10 -1.5900000* .1154123 .000 -1.821812 -1.358188
4 5 -.2500000* .1154123 .035 -.481812 -.018188
6 -.7800000* .1154123 .000 -1.011812 -.548188
7 -.5400000* .1154123 .000 -.771812 -.308188
8 -1.2000000* .1154123 .000 -1.431812 -.968188
9 -1.3800000* .1154123 .000 -1.611812 -1.148188
  201
10 -1.6700000* .1154123 .000 -1.901812 -1.438188
5 6 -.5300000* .1154123 .000 -.761812 -.298188
7 -.2900000* .1154123 .015 -.521812 -.058188
8 -.9500000* .1154123 .000 -1.181812 -.718188
9 -1.1300000* .1154123 .000 -1.361812 -.898188
10 -1.4200000* .1154123 .000 -1.651812 -1.188188
6 7 .2400000* .1154123 .043 .008188 .471812
8 -.4200000* .1154123 .001 -.651812 -.188188
9 -.6000000* .1154123 .000 -.831812 -.368188
10 -.8900000* .1154123 .000 -1.121812 -.658188
7 8 -.6600000* .1154123 .000 -.891812 -.428188
9 -.8400000* .1154123 .000 -1.071812 -.608188
10 -1.1300000* .1154123 .000 -1.361812 -.898188
8 9 -.1800000 .1154123 .125 -.411812 .051812
10 -.4700000* .1154123 .000 -.701812 -.238188
9 10 -.2900000* .1154123 .015 -.521812 -.058188
Col3Day35 LSD 1 2 -.3100000* .1245525 .016 -.560171 -.059829
3 -.5900000* .1245525 .000 -.840171 -.339829
4 -.6100000* .1245525 .000 -.860171 -.359829
5 -1.9800000* .1245525 .000 -2.230171 -1.729829
6 -2.8200000* .1245525 .000 -3.070171 -2.569829
7 -2.4100000* .1245525 .000 -2.660171 -2.159829
8 -3.6900000* .1245525 .000 -3.940171 -3.439829
9 -4.2000000* .1245525 .000 -4.450171 -3.949829
10 -4.8200000* .1245525 .000 -5.070171 -4.569829
2 3 -.2800000* .1245525 .029 -.530171 -.029829
4 -.3000000* .1245525 .020 -.550171 -.049829
5 -1.6700000* .1245525 .000 -1.920171 -1.419829
6 -2.5100000* .1245525 .000 -2.760171 -2.259829
7 -2.1000000* .1245525 .000 -2.350171 -1.849829
8 -3.3800000* .1245525 .000 -3.630171 -3.129829
9 -3.8900000* .1245525 .000 -4.140171 -3.639829
10 -4.5100000* .1245525 .000 -4.760171 -4.259829
3 4 -.0200000 .1245525 .873 -.270171 .230171
  202
5 -1.3900000* .1245525 .000 -1.640171 -1.139829
6 -2.2300000* .1245525 .000 -2.480171 -1.979829
7 -1.8200000* .1245525 .000 -2.070171 -1.569829
8 -3.1000000* .1245525 .000 -3.350171 -2.849829
9 -3.6100000* .1245525 .000 -3.860171 -3.359829
10 -4.2300000* .1245525 .000 -4.480171 -3.979829
4 5 -1.3700000* .1245525 .000 -1.620171 -1.119829
6 -2.2100000* .1245525 .000 -2.460171 -1.959829
7 -1.8000000* .1245525 .000 -2.050171 -1.549829
8 -3.0800000* .1245525 .000 -3.330171 -2.829829
9 -3.5900000* .1245525 .000 -3.840171 -3.339829
10 -4.2100000* .1245525 .000 -4.460171 -3.959829
5 6 -.8400000* .1245525 .000 -1.090171 -.589829
7 -.4300000* .1245525 .001 -.680171 -.179829
8 -1.7100000* .1245525 .000 -1.960171 -1.459829
9 -2.2200000* .1245525 .000 -2.470171 -1.969829
10 -2.8400000* .1245525 .000 -3.090171 -2.589829
6 7 .4100000* .1245525 .002 .159829 .660171
8 -.8700000* .1245525 .000 -1.120171 -.619829
9 -1.3800000* .1245525 .000 -1.630171 -1.129829
10 -2.0000000* .1245525 .000 -2.250171 -1.749829
7 8 -1.2800000* .1245525 .000 -1.530171 -1.029829
9 -1.7900000* .1245525 .000 -2.040171 -1.539829
10 -2.4100000* .1245525 .000 -2.660171 -2.159829
8 9 -.5100000* .1245525 .000 -.760171 -.259829
10 -1.1300000* .1245525 .000 -1.380171 -.879829
9 10 -.6200000* .1245525 .000 -.870171 -.369829
*. The mean difference is significant at the 0.05 level. 
**. 1: 10% FBS without ascorbic acid; 2: 10% FBS with 50µg/ml ascorbic acid; 3: 10% FBS with 100µg/ml 
ascorbic acid; 4: 15% FBS without ascorbic acid; 5: 15% FBS with 50µg/ml ascorbic acid; 6: 15% FBS 
with 100µg/ml ascorbic acid; 7: 20% FBS without ascorbic acid; 8: 20% FBS with 50µg/ml ascorbic acid; 
9: 20% FBS with 100µg/ml ascorbic acid; 10: 25% FBS with 50µg/ml ascorbic acid 
 
Multiple Comparisons of gene expression at different time point under each culture condition 
Dependent 
Variable (I) D (J) D 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
C1Col1 LSD 7 21 -.9500000* .1128421 .000 -1.190517 -.709483
  203
35 -1.7200000* .1128421 .000 -1.960517 -1.479483
21 35 -.7700000* .1128421 .000 -1.010517 -.529483
C2Col1 LSD 7 21 -.9400000* .1368698 .000 -1.231731 -.648269
35 -2.3800000* .1368698 .000 -2.671731 -2.088269
21 35 -1.4400000* .1368698 .000 -1.731731 -1.148269
C3Col1 LSD 7 21 -1.3000000* .1125463 .000 -1.539887 -1.060113
35 -2.5300000* .1125463 .000 -2.769887 -2.290113
21 35 -1.2300000* .1125463 .000 -1.469887 -.990113
C4Col1 LSD 7 21 -1.1500000* .0316228 .000 -1.217402 -1.082598
35 -2.4600000* .0316228 .000 -2.527402 -2.392598
21 35 -1.3100000* .0316228 .000 -1.377402 -1.242598
C5Col1 LSD 7 21 -2.1000000* .1171419 .000 -2.349682 -1.850318
35 -3.2200000* .1171419 .000 -3.469682 -2.970318
21 35 -1.1200000* .1171419 .000 -1.369682 -.870318
C6Col1 LSD 7 21 -2.3300000* .1251222 .000 -2.596692 -2.063308
35 -3.6000000* .1251222 .000 -3.866692 -3.333308
21 35 -1.2700000* .1251222 .000 -1.536692 -1.003308
C7Col1 LSD 7 21 -2.0800000* .0971253 .000 -2.287018 -1.872982
35 -2.9600000* .0971253 .000 -3.167018 -2.752982
21 35 -.8800000* .0971253 .000 -1.087018 -.672982
C8Col1 LSD 7 21 -2.4200000* .1396026 .000 -2.717556 -2.122444
35 -4.3500000* .1396026 .000 -4.647556 -4.052444
21 35 -1.9300000* .1396026 .000 -2.227556 -1.632444
C9Col1 LSD 7 21 -2.5600000* .1458262 .000 -2.870821 -2.249179
35 -5.4577282* .1458262 .000 -5.768549 -5.146907
21 35 -2.8977282* .1458262 .000 -3.208549 -2.586907
C10Col1 LSD 7 21 -2.5500000* .1536952 .000 -2.877594 -2.222406
35 -5.8800000* .1536952 .000 -6.207594 -5.552406
21 35 -3.3300000* .1536952 .000 -3.657594 -3.002406
C1Col3 LSD 7 21 -.6400000* .1021437 .000 -.857714 -.422286
35 -.9200000* .1021437 .000 -1.137714 -.702286
21 35 -.2800000* .1021437 .015 -.497714 -.062286
C2Col3 LSD 7 21 -.7500000* .1193035 .000 -1.004289 -.495711
35 -1.0800000* .1193035 .000 -1.334289 -.825711
  204
21 35 -.3300000* .1193035 .014 -.584289 -.075711
C3Col3 LSD 7 21 -.8400000* .1313604 .000 -1.119988 -.560012
35 -1.2000000* .1313604 .000 -1.479988 -.920012
21 35 -.3600000* .1313604 .015 -.639988 -.080012
C4Col3 LSD 7 21 -.6700000* .0801388 .000 -.840812 -.499188
35 -1.1300000* .0801388 .000 -1.300812 -.959188
21 35 -.4600000* .0801388 .000 -.630812 -.289188
C5Col3 LSD 7 21 -.7100000* .0984886 .000 -.919923 -.500077
35 -2.2900000* .0984886 .000 -2.499923 -2.080077
21 35 -1.5800000* .0984886 .000 -1.789923 -1.370077
C6Col3 LSD 7 21 -.8700000* .0956847 .000 -1.073947 -.666053
35 -2.7600000* .0956847 .000 -2.963947 -2.556053
21 35 -1.8900000* .0956847 .000 -2.093947 -1.686053
C7Col3 LSD 7 21 -.8000000* .1089852 .000 -1.032296 -.567704
35 -2.5200000* .1089852 .000 -2.752296 -2.287704
21 35 -1.7200000* .1089852 .000 -1.952296 -1.487704
C8Col3 LSD 7 21 -1.0900000* .0976388 .000 -1.298112 -.881888
35 -3.4300000* .0976388 .000 -3.638112 -3.221888
21 35 -2.3400000* .0976388 .000 -2.548112 -2.131888
C9Col3 LSD 7 21 -.9400000* .1327487 .000 -1.222947 -.657053
35 -3.6100000* .1327487 .000 -3.892947 -3.327053
21 35 -2.6700000* .1327487 .000 -2.952947 -2.387053
C10Col3 LSD 7 21 -.9500000* .1315295 .000 -1.230348 -.669652
35 -3.9500000* .1315295 .000 -4.230348 -3.669652
21 35 -3.0000000* .1315295 .000 -3.280348 -2.719652
*. The mean difference is significant at the 0.05 level. 
**. 1: 10% FBS without ascorbic acid; 2: 10% FBS with 50µg/ml ascorbic acid; 3: 10% FBS with 100µg/ml 
ascorbic acid; 4: 15% FBS without ascorbic acid; 5: 15% FBS with 50µg/ml ascorbic acid; 6: 15% FBS 
with 100µg/ml ascorbic acid; 7: 20% FBS without ascorbic acid; 8: 20% FBS with 50µg/ml ascorbic acid; 
9: 20% FBS with 100µg/ml ascorbic acid; 10: 25% FBS with 50µg/ml ascorbic acid 
A.8.4 Degradation of Different Scaffold Material in Culture Medium 
Multiple Comparisons of mechanical properties of PLLA scaffold at different time point 
Dependent 
Variable (I) Day (J) Day 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
PLLA LSD 1 7 .3500000 1.5579495 .824 -2.858657 3.558657
  205
14 .8100000 1.5579495 .608 -2.398657 4.018657
21 .5100000 1.5579495 .746 -2.698657 3.718657
28 .7300000 1.5579495 .643 -2.478657 3.938657
7 14 .4600000 1.5579495 .770 -2.748657 3.668657
21 .1600000 1.5579495 .919 -3.048657 3.368657
28 .3800000 1.5579495 .809 -2.828657 3.588657
14 21 -.3000000 1.5579495 .849 -3.508657 2.908657
28 -.0800000 1.5579495 .959 -3.288657 3.128657
21 28 .2200000 1.5579495 .889 -2.988657 3.428657
PLLAstff LSD 1 7 -.1300000 .3918163 .743 -.936961 .676961
14 -.3200000 .3918163 .422 -1.126961 .486961
21 .0300000 .3918163 .940 -.776961 .836961
28 .2700000 .3918163 .497 -.536961 1.076961
7 14 -.1900000 .3918163 .632 -.996961 .616961
21 .1600000 .3918163 .686 -.646961 .966961
28 .4000000 .3918163 .317 -.406961 1.206961
14 21 .3500000 .3918163 .380 -.456961 1.156961
28 .5900000 .3918163 .145 -.216961 1.396961
21 28 .2400000 .3918163 .546 -.566961 1.046961
 
Multiple Comparisons of mechanical properties of silk and silk sponge modified scaffold at 
different time point 





J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
silk LSD 1 7 1.5800000 1.0569831 .147 -.596898 3.756898
14 2.3000000* 1.0569831 .039 .123102 4.476898
28 2.9000000* 1.0569831 .011 .723102 5.076898
42 3.2000000* 1.0569831 .006 1.023102 5.376898
7 14 .7200000 1.0569831 .502 -1.456898 2.896898
28 1.3200000 1.0569831 .223 -.856898 3.496898
42 1.6200000 1.0569831 .138 -.556898 3.796898
14 28 .6000000 1.0569831 .575 -1.576898 2.776898
42 .9000000 1.0569831 .403 -1.276898 3.076898
  206
28 42 .3000000 1.0569831 .779 -1.876898 2.476898
silkstiff LSD 1 7 -.0200000 .0274287 .473 -.076490 .036490
14 -.0800000* .0274287 .007 -.136490 -.023510
28 -.0400000 .0274287 .157 -.096490 .016490
42 .0200000 .0274287 .473 -.036490 .076490
7 14 -.0600000* .0274287 .038 -.116490 -.003510
28 -.0200000 .0274287 .473 -.076490 .036490
42 .0400000 .0274287 .157 -.016490 .096490
14 28 .0400000 .0274287 .157 -.016490 .096490
42 .1000000* .0274287 .001 .043510 .156490
28 42 .0600000* .0274287 .038 .003510 .116490
sponge LSD 1 7 3.9900000* 1.4634343 .012 .976001 7.003999
14 6.4800000* 1.4634343 .000 3.466001 9.493999
28 6.8400000* 1.4634343 .000 3.826001 9.853999
42 7.1900000* 1.4634343 .000 4.176001 10.203999
7 14 2.4900000 1.4634343 .101 -.523999 5.503999
28 2.8500000 1.4634343 .063 -.163999 5.863999
42 3.2000000* 1.4634343 .038 .186001 6.213999
14 28 .3600000 1.4634343 .808 -2.653999 3.373999
42 .7100000 1.4634343 .632 -2.303999 3.723999
28 42 .3500000 1.4634343 .813 -2.663999 3.363999
spongestiff LSD 1 7 .5500000* .1667533 .003 .206565 .893435
14 .4900000* .1667533 .007 .146565 .833435
28 .6200000* .1667533 .001 .276565 .963435
42 .6500000* .1667533 .001 .306565 .993435
7 14 -.0600000 .1667533 .722 -.403435 .283435
28 .0700000 .1667533 .678 -.273435 .413435
42 .1000000 .1667533 .554 -.243435 .443435
14 28 .1300000 .1667533 .443 -.213435 .473435
42 .1600000 .1667533 .346 -.183435 .503435
28 42 .0300000 .1667533 .859 -.313435 .373435
*. The mean difference is significant at the 0.05 level. 
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A.8.5 Dosage Response of Ascorbic Acid on Cell Sheet Formation 








Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Day1 LSD 1 2 -.1463909 .3472996 .679 -.886642 .593861
3 -.0581609 .3472996 .869 -.798412 .682091
2 3 .0882300 .3472996 .803 -.652022 .828482
Day3 LSD 1 2 -1.9408100 1.1069101 .100 -4.300133 .418513
3 -1.0987700 1.1069101 .337 -3.458093 1.260553
2 3 .8420400 1.1069101 .459 -1.517283 3.201363
Day7 LSD 1 2 1.1187100 .9619738 .263 -.931689 3.169109
3 .3580000 .9619738 .715 -1.692399 2.408399
2 3 -.7607100 .9619738 .441 -2.811109 1.289689
Day14 LSD 1 2 .7068000 .7738271 .375 -.942573 2.356173
3 -.8925200 .7738271 .267 -2.541893 .756853
2 3 -1.5993200 .7738271 .056 -3.248693 .050053
Day21 LSD 1 2 .0177100 .4102432 .966 -.856703 .892123
3 -.3743800 .4102432 .376 -1.248793 .500033
2 3 -.3920900 .4102432 .354 -1.266503 .482323
Day28 LSD 1 2 -1.8700600 .9237978 .061 -3.839088 .098968
3 -1.2454000 .9237978 .198 -3.214428 .723628
2 3 .6246600 .9237978 .509 -1.344368 2.593688
*. 1: flat format; 2: fold format; 3: roll format 
 
Multiple Comparisons of cell viability at different time point of each format 
Dependent 
Variable (I) Day (J) Day 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Flat LSD 1 3 -4.0835409* .6504966 .000 -5.412032 -2.755050
7 -8.9887809* .6504966 .000 -10.317272 -7.660290
14 -10.9734709* .6504966 .000 -12.301962 -9.644980
21 -15.6487509* .6504966 .000 -16.977242 -14.320260
28 -22.6588509* .6504966 .000 -23.987342 -21.330360
3 7 -4.9052400* .6504966 .000 -6.233731 -3.576749
  208
14 -6.8899300* .6504966 .000 -8.218421 -5.561439
21 -11.5652100* .6504966 .000 -12.893701 -10.236719
28 -18.5753100* .6504966 .000 -19.903801 -17.246819
7 14 -1.9846900* .6504966 .005 -3.313181 -.656199
21 -6.6599700* .6504966 .000 -7.988461 -5.331479
28 -13.6700700* .6504966 .000 -14.998561 -12.341579
14 21 -4.6752800* .6504966 .000 -6.003771 -3.346789
28 -11.6853800* .6504966 .000 -13.013871 -10.356889
21 28 -7.0101000* .6504966 .000 -8.338591 -5.681609
Fold LSD 1 3 -5.8779600* .8999641 .000 -7.715932 -4.039988
7 -7.7236800* .8999641 .000 -9.561652 -5.885708
14 -10.1202800* .8999641 .000 -11.958252 -8.282308
21 -15.4846500* .8999641 .000 -17.322622 -13.646678
28 -24.3825200* .8999641 .000 -26.220492 -22.544548
3 7 -1.8457200* .8999641 .049 -3.683692 -.007748
14 -4.2423200* .8999641 .000 -6.080292 -2.404348
21 -9.6066900* .8999641 .000 -11.444662 -7.768718
28 -18.5045600* .8999641 .000 -20.342532 -16.666588
7 14 -2.3966000* .8999641 .012 -4.234572 -.558628
21 -7.7609700* .8999641 .000 -9.598942 -5.922998
28 -16.6588400* .8999641 .000 -18.496812 -14.820868
14 21 -5.3643700* .8999641 .000 -7.202342 -3.526398
28 -14.2622400* .8999641 .000 -16.100212 -12.424268
21 28 -8.8978700* .8999641 .000 -10.735842 -7.059898
Roll LSD 1 3 -5.1241500* .8442774 .000 -6.848394 -3.399906
7 -8.5726200* .8442774 .000 -10.296864 -6.848376
14 -11.8078300* .8442774 .000 -13.532074 -10.083586
21 -15.9649700* .8442774 .000 -17.689214 -14.240726
28 -23.8460900* .8442774 .000 -25.570334 -22.121846
3 7 -3.4484700* .8442774 .000 -5.172714 -1.724226
14 -6.6836800* .8442774 .000 -8.407924 -4.959436
21 -10.8408200* .8442774 .000 -12.565064 -9.116576
28 -18.7219400* .8442774 .000 -20.446184 -16.997696
7 14 -3.2352100* .8442774 .001 -4.959454 -1.510966
  209
21 -7.3923500* .8442774 .000 -9.116594 -5.668106
28 -15.2734700* .8442774 .000 -16.997714 -13.549226
14 21 -4.1571400* .8442774 .000 -5.881384 -2.432896
28 -12.0382600* .8442774 .000 -13.762504 -10.314016
21 28 -7.8811200* .8442774 .000 -9.605364 -6.156876
*. The mean difference is significant at the 0.05 level. 
 
Multiple Comparisons of collagen content at different time point of each format 
Dependent 
Variable (I) Day (J) Day 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
FlatCol LSD 7 14 -24.3600423* 1.2912617 .000 -27.072882 -21.647202
21 -48.2429211* .9761021 .000 -50.293636 -46.192207
28 -54.5365493* 1.2912617 .000 -57.249389 -51.823709
14 21 -23.8828788* 1.3365828 .000 -26.690935 -21.074822
28 -30.1765070* 1.5814661 .000 -33.499044 -26.853970
21 28 -6.2936282* 1.3365828 .000 -9.101685 -3.485572
FoldCol LSD 7 14 -28.0025312* 1.3040799 .000 -30.700226 -25.304836
21 -49.9390472* 1.1664045 .000 -52.351939 -47.526156
28 -53.7591012* 1.6495451 .000 -57.171445 -50.346757
14 21 -21.9365160* 1.3040799 .000 -24.634211 -19.238821
28 -25.7565700* 1.7496067 .000 -29.375907 -22.137233
21 28 -3.8200540* 1.6495451 .030 -7.232398 -.407710
RollCol LSD 7 14 -27.5099418* 2.7022186 .000 -33.238389 -21.781494
21 -50.6133156* 2.7828996 .000 -56.512799 -44.713832
28 -54.4573649* 3.2927712 .000 -61.437728 -47.477002
14 21 -23.1033738* 2.3985578 .000 -28.188089 -18.018658
28 -26.9474231* 2.9750448 .000 -33.254236 -20.640610
21 28 -3.8440493 3.0485137 .225 -10.306610 2.618511
*. The mean difference is significant at the 0.05 level. 
 









J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
ColDay7 LSD 1 2 .0863832 .6123729 .889 -1.195328 1.368094
  210
3 -.2231563 .7806253 .778 -1.857024 1.410711
2 3 -.3095395 .7806253 .696 -1.943407 1.324328
ColDay14 LSD 1 2 -3.5561057 3.0223143 .260 -10.085419 2.973207
3 -3.3730557 2.9494768 .273 -9.745013 2.998901
2 3 .1830499 2.3779442 .940 -4.954186 5.320286
ColDay21 LSD 1 2 -1.6097429 1.7393499 .366 -5.250244 2.030758
3 -2.5935507 1.9201903 .193 -6.612555 1.425454
2 3 -.9838079 1.8190557 .595 -4.791135 2.823519
ColDay28 LSD 1 2 .8638313 1.0456232 .440 -1.694717 3.422379
3 -.1439718 1.0456232 .895 -2.702520 2.414576
2 3 -1.0078032 1.0456232 .372 -3.566351 1.550745
*. 1: flat format; 2: fold format; 3: roll format 
 









J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Strength LSD 1 2 -1.4900000 1.5388437 .342 -4.659308 1.679308
3 -.1900000 1.5388437 .903 -3.359308 2.979308
4 -.6500000 1.5388437 .676 -3.819308 2.519308
5 .7300000 1.5388437 .639 -2.439308 3.899308
2 3 1.3000000 1.5388437 .406 -1.869308 4.469308
4 .8400000 1.5388437 .590 -2.329308 4.009308
5 2.2200000 1.5388437 .162 -.949308 5.389308
3 4 -.4600000 1.5388437 .767 -3.629308 2.709308
5 .9200000 1.5388437 .555 -2.249308 4.089308
4 5 1.3800000 1.5388437 .378 -1.789308 4.549308
Stiffness LSD 1 2 -.3000000 .4118171 .473 -1.148153 .548153
3 -.4500000 .4118171 .285 -1.298153 .398153
4 -.4200000 .4118171 .318 -1.268153 .428153
5 .2700000 .4118171 .518 -.578153 1.118153
2 3 -.1500000 .4118171 .719 -.998153 .698153
4 -.1200000 .4118171 .773 -.968153 .728153
5 .5700000 .4118171 .179 -.278153 1.418153
3 4 .0300000 .4118171 .943 -.818153 .878153
  211
5 .7200000 .4118171 .093 -.128153 1.568153
4 5 .6900000 .4118171 .106 -.158153 1.538153
*. 1: scaffold only on day 1; 2: flat format; 3: fold format; 4: roll format; 5: scaffold only on day 28 
 
A.8.6 Dosage Response of Ascorbic Acid on Cell Sheet Formation 








Difference (I-J) Std. Error Sig. 




Day1 LSD 1 2 -5.13931* .40427 .000 -6.0010 -4.2776
3 -9.92822* .40427 .000 -10.7899 -9.0665
2 3 -4.78891* .40427 .000 -5.6506 -3.9272
Day3 LSD 1 2 -3.20489* .53968 .000 -4.3552 -2.0546
3 -8.41410* .53968 .000 -9.5644 -7.2638
2 3 -5.20921* .53968 .000 -6.3595 -4.0589
Day6 LSD 1 2 -3.81455* .51053 .000 -4.9027 -2.7264
3 -6.48062* .51053 .000 -7.5688 -5.3925
2 3 -2.66607* .51053 .000 -3.7542 -1.5779
Day10 LSD 1 2 -5.52937* .41692 .000 -6.4180 -4.6407
3 -15.32220* .41692 .000 -16.2108 -14.4336
2 3 -9.79283* .41692 .000 -10.6815 -8.9042
Day15 LSD 1 2 -4.27198* .23415 .000 -4.7711 -3.7729
3 -14.69979* .23415 .000 -15.1989 -14.2007
2 3 -10.42781* .23415 .000 -10.9269 -9.9287
Day20 LSD 1 2 -6.98221* .30288 .000 -7.6278 -6.3366
3 -14.72067* .30288 .000 -15.3662 -14.0751
2 3 -7.73846* .30288 .000 -8.3840 -7.0929
*. The mean difference is significant at the 0.05 level. 
**. 1: PLLA scaffold; 2: silk scaffold; 3: sponge modified silk scaffold 
 
Multiple Comparisons of cell viability on each scaffold system at different time point 
Dependent 
Variable (I) Day (J) Day 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
PLLA LSD 1 3 -4.8399200* .3585112 .000 -5.572098 -4.107742
  212
6 -7.9916000* .3585112 .000 -8.723778 -7.259422
10 -11.6544200* .3585112 .000 -12.386598 -10.922242
15 -17.2043300* .3585112 .000 -17.936508 -16.472152
20 -26.1331500* .3585112 .000 -26.865328 -25.400972
3 6 -3.1516800* .3585112 .000 -3.883858 -2.419502
10 -6.8145000* .3585112 .000 -7.546678 -6.082322
15 -12.3644100* .3585112 .000 -13.096588 -11.632232
20 -21.2932300* .3585112 .000 -22.025408 -20.561052
6 10 -3.6628200* .3585112 .000 -4.394998 -2.930642
15 -9.2127300* .3585112 .000 -9.944908 -8.480552
20 -18.1415500* .3585112 .000 -18.873728 -17.409372
10 15 -5.5499100* .3585112 .000 -6.282088 -4.817732
20 -14.4787300* .3585112 .000 -15.210908 -13.746552
15 20 -8.9288200* .3585112 .000 -9.660998 -8.196642
Silk LSD 1 3 -2.9055000* .4537764 .000 -3.832235 -1.978765
6 -6.6668400* .4537764 .000 -7.593575 -5.740105
10 -12.0444800* .4537764 .000 -12.971215 -11.117745
15 -16.3370000* .4537764 .000 -17.263735 -15.410265
20 -27.9760500* .4537764 .000 -28.902785 -27.049315
3 6 -3.7613400* .4537764 .000 -4.688075 -2.834605
10 -9.1389800* .4537764 .000 -10.065715 -8.212245
15 -13.4315000* .4537764 .000 -14.358235 -12.504765
20 -25.0705500* .4537764 .000 -25.997285 -24.143815
6 10 -5.3776400* .4537764 .000 -6.304375 -4.450905
15 -9.6701600* .4537764 .000 -10.596895 -8.743425
20 -21.3092100* .4537764 .000 -22.235945 -20.382475
10 15 -4.2925200* .4537764 .000 -5.219255 -3.365785
20 -15.9315700* .4537764 .000 -16.858305 -15.004835
15 20 -11.6390500* .4537764 .000 -12.565785 -10.712315
sponge LSD 1 3 -3.3258000* .4282624 .000 -4.200428 -2.451172
6 -4.5440000* .4282624 .000 -5.418628 -3.669372
10 -17.0484000* .4282624 .000 -17.923028 -16.173772
15 -21.9759000* .4282624 .000 -22.850528 -21.101272
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20 -30.9256000* .4282624 .000 -31.800228 -30.050972
3 6 -1.2182000* .4282624 .008 -2.092828 -.343572
10 -13.7226000* .4282624 .000 -14.597228 -12.847972
15 -18.6501000* .4282624 .000 -19.524728 -17.775472
20 -27.5998000* .4282624 .000 -28.474428 -26.725172
6 10 -12.5044000* .4282624 .000 -13.379028 -11.629772
15 -17.4319000* .4282624 .000 -18.306528 -16.557272
20 -26.3816000* .4282624 .000 -27.256228 -25.506972
10 15 -4.9275000* .4282624 .000 -5.802128 -4.052872
20 -13.8772000* .4282624 .000 -14.751828 -13.002572
15 20 -8.9497000* .4282624 .000 -9.824328 -8.075072
*. The mean difference is significant at the 0.05 level. 
 









J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
ColDay6 LSD 1 2 -40.5938300* 1.8825988 .000 -44.606494 -36.581166
3 -75.9394000* 1.8825988 .000 -79.952064 -71.926736
2 3 -35.3455700* 1.8825988 .000 -39.358234 -31.332906
ColDay10 LSD 1 2 -9.5704600* 1.8624150 .000 -13.540104 -5.600816
3 -1.0326874E2 1.8624150 .000 -107.238384 -99.299096
2 3 -93.6982800* 1.8624150 .000 -97.667924 -89.728636
ColDay20 LSD 1 2 -16.9528900* 1.2880844 .000 -19.698377 -14.207403
3 -1.0341018E2 1.2880844 .000 -106.155667 -100.664693
2 3 -86.4572900* 1.2880844 .000 -89.202777 -83.711803
*. The mean difference is significant at the 0.05 level. 
**. 1: PLLA scaffold; 2: silk scaffold; 3: sponge modified silk scaffold 
 
Multiple Comparisons of collagen content of each scaffold system at different time point 





J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
PLLACol LSD 6 15 -47.0042500* 1.4181742 .000 -50.027017 -43.981483
20 -56.2894900* 1.4181742 .000 -59.312257 -53.266723
15 20 -9.2852400* 1.4181742 .000 -12.308007 -6.262473
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SilkCol LSD 6 15 -15.9808800* 1.7059721 .000 -19.617073 -12.344687
20 -32.6485500* 1.7059721 .000 -36.284743 -29.012357
15 20 -16.6676700* 1.7059721 .000 -20.303863 -13.031477
SpongeCol LSD 6 15 -74.3335900* 1.9365873 .000 -78.461328 -70.205852
20 -83.7602700* 1.9365873 .000 -87.888008 -79.632532
15 20 -9.4266800* 1.9365873 .000 -13.554418 -5.298942
*. The mean difference is significant at the 0.05 level. 
 
Multiple Comparisons of gene expression of different scaffold system at each time point 
Dependent Variable (I) C** (J) C**
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Col1day10 LSD 1 2 -.4200000* .1308519 .006 -.698904 -.141096
3 -1.5500000* .1308519 .000 -1.828904 -1.271096
2 3 -1.1300000* .1308519 .000 -1.408904 -.851096
Col1Day20 LSD 1 2 -.8800000* .0855050 .000 -1.062250 -.697750
3 -1.7600000* .0855050 .000 -1.942250 -1.577750
2 3 -.8800000* .0855050 .000 -1.062250 -.697750
Col3Day10 LSD 1 2 -.2100000* .0984886 .050 -.419923 -.000077
3 -.5700000* .0984886 .000 -.779923 -.360077
2 3 -.3600000* .0984886 .002 -.569923 -.150077
Col3Day20 LSD 1 2 -.3800000* .1097978 .003 -.614028 -.145972
3 -1.0900000* .1097978 .000 -1.324028 -.855972
2 3 -.7100000* .1097978 .000 -.944028 -.475972
TenDay10 LSD 1 2 -.4700000* .1319091 .003 -.751158 -.188842
3 -1.3400000* .1319091 .000 -1.621158 -1.058842
2 3 -.8700000* .1319091 .000 -1.151158 -.588842
TenDay20 LSD 1 2 -.5700000* .1308944 .001 -.848995 -.291005
3 -1.4100000* .1308944 .000 -1.688995 -1.131005
2 3 -.8400000* .1308944 .000 -1.118995 -.561005
*. The mean difference is significant at the 0.05 level. 
**. 1: PLLA scaffold; 2: silk scaffold; 3: sponge modified silk scaffold 
 
ANOVA analysis of gene expression of each scaffold system at different time point 
  Sum of Squares df Mean Square F Sig. 
C1Col1* Between Time 
points 
.367 1 .367 12.716 .005
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C2Col1* Between Time 
points 
1.968 1 1.968 43.691 .000
C3Col1* Between Time 
points 
.941 1 .941 26.133 .000
C1Col3 Between Time 
points 
.097 1 .097 5.507 .041
C2Col3 Between Time 
points 
.367 1 .367 33.258 .000
C3Col3 Between Time 
points 
1.470 1 1.470 21.243 .001
C1Ten Between Time 
points 
.433 1 .433 9.735 .011
C2Ten Between Time 
points 
.691 1 .691 13.066 .005
C3Ten Between Time 
points 
.607 1 .607 10.474 .009
*. C1: PLLA scaffold; C2: silk scaffold; C3: sponge modified silk scaffold 
 








Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Strength LSD 1 2 -1.0500000 1.5233333 .501 -4.296908 2.196908
3 .5100000 1.5233333 .742 -2.736908 3.756908
2 3 1.5600000 1.5233333 .322 -1.686908 4.806908
Stiffness LSD 1 2 -.0700000 .3398856 .840 -.794449 .654449
3 .0300000 .3398856 .931 -.694449 .754449
2 3 .1000000 .3398856 .773 -.624449 .824449
*. 1: PLLA scaffold only at day 1; 2: cell sheet-PLLA scaffold at day 20; 3: PLLA scaffold only at day 20 
 








Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Strength2 LSD 4 5 .6200000 1.5789554 .697 -2.604657 3.844657
6 2.9000000 1.5789554 .076 -.324657 6.124657
7 -16.4600000* 1.5789554 .000 -19.684657 -13.235343
8 -11.4700000* 1.5789554 .000 -14.694657 -8.245343
9 -10.0800000* 1.5789554 .000 -13.304657 -6.855343
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5 6 2.2800000 1.5789554 .159 -.944657 5.504657
7 -17.0800000* 1.5789554 .000 -20.304657 -13.855343
8 -12.0900000* 1.5789554 .000 -15.314657 -8.865343
9 -10.7000000* 1.5789554 .000 -13.924657 -7.475343
6 7 -19.3600000* 1.5789554 .000 -22.584657 -16.135343
8 -14.3700000* 1.5789554 .000 -17.594657 -11.145343
9 -12.9800000* 1.5789554 .000 -16.204657 -9.755343
7 8 4.9900000* 1.5789554 .004 1.765343 8.214657
9 6.3800000* 1.5789554 .000 3.155343 9.604657
8 9 1.3900000 1.5789554 .386 -1.834657 4.614657
Stiffness2 LSD 4 5 -.0400000 .1875424 .833 -.423013 .343013
6 -.0400000 .1875424 .833 -.423013 .343013
7 -1.5700000* .1875424 .000 -1.953013 -1.186987
8 -.8200000* .1875424 .000 -1.203013 -.436987
9 -1.1000000* .1875424 .000 -1.483013 -.716987
5 6 .0000000 .1875424 1.000 -.383013 .383013
7 -1.5300000* .1875424 .000 -1.913013 -1.146987
8 -.7800000* .1875424 .000 -1.163013 -.396987
9 -1.0600000* .1875424 .000 -1.443013 -.676987
6 7 -1.5300000* .1875424 .000 -1.913013 -1.146987
8 -.7800000* .1875424 .000 -1.163013 -.396987
9 -1.0600000* .1875424 .000 -1.443013 -.676987
7 8 .7500000* .1875424 .000 .366987 1.133013
9 .4700000* .1875424 .018 .086987 .853013
8 9 -.2800000 .1875424 .146 -.663013 .103013
*. The mean difference is significant at the 0.05 level. 
**. 4: silk scaffold only at day 1; 5: cell sheet-silk scaffold at day 20; 6: silk scaffold only at day 20; 7: 
sponge scaffold only at day 1; 8: cell sheet-sponge scaffold at day 20; 9: sponge scaffold only at day 20 
A.8.7 Dosage Response of Ascorbic Acid on Cell Sheet Formation 








Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Day1 LSD 1 2 -1.8094000* .3983755 .000 -2.640397 -.978403
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3 -4.7889100* .3983755 .000 -5.619907 -3.957913
4 -6.4603100* .3983755 .000 -7.291307 -5.629313
2 3 -2.9795100* .3983755 .000 -3.810507 -2.148513
4 -4.6509100* .3983755 .000 -5.481907 -3.819913
3 4 -1.6714000* .3983755 .000 -2.502397 -.840403
Day3 LSD 1 2 -4.0817000* .5671413 .000 -5.264736 -2.898664
3 -5.2092100* .5671413 .000 -6.392246 -4.026174
4 -7.1047100* .5671413 .000 -8.287746 -5.921674
2 3 -1.1275100 .5671413 .061 -2.310546 .055526
4 -3.0230100* .5671413 .000 -4.206046 -1.839974
3 4 -1.8955000* .5671413 .003 -3.078536 -.712464
Day6 LSD 1 2 -4.3249400* .6022989 .000 -5.581314 -3.068566
3 -2.6660700* .6022989 .000 -3.922444 -1.409696
4 -10.5227700* .6022989 .000 -11.779144 -9.266396
2 3 1.6588700* .6022989 .012 .402496 2.915244
4 -6.1978300* .6022989 .000 -7.454204 -4.941456
3 4 -7.8567000* .6022989 .000 -9.113074 -6.600326
Day10 LSD 1 2 -1.0307700* .4277899 .026 -1.923124 -.138416
3 -9.7928300* .4277899 .000 -10.685184 -8.900476
4 -12.5633300* .4277899 .000 -13.455684 -11.670976
2 3 -8.7620600* .4277899 .000 -9.654414 -7.869706
4 -11.5325600* .4277899 .000 -12.424914 -10.640206
3 4 -2.7705000* .4277899 .000 -3.662854 -1.878146
Day15 LSD 1 2 -4.9145600* .1908047 .000 -5.312572 -4.516548
3 -10.4278100* .1908047 .000 -10.825822 -10.029798
4 -12.6864100* .1908047 .000 -13.084422 -12.288398
2 3 -5.5132500* .1908047 .000 -5.911262 -5.115238
4 -7.7718500* .1908047 .000 -8.169862 -7.373838
3 4 -2.2586000* .1908047 .000 -2.656612 -1.860588
Day20 LSD 1 2 -3.1714100* .4073627 .000 -4.021154 -2.321666
3 -7.7384600* .4073627 .000 -8.588204 -6.888716
4 -11.7694600* .4073627 .000 -12.619204 -10.919716
2 3 -4.5670500* .4073627 .000 -5.416794 -3.717306
4 -8.5980500* .4073627 .000 -9.447794 -7.748306
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3 4 -4.0310000* .4073627 .000 -4.880744 -3.181256
*. The mean difference is significant at the 0.05 level. 
**. 1: silk scaffold under static culture; 2: silk scaffold cultured in bioreactor; 3: sponge scaffold under 
static culture; 4: sponge scaffold cultured in bioreactor. 
 
Multiple Comparisons of cell viability at different time point under each culture condition 
Dependent 
Variable** (I) Day (J) Day 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
ABC1 LSD 1 3 -2.9055000* .4537764 .000 -3.832235 -1.978765
6 -6.6668400* .4537764 .000 -7.593575 -5.740105
10 -12.0444800* .4537764 .000 -12.971215 -11.117745
15 -16.3370000* .4537764 .000 -17.263735 -15.410265
20 -27.9760500* .4537764 .000 -28.902785 -27.049315
3 6 -3.7613400* .4537764 .000 -4.688075 -2.834605
10 -9.1389800* .4537764 .000 -10.065715 -8.212245
15 -13.4315000* .4537764 .000 -14.358235 -12.504765
20 -25.0705500* .4537764 .000 -25.997285 -24.143815
6 10 -5.3776400* .4537764 .000 -6.304375 -4.450905
15 -9.6701600* .4537764 .000 -10.596895 -8.743425
20 -21.3092100* .4537764 .000 -22.235945 -20.382475
10 15 -4.2925200* .4537764 .000 -5.219255 -3.365785
20 -15.9315700* .4537764 .000 -16.858305 -15.004835
15 20 -11.6390500* .4537764 .000 -12.565785 -10.712315
ABC2 LSD 1 3 -5.1778000* .5269871 .000 -6.254051 -4.101549
6 -9.1823800* .5269871 .000 -10.258631 -8.106129
10 -11.2658500* .5269871 .000 -12.342101 -10.189599
15 -19.4421600* .5269871 .000 -20.518411 -18.365909
20 -29.3380600* .5269871 .000 -30.414311 -28.261809
3 6 -4.0045800* .5269871 .000 -5.080831 -2.928329
10 -6.0880500* .5269871 .000 -7.164301 -5.011799
15 -14.2643600* .5269871 .000 -15.340611 -13.188109
20 -24.1602600* .5269871 .000 -25.236511 -23.084009
6 10 -2.0834700* .5269871 .000 -3.159721 -1.007219
15 -10.2597800* .5269871 .000 -11.336031 -9.183529
20 -20.1556800* .5269871 .000 -21.231931 -19.079429
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10 15 -8.1763100* .5269871 .000 -9.252561 -7.100059
20 -18.0722100* .5269871 .000 -19.148461 -16.995959
15 20 -9.8959000* .5269871 .000 -10.972151 -8.819649
ABC3 LSD 1 3 -3.3258000* .4282624 .000 -4.200428 -2.451172
6 -4.5440000* .4282624 .000 -5.418628 -3.669372
10 -17.0484000* .4282624 .000 -17.923028 -16.173772
15 -21.9759000* .4282624 .000 -22.850528 -21.101272
20 -30.9256000* .4282624 .000 -31.800228 -30.050972
3 6 -1.2182000* .4282624 .008 -2.092828 -.343572
10 -13.7226000* .4282624 .000 -14.597228 -12.847972
15 -18.6501000* .4282624 .000 -19.524728 -17.775472
20 -27.5998000* .4282624 .000 -28.474428 -26.725172
6 10 -12.5044000* .4282624 .000 -13.379028 -11.629772
15 -17.4319000* .4282624 .000 -18.306528 -16.557272
20 -26.3816000* .4282624 .000 -27.256228 -25.506972
10 15 -4.9275000* .4282624 .000 -5.802128 -4.052872
20 -13.8772000* .4282624 .000 -14.751828 -13.002572
15 20 -8.9497000* .4282624 .000 -9.824328 -8.075072
ABC4 LSD 1 3 -3.5499000* .3897998 .000 -4.345977 -2.753823
6 -10.7293000* .3897998 .000 -11.525377 -9.933223
10 -18.1475000* .3897998 .000 -18.943577 -17.351423
15 -22.5631000* .3897998 .000 -23.359177 -21.767023
20 -33.2852000* .3897998 .000 -34.081277 -32.489123
3 6 -7.1794000* .3897998 .000 -7.975477 -6.383323
10 -14.5976000* .3897998 .000 -15.393677 -13.801523
15 -19.0132000* .3897998 .000 -19.809277 -18.217123
20 -29.7353000* .3897998 .000 -30.531377 -28.939223
6 10 -7.4182000* .3897998 .000 -8.214277 -6.622123
15 -11.8338000* .3897998 .000 -12.629877 -11.037723
20 -22.5559000* .3897998 .000 -23.351977 -21.759823
10 15 -4.4156000* .3897998 .000 -5.211677 -3.619523
20 -15.1377000* .3897998 .000 -15.933777 -14.341623
15 20 -10.7221000* .3897998 .000 -11.518177 -9.926023
*. The mean difference is significant at the 0.05 level. 
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**. ABC1: silk scaffold under static culture; ABC2: silk scaffold cultured in bioreactor; ABC3: sponge 
scaffold under static culture; ABC4: sponge scaffold cultured in bioreactor. 
 
 














ColDay6 LSD 1 2 -22.3246400* 1.4028108 .000 -25.250852 -19.398428
3 -35.3455700* 1.4028108 .000 -38.271782 -32.419358
4 -83.5987200* 1.4028108 .000 -86.524932 -80.672508
2 3 -13.0209300* 1.4028108 .000 -15.947142 -10.094718
4 -61.2740800* 1.4028108 .000 -64.200292 -58.347868
3 4 -48.2531500* 1.4028108 .000 -51.179362 -45.326938
ColDay10 LSD 1 2 -45.0540700* 1.6827286 .000 -48.564180 -41.543960
3 -93.6982800* 1.6827286 .000 -97.208390 -90.188170
4 -1.1401644E2 1.6827286 .000 -117.526550 -110.50633
2 3 -48.6442100* 1.6827286 .000 -52.154320 -45.134100
4 -68.9623700* 1.6827286 .000 -72.472480 -65.452260
3 4 -20.3181600* 1.6827286 .000 -23.828270 -16.808050
ColDay20 LSD 1 2 -56.7850000* 1.7044631 .000 -60.340448 -53.229552
3 -86.4572900* 1.7044631 .000 -90.012738 -82.901842
4 -1.3454966E2 1.7044631 .000 -138.105108 -130.99421
2 3 -29.6722900* 1.7044631 .000 -33.227738 -26.116842
4 -77.7646600* 1.7044631 .000 -81.320108 -74.209212
3 4 -48.0923700* 1.7044631 .000 -51.647818 -44.536922
*. The mean difference is significant at the 0.05 level. 
**. 1: silk scaffold under static culture; 2: silk scaffold cultured in bioreactor; 3: sponge scaffold under 
static culture; 4: sponge scaffold cultured in bioreactor. 
 
Multiple Comparisons of collagen content at different time point under each culture condition 
Dependent 
Variable** (I) Day (J) Day 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
ColC1 LSD 6 10 -15.9808800* 1.7059721 .000 -19.617073 -12.344687
20 -32.6485500* 1.7059721 .000 -36.284743 -29.012357
10 20 -16.6676700* 1.7059721 .000 -20.303863 -13.031477
ColC2 LSD 6 10 -38.7103100* .5334325 .000 -39.847294 -37.573326
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20 -67.1089100* .5334325 .000 -68.245894 -65.971926
10 20 -28.3986000* .5334325 .000 -29.535584 -27.261616
ColC3 LSD 6 10 -74.3335900* 1.9365873 .000 -78.461328 -70.205852
20 -83.7602700* 1.9365873 .000 -87.888008 -79.632532
10 20 -9.4266800* 1.9365873 .000 -13.554418 -5.298942
ColC4 LSD 6 10 -46.3986000* 1.8241718 .000 -50.286730 -42.510470
20 -83.5994900* 1.8241718 .000 -87.487620 -79.711360
10 20 -37.2008900* 1.8241718 .000 -41.089020 -33.312760
*. The mean difference is significant at the 0.05 level. 
**. ColC1: silk scaffold under static culture; ColC2: silk scaffold cultured in bioreactor; ColC3: sponge 
scaffold under static culture; ColC4: sponge scaffold cultured in bioreactor. 
 
Multiple Comparisons of gene expression under different culture condition at each time point 
Dependent Variable (I) C** (J) C**
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
Col1day10 LSD 1 2 -.2200000* .0998332 .039 -.428248 -.011752
3 -1.5500000* .0998332 .000 -1.758248 -1.341752
4 -2.1100000* .0998332 .000 -2.318248 -1.901752
2 3 -1.3300000* .0998332 .000 -1.538248 -1.121752
4 -1.8900000* .0998332 .000 -2.098248 -1.681752
3 4 -.5600000* .0998332 .000 -.768248 -.351752
Col1Day20 LSD 1 2 -.3600000* .1287439 .011 -.628555 -.091445
3 -2.4018300* .1287439 .000 -2.670385 -2.133275
4 -3.5285900* .1287439 .000 -3.797145 -3.260035
2 3 -2.0418300* .1287439 .000 -2.310385 -1.773275
4 -3.1685900* .1287439 .000 -3.437145 -2.900035
3 4 -1.1267600* .1287439 .000 -1.395315 -.858205
Col3Day10 LSD 1 2 -.4100000* .0934077 .000 -.604845 -.215155
3 -.5700000* .0934077 .000 -.764845 -.375155
4 -1.2700000* .0934077 .000 -1.464845 -1.075155
2 3 -.1600000 .0934077 .102 -.354845 .034845
4 -.8600000* .0934077 .000 -1.054845 -.665155
3 4 -.7000000* .0934077 .000 -.894845 -.505155
Col3Day20 LSD 1 2 -.2100000 .1330727 .130 -.487585 .067585
3 -1.5853200* .1330727 .000 -1.862905 -1.307735
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4 -2.9546800* .1330727 .000 -3.232265 -2.677095
2 3 -1.3753200* .1330727 .000 -1.652905 -1.097735
4 -2.7446800* .1330727 .000 -3.022265 -2.467095
3 4 -1.3693600* .1330727 .000 -1.646945 -1.091775
TenDay10 LSD 1 2 -.4900000* .0986154 .000 -.695708 -.284292
3 -1.3400000* .0986154 .000 -1.545708 -1.134292
4 -2.2600000* .0986154 .000 -2.465708 -2.054292
2 3 -.8500000* .0986154 .000 -1.055708 -.644292
4 -1.7700000* .0986154 .000 -1.975708 -1.564292
3 4 -.9200000* .0986154 .000 -1.125708 -.714292
TenDay20 LSD 1 2 -.6800000* .1133211 .000 -.916384 -.443616
3 -1.5022400* .1133211 .000 -1.738624 -1.265856
4 -2.3389800* .1133211 .000 -2.575364 -2.102596
2 3 -.8222400* .1133211 .000 -1.058624 -.585856
4 -1.6589800* .1133211 .000 -1.895364 -1.422596
3 4 -.8367400* .1133211 .000 -1.073124 -.600356
*. The mean difference is significant at the 0.05 level. 
**. 1: silk scaffold under static culture; 2: silk scaffold cultured in bioreactor; 3: sponge scaffold under 
static culture; 4: sponge scaffold cultured in bioreactor. 
 
ANOVA analysis of gene expression at different time point under culture condition 
  Sum of Squares df Mean Square F Sig. 
C1Col1 Between Time 
points 
.975 1 .975 19.572 .001
C2Col1 Between Time 
points 
1.512 1 1.512 84.017 .000
C3Col1 Between Time 
points 
6.065 1 6.065 168.467 .000
C4Col1 Between Time 
points 
11.863 1 11.863 213.949 .000
C1Col3 Between Time 
points 
1.599 1 1.599 104.490 .000
C2Col3 Between Time 
points 
.843 1 .843 37.874 .000
C3Col3 Between Time 
points 
9.138 1 9.138 132.058 .000
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C4Col3 Between Time 
points 
17.492 1 17.492 337.359 .000
C1Ten Between Time 
points 
3.696 1 3.696 242.380 .000
C2Ten Between Time 
points 
5.070 1 5.070 154.338 .000
C3Ten Between Time 
points 
4.856 1 4.856 83.720 .000
C4Ten Between Time 
points 
4.241 1 4.241 144.745 .000
**. C1: silk scaffold under static culture; C2: silk scaffold cultured in bioreactor; C3: sponge scaffold under 
static culture; C4: sponge scaffold cultured in bioreactor. 
 














silkstrength LSD 1 2 .3236326 1.5362309 .834 -2.786304 3.433570
3 -1.5413163 1.5362309 .322 -4.651253 1.568621
4 2.9000000* 1.2543273 .026 .360747 5.439253
5 3.9500000* 1.2543273 .003 1.410747 6.489253
6 -16.4600000* 1.2543273 .000 -18.999253 -13.92074
7 -11.8768009* 1.5362309 .000 -14.986738 -8.766864
8 -12.2383216* 1.5362309 .000 -15.348259 -9.128385
9 -10.0800000* 1.2543273 .000 -12.619253 -7.540747
10 -8.9900000* 1.2543273 .000 -11.529253 -6.450747
2 3 -1.8649489 1.7738867 .300 -5.455995 1.726097
4 2.5763674 1.5362309 .102 -.533570 5.686304
5 3.6263674* 1.5362309 .023 .516430 6.736304
6 -16.7836326* 1.5362309 .000 -19.893570 -13.67370
7 -12.2004335* 1.7738867 .000 -15.791479 -8.609388
8 -12.5619542* 1.7738867 .000 -16.153000 -8.970908
9 -10.4036326* 1.5362309 .000 -13.513570 -7.293696
10 -9.3136326* 1.5362309 .000 -12.423570 -6.203696
3 4 4.4413163* 1.5362309 .006 1.331379 7.551253
5 5.4913163* 1.5362309 .001 2.381379 8.601253
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6 -14.9186837* 1.5362309 .000 -18.028621 -11.80874
7 -10.3354846* 1.7738867 .000 -13.926530 -6.744439
8 -10.6970053* 1.7738867 .000 -14.288051 -7.105959
9 -8.5386837* 1.5362309 .000 -11.648621 -5.428747
10 -7.4486837* 1.5362309 .000 -10.558621 -4.338747
4 5 1.0500000 1.2543273 .408 -1.489253 3.589253
6 -19.3600000* 1.2543273 .000 -21.899253 -16.82074
7 -14.7768009* 1.5362309 .000 -17.886738 11.666864
8 -15.1383216* 1.5362309 .000 -18.248259 -12.02838
9 -12.9800000* 1.2543273 .000 -15.519253 -10.44074
10 -11.8900000* 1.2543273 .000 -14.429253 -9.350747
5 6 -20.4100000* 1.2543273 .000 -22.949253 -17.87074
7 -15.8268009* 1.5362309 .000 -18.936738 -12.71686
8 -16.1883216* 1.5362309 .000 -19.298259 -13.07838
9 -14.0300000* 1.2543273 .000 -16.569253 -11.49074
10 -12.9400000* 1.2543273 .000 -15.479253 -10.40074
6 7 4.5831991* 1.5362309 .005 1.473262 7.693136
8 4.2216784* 1.5362309 .009 1.111741 7.331615
9 6.3800000* 1.2543273 .000 3.840747 8.919253
10 7.4700000* 1.2543273 .000 4.930747 10.009253
7 8 -.3615207 1.7738867 .840 -3.952567 3.229525
9 1.7968009 1.5362309 .249 -1.313136 4.906738
10 2.8868009 1.5362309 .068 -.223136 5.996738
8 9 2.1583216 1.5362309 .168 -.951615 5.268259
10 3.2483216* 1.5362309 .041 .138385 6.358259
9 10 1.0900000 1.2543273 .390 -1.449253 3.629253
silkstiffess LSD 1 2 .1460000 .2333329 .535 -.326358 .618358
3 1.2800000* .2333329 .000 .807642 1.752358
4 -.0400000 .1905155 .835 -.425679 .345679
5 1.3800000* .1905155 .000 .994321 1.765679
6 -1.5700000* .1905155 .000 -1.955679 -1.184321
7 -.8200000* .2333329 .001 -1.292358 -.347642
8 -.2600000 .2333329 .272 -.732358 .212358
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9 -1.1000000* .1905155 .000 -1.485679 -.714321
10 -.0600000 .1905155 .755 -.445679 .325679
2 3 1.1340000* .2694297 .000 .588568 1.679432
4 -.1860000 .2333329 .430 -.658358 .286358
5 1.2340000* .2333329 .000 .761642 1.706358
6 -1.7160000* .2333329 .000 -2.188358 -1.243642
7 -.9660000* .2694297 .001 -1.511432 -.420568
8 -.4060000 .2694297 .140 -.951432 .139432
9 -1.2460000* .2333329 .000 -1.718358 -.773642
10 -.2060000 .2333329 .383 -.678358 .266358
3 4 -1.3200000* .2333329 .000 -1.792358 -.847642
5 .1000000 .2333329 .671 -.372358 .572358
6 -2.8500000* .2333329 .000 -3.322358 -2.377642
7 -2.1000000* .2694297 .000 -2.645432 -1.554568
8 -1.5400000* .2694297 .000 -2.085432 -.994568
9 -2.3800000* .2333329 .000 -2.852358 -1.907642
10 -1.3400000* .2333329 .000 -1.812358 -.867642
4 5 1.4200000* .1905155 .000 1.034321 1.805679
6 -1.5300000* .1905155 .000 -1.915679 -1.144321
7 -.7800000* .2333329 .002 -1.252358 -.307642
8 -.2200000 .2333329 .352 -.692358 .252358
9 -1.0600000* .1905155 .000 -1.445679 -.674321
10 -.0200000 .1905155 .917 -.405679 .365679
5 6 -2.9500000* .1905155 .000 -3.335679 -2.564321
7 -2.2000000* .2333329 .000 -2.672358 -1.727642
8 -1.6400000* .2333329 .000 -2.112358 -1.167642
9 -2.4800000* .1905155 .000 -2.865679 -2.094321
10 -1.4400000* .1905155 .000 -1.825679 -1.054321
6 7 .7500000* .2333329 .003 .277642 1.222358
8 1.3100000* .2333329 .000 .837642 1.782358
9 .4700000* .1905155 .018 .084321 .855679
10 1.5100000* .1905155 .000 1.124321 1.895679
7 8 .5600000* .2694297 .044 .014568 1.105432
9 -.2800000 .2333329 .238 -.752358 .192358
  226
10 .7600000* .2333329 .002 .287642 1.232358
8 9 -.8400000* .2333329 .001 -1.312358 -.367642
10 .2000000 .2333329 .397 -.272358 .672358
9 10 1.0400000* .1905155 .000 .654321 1.425679
*. The mean difference is significant at the 0.05 level. 
**. C1: silk scaffold only at day 1; C2: cell sheet-silk scaffold under static culture; C3: cell sheet-silk 
scaffold cultured in bioreactor; C4: silk scaffold only after 20 days in culture medium; C5: silk scaffold 
only after 20 days in bioreactor; C6: sponge scaffold only at day 1; C7: cell sheet-sponge scaffold under 
static culture; C8: cell sheet-sponge scaffold cultured in bioreactor; C9: sponge scaffold only after 20 
days in culture medium; C4: sponge scaffold only after 20 days in bioreactor. 
